UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2020

OR

TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File No. 001-35806

 

The ExOne Company

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

46-1684608

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

127 Industry Boulevard

North Huntingdon, Pennsylvania 15642

(Address of principal executive offices) (Zip Code)

(724) 863-9663

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of class

Trading symbol

Name of exchange on which registered

Common stock

XONE

The Nasdaq Stock Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

 

 

 

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

As of May 7, 2020, 16,455,000 shares of common stock, par value $0.01, were outstanding.

 

 

 

 


PART I – FINANCIAL INFORMATION

Item 1.     Financial Statements.

The ExOne Company and Subsidiaries

Condensed Statement of Consolidated Operations and Comprehensive Loss (Unaudited)

(in thousands, except per-share amounts)

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Revenue

 

$

13,383

 

 

$

9,579

 

Cost of sales

 

 

9,754

 

 

 

6,937

 

Gross profit

 

 

3,629

 

 

 

2,642

 

Operating expenses

 

 

 

 

 

 

 

 

Research and development

 

 

2,476

 

 

 

2,432

 

Selling, general and administrative

 

 

6,163

 

 

 

5,423

 

Gain from sale-leaseback of property and equipment

 

 

(1,462

)

 

 

 

 

 

 

7,177

 

 

 

7,855

 

Loss from operations

 

 

(3,548

)

 

 

(5,213

)

Other (income) expense

 

 

 

 

 

 

 

 

Interest expense

 

 

64

 

 

 

71

 

Other (income) expense  ̶  net

 

 

(190

)

 

 

12

 

 

 

 

(126

)

 

 

83

 

Loss before income taxes

 

 

(3,422

)

 

 

(5,296

)

Provision (benefit) for income taxes

 

 

226

 

 

 

(800

)

Net loss

 

$

(3,648

)

 

$

(4,496

)

Net loss per common share:

 

 

 

 

 

 

 

 

Basic

 

$

(0.22

)

 

$

(0.28

)

Diluted

 

$

(0.22

)

 

$

(0.28

)

Comprehensive loss:

 

 

 

 

 

 

 

 

Net loss

 

$

(3,648

)

 

$

(4,496

)

Other comprehensive loss:

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

(838

)

 

 

(776

)

Comprehensive loss

 

$

(4,486

)

 

$

(5,272

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2


The ExOne Company and Subsidiaries

Condensed Consolidated Balance Sheet (Unaudited)

(in thousands, except per-share and share amounts)

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

16,813

 

 

$

5,265

 

Restricted cash

 

 

508

 

 

 

978

 

Accounts receivable  ̶  net

 

 

4,954

 

 

 

6,522

 

Current portion of net investment in sales-type leases

 

 

289

 

 

 

213

 

Inventories  ̶  net

 

 

21,653

 

 

 

19,770

 

Prepaid expenses and other current assets

 

 

2,787

 

 

 

2,182

 

Total current assets

 

 

47,004

 

 

 

34,930

 

Property and equipment  ̶  net

 

 

20,720

 

 

 

38,895

 

Operating lease right-of-use assets

 

 

4,789

 

 

 

432

 

Net investment in sales-type leases  ̶  net of current portion

 

 

712

 

 

 

738

 

Other noncurrent assets

 

 

244

 

 

 

371

 

Total assets

 

$

73,469

 

 

$

75,366

 

Liabilities

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Current portion of long-term debt

 

$

155

 

 

$

153

 

Accounts payable

 

 

4,385

 

 

 

5,818

 

Accrued expenses and other current liabilities

 

 

4,590

 

 

 

6,942

 

Current portion of operating lease liabilities

 

 

1,684

 

 

 

158

 

Current portion of contract liabilities

 

 

13,646

 

 

 

11,846

 

Total current liabilities

 

 

24,460

 

 

 

24,917

 

Long-term debt  ̶  net of current portion

 

 

1,171

 

 

 

1,211

 

Operating lease liabilities  ̶  net of current portion

 

 

3,105

 

 

 

274

 

Contract liabilities  ̶  net of current portion

 

 

230

 

 

 

286

 

Other noncurrent liabilities

 

 

115

 

 

 

96

 

Total liabilities

 

 

29,081

 

 

 

26,784

 

Contingencies and commitments

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

 

Common stock, $0.01 par value, 200,000,000 shares authorized,

   16,386,487 (2020) and 16,346,960 (2019) shares issued and outstanding

 

 

164

 

 

 

163

 

Additional paid-in capital

 

 

177,141

 

 

 

176,850

 

Accumulated deficit

 

 

(120,596

)

 

 

(116,948

)

Accumulated other comprehensive loss

 

 

(12,321

)

 

 

(11,483

)

Total stockholders' equity

 

 

44,388

 

 

 

48,582

 

Total liabilities and stockholders' equity

 

$

73,469

 

 

$

75,366

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3


The ExOne Company and Subsidiaries

Condensed Statement of Consolidated Cash Flows (Unaudited)

(in thousands)

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Operating activities

 

 

 

 

 

 

 

 

Net loss

 

$

(3,648

)

 

$

(4,496

)

Adjustments to reconcile net loss to net cash used for operations:

 

 

 

 

 

 

 

 

Depreciation

 

 

923

 

 

 

1,165

 

Equity-based compensation

 

 

292

 

 

 

439

 

Amortization of debt issuance costs

 

 

19

 

 

 

23

 

Provision (recoveries) for bad debts  ̶  net

 

 

51

 

 

 

(73

)

Provision for slow-moving, obsolete and lower of cost or

   net realizable value inventories  ̶  net

 

 

22

 

 

 

107

 

Foreign exchange (gains) losses on intercompany transactions  ̶  net

 

 

(165

)

 

 

(11

)

Gain from sale-leaseback of property and equipment

 

 

(1,462

)

 

 

 

Gain from disposal of property and equipment  ̶  net

 

 

(2

)

 

 

 

Deferred income taxes

 

 

195

 

 

 

 

Changes in assets and liabilities, excluding effects of foreign currency

   translation adjustments:

 

 

 

 

 

 

 

 

Decrease in accounts receivable

 

 

1,487

 

 

 

2,877

 

(Increase) decrease in net investment in sales-type leases

 

 

(50

)

 

 

87

 

Increase in inventories

 

 

(2,146

)

 

 

(1,576

)

Increase in prepaid expenses and other assets

 

 

(672

)

 

 

(509

)

Decrease in accounts payable

 

 

(1,408

)

 

 

(793

)

Decrease in accrued expenses and other liabilities

 

 

(24

)

 

 

(1,748

)

Increase in contract liabilities

 

 

1,849

 

 

 

3,122

 

Net cash used for operating activities

 

 

(4,739

)

 

 

(1,386

)

Investing activities

 

 

 

 

 

 

 

 

Capital expenditures

 

 

(338

)

 

 

(347

)

Proceeds from sale of property and equipment

 

 

16,228

 

 

 

 

Net cash provided by (used for) investing activities

 

 

15,890

 

 

 

(347

)

Financing activities

 

 

 

 

 

 

 

 

Payments on long-term debt

 

 

(39

)

 

 

(36

)

Proceeds from exercise of employee stock options

 

 

 

 

 

165

 

Taxes related to the net share settlement of equity-based awards

 

 

 

 

 

(68

)

Other

 

 

(3

)

 

 

(5

)

Net cash (used for) provided by financing activities

 

 

(42

)

 

 

56

 

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

 

 

(31

)

 

 

(121

)

Net change in cash, cash equivalents, and restricted cash

 

 

11,078

 

 

 

(1,798

)

Cash, cash equivalents, and restricted cash at beginning of period

 

 

6,243

 

 

 

9,140

 

Cash, cash equivalents, and restricted cash at end of period

 

$

17,321

 

 

$

7,342

 

Supplemental disclosure of noncash investing and financing activities

 

 

 

 

 

 

 

 

Transfer of internally developed 3D printing machines from inventories to

   property and equipment for internal use or leasing activities

 

$

852

 

 

$

819

 

Transfer of internally developed 3D printing machines from property

   and equipment to inventories for sale

 

$

823

 

 

$

 

Property and equipment included in accounts payable

 

$

56

 

 

$

23

 

Property and equipment included in accrued expenses and other current liabilities

 

$

 

 

$

7

 

Debt issuance costs included in accounts payable

 

$

41

 

 

$

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4


The ExOne Company and Subsidiaries

Condensed Statement of Changes in Consolidated Stockholders’ Equity (Unaudited)

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

other

 

 

Total

 

 

 

Common stock

 

 

Additional

 

 

Accumulated

 

 

comprehensive

 

 

stockholders'

 

 

 

Shares

 

 

$

 

 

paid-in capital

 

 

deficit

 

 

loss

 

 

equity

 

Balance at December 31, 2018

 

 

16,234

 

 

$

162

 

 

$

175,214

 

 

$

(101,853

)

 

$

(10,748

)

 

$

62,775

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(4,496

)

 

 

 

 

 

(4,496

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(776

)

 

 

(776

)

Equity-based compensation

 

 

 

 

 

 

 

 

439

 

 

 

 

 

 

 

 

 

439

 

Exercise of employee stock options

 

 

23

 

 

 

1

 

 

 

164

 

 

 

 

 

 

 

 

 

165

 

Taxes related to the net share settlement of

   equity-based awards

 

 

 

 

 

 

 

 

(68

)

 

 

 

 

 

 

 

 

(68

)

Common stock issued from equity incentive plan

 

 

28

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at March 31, 2019

 

 

16,285

 

 

$

163

 

 

$

175,749

 

 

$

(106,349

)

 

$

(11,524

)

 

$

58,039

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2019

 

 

16,347

 

 

$

163

 

 

$

176,850

 

 

$

(116,948

)

 

$

(11,483

)

 

$

48,582

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(3,648

)

 

 

 

 

 

(3,648

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(838

)

 

 

(838

)

Equity-based compensation

 

 

 

 

 

1

 

 

 

291

 

 

 

 

 

 

 

 

 

292

 

Common stock issued from equity incentive plan

 

 

39

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at March 31, 2020

 

 

16,386

 

 

$

164

 

 

$

177,141

 

 

$

(120,596

)

 

$

(12,321

)

 

$

44,388

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5


The ExOne Company and Subsidiaries

Notes to the Condensed Consolidated Financial Statements (Unaudited)

(dollars in thousands, except per-share and share amounts)

Note 1. Basis of Presentation

Organization

The ExOne Company (“ExOne”) is a corporation organized under the laws of the state of Delaware. ExOne was formed on January 1, 2013, when The Ex One Company, LLC, a Delaware limited liability company, merged with and into a Delaware corporation, which survived and changed its name to The ExOne Company (the “Reorganization”). As a result of the Reorganization, The Ex One Company, LLC became ExOne, the common and preferred interest holders of The Ex One Company, LLC became holders of common stock and preferred stock, respectively, of ExOne, and the subsidiaries of The Ex One Company, LLC became the subsidiaries of ExOne. The condensed consolidated financial statements include the accounts of ExOne, its wholly-owned subsidiaries, ExOne Americas LLC (United States); ExOne GmbH (Germany); ExOne Property GmbH (Germany); and ExOne KK (Japan). Collectively, the consolidated group is referred to as the “Company”.

The Company filed a registration statement on Form S-3 (No. 333-223690) with the Securities and Exchange Commission on March 15, 2018. The purpose of the Form S-3 was to register various equity and debt securities. Subsidiaries of the Company are co-registrants with the Company (“Subsidiary Guarantors”), and the registration statement registered guarantees of debt securities by one or more of the Subsidiary Guarantors. The Subsidiary Guarantors are 100% owned by the Company and any guarantees by the Subsidiary Guarantors will be full and unconditional. There have been no transactions undertaken subject to the Form S-3 since its initial filing.

Basis of Presentation

The condensed consolidated financial statements of the Company are unaudited. The condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, considered necessary by management to fairly state the results of operations, financial position and cash flows of the Company. All material intercompany transactions and balances have been eliminated in consolidation. The results reported in these condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the entire year. The December 31, 2019 condensed consolidated balance sheet data was derived from the audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). This Quarterly Report on Form 10-Q should be read in connection with the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, which includes all disclosures required by GAAP.

The preparation of these condensed consolidated financial statements requires the Company to make certain judgments, estimates and assumptions regarding uncertainties that affect the reported amounts of assets, liabilities, revenue and expenses and related disclosure of contingent assets and liabilities. Areas that require significant judgments, estimates and assumptions include accounting for accounts receivable (including the allowance for doubtful accounts); inventories (including the allowance for slow-moving and obsolete inventories); product warranty reserves; contingencies; income taxes (including the valuation allowance on certain deferred tax assets and liabilities for uncertain tax positions); equity-based compensation (including the valuation of certain equity-based compensation awards issued by the Company); and testing for impairment of long-lived assets (including the identification of asset groups by management, estimates of future cash flows of identified asset groups and fair value estimates used in connection with assessing the valuation of identified asset groups). The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

Certain amounts relating to operating lease right-of-use assets ($432), current portion of operating lease liabilities ($158) and operating lease liabilities – net of current portion ($274) in the accompanying condensed consolidated balance sheet at December 31, 2019, have been reclassified from other noncurrent assets, accrued expenses and other current liabilities and other noncurrent liabilities, respectively, to conform to current period presentation.

Certain amounts relating to foreign exchange (gains) losses on intercompany transactions – net, for 2019 ($11) in the accompanying condensed statement of consolidated cash flows have been reclassified from effect of exchange rate changes on cash, cash equivalents, and restricted cash, to conform to current period presentation.

COVID-19

In March 2020, the World Health Organization declared the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide. The impact of the COVID-19 global pandemic and related economic, business and market disruptions are evolving rapidly, and their effects are uncertain. Other than a temporary closure of the Company’s North Huntingdon, Pennsylvania facility effective for the period from March 23 through March 30, 2020, the Company’s operations were not materially affected by the COVID-19 outbreak as of and for the three months ended March 31, 2020. Beginning in March 2020, restrictions imposed by various governmental authorities on international shipping and travel have caused a disruption to the timing of shipment of the Company’s 3D printing machines and the Company’s ability to complete installations of 3D printing machines. The duration and severity of the outbreak and its long-term impact on the Company’s business are uncertain at this time.

6


The Company is unable to predict the impact that COVID-19 will have on its future financial position, results of operations and cash flows.

Recently Accounting Pronouncements

The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (the “FASB”). Recently issued ASUs not listed below either were assessed and determined to be not applicable or are currently expected to have no impact on the consolidated financial statements of the Company.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses.” This ASU added a new impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses. The CECL model applies to most debt instruments, trade receivables, lease receivables, financial guarantee contracts, and other loan commitments. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. As a smaller reporting company pursuant to Rule 12b-2 of the Securities Exchange Act of 1934, as amended, these changes become effective for the Company on January 1, 2023. Management is currently evaluating the potential impact of these changes on the consolidated financial statements of the Company.

Note 2. Liquidity

The Company has incurred a net loss in each of its annual periods since its inception. As shown in the accompanying condensed statement of consolidated operations and comprehensive loss, the Company incurred a net loss of $3,648 for the three months ended March 31, 2020. At March 31, 2020, the Company had $16,813 in unrestricted cash and cash equivalents.

In addition to its unrestricted cash and cash equivalents, the Company also has access to additional capital through its $10,000 related party revolving credit facility (Note 12). Also, on April 18, 2020, the Company received additional unrestricted cash proceeds of $2,194 in connection with a Paycheck Protection Program loan (Note 19).

Since its inception, the Company has received cumulative unrestricted net proceeds from the sale of its common stock (through its initial public offering and subsequent secondary offerings) of $168,361 to fund its operations. The Company maintains additional access to capital through its active shelf registration statement (Note 1) which allows for the sale of various equity or debt instruments up to an aggregate amount of $125,000. Future sales of securities through the Company’s active shelf registration are dependent on market conditions which may restrict the timing and extent of any future offering of securities by the Company.

The Company has previously exhibited its ability to modify its operating structure and support its liquidity position through various restructuring and other actions, including its 2018 global cost realignment program. In response to adverse market conditions associated with the COVID-19 global pandemic, beginning in March 2020 and through April 2020, the Company initiated various cost savings actions including a mix of employee terminations, furloughs and pay rate reductions, as well as reductions in consulting and other expenses, all in an effort to conserve cash and maintain adequate liquidity.  

Management believes that the Company’s existing capital resources will be sufficient to support the Company’s operating plan. If management anticipates that the Company’s actual results will differ from its operating plan, management believes it has sufficient capabilities to enact cost savings measures to preserve capital (in addition to those further described above). The Company may also seek to raise additional capital to support its growth through additional debt, equity or other alternatives (including asset sales) or a combination thereof.

Note 3. Accumulated Other Comprehensive Loss

The following table summarizes changes in the components of accumulated other comprehensive loss for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Foreign currency translation adjustments

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$

(11,483

)

 

$

(10,748

)

Other comprehensive loss

 

 

(838

)

 

 

(776

)

Balance at end of period

 

$

(12,321

)

 

$

(11,524

)

 

Foreign currency translation adjustments consist of the effect of translation of functional currency financial statements (denominated in the euro and Japanese yen) to the reporting currency of the Company (United States dollar) and certain long-term intercompany transactions between subsidiaries for which settlement is not planned or anticipated in the foreseeable future.

There were no tax impacts related to income tax rate changes and no amounts were reclassified to earnings for either of the periods presented.

7


Note 4. Loss Per Share

The Company presents basic and diluted loss per common share amounts. Basic loss per common share is calculated by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the applicable period. Diluted loss per common share is calculated by dividing net loss available to common stockholders by the weighted average number of common shares and common equivalent shares outstanding during the applicable period.

As the Company incurred a net loss during each of the three months ended March 31, 2020 and 2019, basic average common shares outstanding and diluted average common shares outstanding were the same because the effect of potential shares of common stock, including stock options (838,383 – 2020 and 594,539 – 2019) and unvested restricted stock issued (66,513 – 2020 and 69,501 – 2019), was anti-dilutive.

The information used to compute basic and diluted net loss per common share was as follows for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Net loss

 

$

(3,648

)

 

$

(4,496

)

Weighted average shares outstanding (basic and diluted)

 

 

16,369,390

 

 

 

16,253,104

 

Net loss per common share:

 

 

 

 

 

 

 

 

Basic

 

$

(0.22

)

 

$

(0.28

)

Diluted

 

$

(0.22

)

 

$

(0.28

)

 

Note 5. Revenue

The Company derives revenue from the sale of 3D printing machines and 3D printed and other products, materials and services. Revenue is recognized when the Company satisfies its performance obligation(s) under a contract (either implicit or explicit) by transferring the promised product or service to a customer either when (or as) the customer obtains control of the product or service. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. A contract’s transaction price is allocated to each distinct performance obligation.

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales, value add, and other taxes collected from customers and remitted to governmental authorities are accounted for on a net (excluded from revenue) basis. Shipping and handling costs are included in cost of sales.

Certain of the Company’s contracts with customers provide for multiple performance obligations. Sales of 3D printing machines may also include optional equipment, materials, replacement components and services (installation, training and other services, including maintenance services and/or an extended warranty). Certain other contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation using the Company’s best estimate of stand-alone selling price for each distinct product or service in the contract, which is generally based on an observable price.

The Company’s revenue from products is transferred to customers at a point in time. The Company’s contracts for 3D printing machines generally include substantive customer acceptance provisions. Revenue under these contracts is recognized when customer acceptance provisions have been satisfied. For all other product sales, the Company recognizes revenue at the point in time in which the customer obtains control of the product, which is generally when product title passes to the customer upon delivery. In limited cases, title does not transfer and revenue is not recognized until the customer has received the products at its physical location.

The Company’s revenue from service arrangements includes deferred maintenance contracts and extended warranties that can be purchased at the customer’s option. The Company generally provides a standard one-year warranty on the Company’s 3D printing machines, which is considered an assurance type warranty, and not considered a separate performance obligation (Note 9). Revenue associated with deferred maintenance contracts is generally recognized at a point in time when the related services are performed where sufficient historical evidence indicates that the costs of performing the related services under the contract are not incurred on a straight-line basis, with such revenue recognized in proportion to the costs expected to be incurred. Revenue associated with extended warranties is generally recognized over time on a straight-line basis over the related contract period.

The Company’s revenue from service arrangements includes contracts with the Federal government under fixed-fee, cost reimbursable and time and materials arrangements (certain of which may have periods of performance greater than one year). Revenue under these contracts is generally recognized over time using an input measure based upon labor hours incurred and provisional rates provided under the contracts. As such, the nature of these contracts may give rise to variable consideration, primarily based upon completion of the Company’s annual Incurred Cost Submission filing as required by the Federal government. Historically, amounts associated with variable consideration have not been significant.

8


The Company’s revenue from service arrangements includes certain research and development services. Revenue under research and development service contracts is generally recognized over time using an output measure, specifically units or parts delivered, based upon certain customer acceptance and delivery requirements. Revenue recognized over time using an output measure is not significant.

The following table summarizes the Company’s revenue by product group for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

2019

 

3D printing machines

 

$

6,317

 

 

$

3,329

 

3D printed and other products, materials and services

 

 

7,066

 

 

 

6,250

 

 

 

$

13,383

 

 

$

9,579

 

 

Revenue from 3D printing machines includes leasing revenue whereby the Company is the lessor of 3D printing machines to its customers. Leasing revenue is accounted for under ASU 2016-02 (Note 10).

The timing of revenue recognition, billings and cash collections results in billed receivables, unbilled receivables (contract assets) and deferred revenue and customer prepayments (contract liabilities) in the accompanying condensed consolidated balance sheet. The Company considers a number of factors in its evaluation of the creditworthiness of its customers, including past due amounts, past payment history, and current economic conditions. For 3D printing machines, the Company’s terms of sale vary by transaction. To reduce credit risk in connection with 3D printing machine sales, the Company may, depending upon the circumstances, require customers to furnish letters of credit or bank guarantees or to provide advanced payment (either partial or in full). For 3D printed and other products and materials, the Company’s terms of sale generally require payment within 30 to 60 days after delivery, although the Company also recognizes that longer payment periods are customary in certain countries where it transacts business. Service arrangements are generally billed in accordance with specific contract terms and are typically billed in advance or in proportion to performance of the related services.

For the three months ended March 31, 2020, the Company recognized revenue of $3,902 related to contract liabilities at January 1, 2020. There were no other significant changes in contract liabilities during the three months ended March 31, 2020. Contract assets are not significant.

As of March 31, 2020, the Company has approximately $33,800 of remaining performance obligations (including contract liabilities), which is also referred to as backlog, of which approximately $29,800 is expected to be fulfilled during the next twelve months notwithstanding uncertainty related to the impact of the COVID-19 global pandemic (Note 1) including, but not limited to, international shipping and travel restrictions brought about by the global pandemic which could have an adverse effect on the timing of delivery of products and/or services to customers.

The Company has elected to apply the practical expedient associated with incremental costs of obtaining a contract, and as such, sales commission expense is generally expensed when incurred because the amortization period would be one year or less. These costs are recorded within selling, general and administrative expenses.

Accounts receivable and net investment in sales-type leases (Note 10) are reported at their net realizable value. The Company carries its investment in sales-type leases based on discounting the minimum lease payments by the interest rate implicit in the lease and less an allowance for doubtful accounts. The Company’s estimate of the allowance for doubtful accounts related to accounts receivable and net investment in sales-type leases is based on the Company’s evaluation of customer accounts with past-due outstanding balances or specific accounts for which it has information that the customer may be unable to meet its financial obligations. Based upon review of these accounts, and management’s analysis and judgment, the Company records a specific allowance for that customer’s accounts receivable or net investment in sales-type lease balance to reduce the outstanding balance to the amount expected to be collected. The allowance is re-evaluated and adjusted periodically as additional information is received that impacts the allowance amount reserved. At March 31, 2020 and December 31, 2019, the allowance for doubtful accounts was $548 and $508, respectively. During the three months ended March 31, 2020 and 2019, the Company recorded a net provision (recoveries) for bad debts of $51 and ($73), respectively.

9


Note 6. Cash, Cash Equivalents, and Restricted Cash

The following provides a reconciliation of cash, cash equivalents, and restricted cash as reported in the accompanying condensed consolidated balance sheet to the same such amounts shown in the accompanying condensed statement of consolidated cash flows as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Cash and cash equivalents

 

$

16,813

 

 

$

5,265

 

Restricted cash

 

 

508

 

 

 

978

 

Cash, cash equivalents, and restricted cash

 

$

17,321

 

 

$

6,243

 

 

Restricted cash at both March 31, 2020 and December 31, 2019 included $508 associated with cash collateral required by a United States bank to offset certain short-term, unsecured lending commitments associated with the Company’s corporate credit card program. 

Restricted cash at December 31, 2019 included $470 associated with cash collateral required by a German bank for short-term financial guarantees issued by ExOne GmbH in connection with certain commercial transactions requiring security. Refer to Note 11 for further discussion related to an amendment to this cash collateral requirement effective in February 2020.

Each of the balances described above are considered legally restricted by the Company.

Note 7. Inventories

Inventories consisted of the following as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Raw materials and components

 

$

9,374

 

 

$

8,841

 

Work in process

 

 

5,284

 

 

 

4,922

 

Finished goods

 

 

6,995

 

 

 

6,007

 

 

 

$

21,653

 

 

$

19,770

 

 

Raw materials and components consist of consumable materials and component parts and subassemblies associated with 3D printing machine manufacturing and support activities. Work in process consists of 3D printing machines and other products in varying stages of completion. Finished goods consist of 3D printing machines and other products prepared for sale in accordance with customer specifications.

At March 31, 2020 and December 31, 2019, the allowance for slow-moving and obsolete inventories was $3,370 and $3,443, respectively, and has been reflected as a reduction to inventories (principally raw materials and components). The following table summarizes changes in the allowance for slow-moving and obsolete inventories for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Balance at beginning of period

 

$

3,443

 

 

$

4,143

 

Provision for slow-moving and obsolete inventories  ̶  net

 

 

22

 

 

 

107

 

Reductions for physical disposal (sale or scrap) of previously reserved

   amounts

 

 

(36

)

 

 

 

Foreign currency translation adjustments

 

 

(59

)

 

 

(73

)

Balance at end of period

 

$

3,370

 

 

$

4,177

 

 

10


Note 8. Property and Equipment

Property and equipment consisted of the following as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

Economic Life

 

 

2020

 

 

2019

 

 

(in years)

Land

 

$

3,378

 

 

$

6,980

 

 

N/A

Buildings and related improvements

 

 

9,989

 

 

 

25,675

 

 

5 - 40

Machinery and equipment

 

 

19,208

 

 

 

19,531

 

 

3 - 20

Other

 

 

6,049

 

 

 

7,086

 

 

3 - 20

 

 

 

38,624

 

 

 

59,272

 

 

 

Less: Accumulated depreciation

 

 

(18,306

)

 

 

(21,478

)

 

 

 

 

 

20,318

 

 

 

37,794

 

 

 

Construction-in-progress

 

 

402

 

 

 

1,101

 

 

 

Property and equipment  ̶  net

 

$

20,720

 

 

$

38,895

 

 

 

 

For the three months ended March 31, 2020 and 2019, depreciation expense was $923 and $1,165, respectively.

On February 18, 2020, the Company completed a sale-leaseback transaction associated with its European headquarters and operating facility in Gersthofen, Germany (Note 10). As a result of the completion of this transaction, the Company derecognized $17,282 in net property and equipment during the three months ended March 31, 2020. Sale of the facility resulted in a gain of $1,462 during the three months ended March 31, 2020.

During the three months ended March 31, 2020, as a result of continued operating losses and cash flow deficiencies, the Company identified a triggering event requiring a test for the recoverability of long-lived assets held and used at the asset group level. Assessing the recoverability of long-lived assets held and used requires significant judgments and estimates by management.

For purposes of testing long-lived assets for recoverability, the Company operates as three separate asset groups: United States, Europe and Japan. In assessing the recoverability of long-lived assets held and used, the Company determined the carrying amount of long-lived assets held and used to be in excess of the estimated future undiscounted net cash flows of the related assets. The Company proceeded to determine the fair value of its long-lived assets held and used, principally through use of the market approach. The Company’s use of the market approach included consideration of market transactions for comparable assets. Management concluded that the fair value of long-lived assets held and used exceeded their carrying value, and as such, no impairment loss was recorded.   

A significant decrease in the market price of a long-lived asset, adverse change in the use or condition of a long-lived asset, adverse change in the business climate or legal or regulatory factors impacting a long-lived asset and continued operating losses and cash flow deficiencies associated with a long-lived asset, among other indicators, could cause a future assessment to be performed which may result in an impairment of long-lived assets held and used, which could result in a material adverse effect on the financial position and results of operations of the Company.

Note 9. Product Warranty Reserves

Substantially all of the Company’s 3D printing machines are covered by a standard one-year warranty. Generally, at the time of sale, a liability is recorded (with an offset to cost of sales) based upon the expected cost of replacement parts and labor to be incurred over the life of the standard warranty. Expected cost is estimated using historical experience for similar products. The Company periodically assesses the adequacy of the product warranty reserves based on changes in these factors and records any necessary adjustments if actual experience indicates that adjustments are necessary. Future claims experience could be materially different from prior results because of the introduction of new, more complex products, a change in the Company’s warranty policy in response to industry trends, competition or other external forces, or manufacturing changes that could impact product quality. In the event that the Company determines that its current or future product repair and replacement costs exceed estimates, an adjustment to these reserves would be charged to cost of sales in the period such a determination is made.

11


The following table summarizes changes in product warranty reserves, which amounts were reflected in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Balance at beginning of period

 

$

866

 

 

$

1,670

 

     Provisions for new issuances

 

 

276

 

 

 

146

 

     Payments

 

 

(344

)

 

 

(391

)

     Reserve adjustments

 

 

20

 

 

 

(159

)

     Foreign currency translation adjustments

 

 

(8

)

 

 

(15

)

Balance at end of period

 

$

810

 

 

$

1,251

 

 

Note 10. Leases

Lessee

The Company leases facilities, machinery and other equipment and vehicles under operating lease arrangements (with initial terms greater than twelve months), expiring in various years through 2026. In addition, the Company leases certain equipment and vehicles under finance lease arrangements, which are not significant.

For all operating lease arrangements (with the exception of short-term lease arrangements), the Company presents at the commencement date: a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. 

The Company has elected, as a practical expedient, not to separate non-lease components from lease components, and instead account for each separate component as a single lease component for all lease arrangements, as lessee. In addition, the Company has elected, as a practical expedient, not to apply lease recognition requirements to short-term lease arrangements, generally those with a lease term of less than twelve months, for all classes of underlying assets. In determination of the lease term, the Company considers the likelihood of lease renewal options and lease termination provisions. As a result, lease payments under these short-term lease arrangements are recognized in the accompanying condensed statement of consolidated operations and comprehensive loss on a straight-line basis over the lease term.  

The Company uses its incremental borrowing rate in determining the present value of lease payments, as the implicit rate of the lease arrangements is generally not readily determinable.

Through July 2019, certain of the Company’s operating lease arrangements were with related parties under common control (Note 17). Lease cost under operating lease agreements with related parties, included within short-term lease cost below, was $12 for the three months ended March 31, 2019.

Future minimum lease payments of operating lease arrangements (with initial terms greater than twelve months) at March 31, 2020, were as follows:

 

2020

 

$

1,419

 

2021

 

 

1,861

 

2022

 

 

1,827

 

2023

 

 

23

 

2024

 

 

11

 

Thereafter

 

 

2

 

Total minimum lease payments

 

 

5,143

 

Less: Present value discount

 

 

(354

)

Total operating lease liabilities

 

$

4,789

 

 

For the three months ended March 31, 2020 and 2019, lease cost under operating lease arrangements was $504 and $113, including $31 and $65 relating to short-term lease arrangements, respectively.

12


Supplemental information related to operating lease arrangements was as follows as of and for the three months ended March 31, 2020:

 

Operating lease right-of-use assets

 

$

4,789

 

Current portion of operating lease liabilities

 

$

1,684

 

Operating lease liabilities  ̶  net of current portion

 

$

3,105

 

Right-of-use assets obtained in exchange for new operating lease liabilities

 

$

4,785

 

Cash paid for amounts included in the measurement of operating lease liabilities

 

$

473

 

Weighted average remaining lease term (in years)

 

 

2.8

 

Weighted average discount rate

 

 

5.1

%

On December 10, 2019, ExOne Property GmbH and ExOne GmbH, the German subsidiaries of the Company (the “German Subsidiaries”), entered into a purchase agreement (the “Purchase Agreement”) with Solidas Immobilien und Grundbesitz GmbH, a private, unaffiliated German real estate investor (the “Buyer”), for the sale of the Company’s European headquarters and operating facility in Gersthofen, Germany (the “Facility”) for a purchase price of approximately $18,500 (€17,000), of which approximately $2,200 (€2,000) was received prior to December 31, 2019. Concurrent with the execution of the Purchase Agreement, ExOne GmbH and the Buyer entered into a rental contract (the “Lease”) for the leaseback of the Facility for an initial aggregate annual rent totaling approximately $1,700 (€1,500), plus applicable taxes, which is fixed during the initial three-year term and is subject to adjustment on an annual basis (in accordance with the consumer price index for Germany) during the two five-year option extension periods. The sale-leaseback transaction closed on February 18, 2020. In connection with the completion of the sale-leaseback transaction, the Company recorded an operating lease right-of-use asset and corresponding operating lease liability of $4,605, which was representative of the present value of future minimum lease payments over the initial three-year term, as there were no penalties or other factors associated with the lease that result in reasonable assurance of its extension at inception.

Lessor

The Company leases machinery and equipment to customers (principally 3D printing machines and related equipment) under lease arrangements classified as either operating leases or sales-type leases. The Company’s operating lease arrangements have initial terms generally ranging from one to five years, certain of which may contain extension or termination clauses, or both. Such operating lease arrangements also generally include a purchase option to acquire the related machinery and equipment at the end of the lease term for either a fixed amount as determined at inception, or a subsequently negotiated fair market value. At March 31, 2020, the Company estimated that the total fair market value significantly exceeded the related net book value of the machinery and equipment held under the Company’s operating lease arrangements. The Company’s sales-type lease arrangements generally include transfer of ownership at the end of the lease term, and as such, the Company’s net investment in sale-type lease arrangements presented in the Company’s accompanying condensed consolidated balance sheet generally does not include an amount of unguaranteed residual value.

For certain of its arrangements, the Company separates and allocates (Note 5) certain non-lease components (principally maintenance services) from lease components. Sales, value add, and other taxes collected from customers and remitted to governmental authorities are accounted for on a net (excluded from lease income) basis. In determination of the lease term, the Company considers the likelihood of lease renewal options and lease termination provisions. Additionally, certain of the Company’s lease arrangements do not qualify as sale-type leases, as collectability is not reasonably assured.

The Company recognized the following components under operating and sales-type lease arrangements in the accompanying condensed statement of consolidated operations and comprehensive loss for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

 

 

Operating

 

 

Sales-type

 

 

Operating

 

 

Sales-type

 

Revenue

 

$

208

 

 

$

 

 

$

320

 

 

$

 

Interest income(a)

 

$

 

 

$

18

 

 

$

 

 

$

28

 

 

(a)

Interest income relating to sales-type leases is recorded as a component of revenue in the accompanying condensed statement of consolidated operations and comprehensive loss for each of the periods presented.

13


The Company’s net investment in sales-type leases consisted of the following as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Future minimum lease payments receivable

 

$

1,624

 

 

$

1,595

 

Less: Allowance for doubtful accounts

 

 

(415

)

 

 

(424

)

Net future minimum lease payments receivable

 

 

1,209

 

 

 

1,171

 

Less: Unearned interest income

 

 

(208

)

 

 

(220

)

   Net investment in sales-type leases

 

$

1,001

 

 

$

951

 

 

Future minimum lease payments of non-cancellable operating and sales-type lease arrangements at March 31, 2020 were as follows:

 

 

 

Operating

 

 

Sales-type

 

2020

 

$

432

 

 

$

411

 

2021

 

 

48

 

 

 

427

 

2022

 

 

 

 

 

378

 

2023

 

 

 

 

 

408

 

2024

 

 

 

 

 

 

Thereafter

 

 

 

 

 

 

Total minimum lease payments

 

$

480

 

 

$

1,624

 

Less: Allowance for doubtful accounts

 

 

 

 

 

 

(415

)

Less: Present value discount

 

 

 

 

 

 

(208

)

Future minimum lease payments receivable

 

 

 

 

 

$

1,001

 

 

Note 11. Contingencies and Commitments

Contingencies

On March 1, 2018, the Company’s ExOne GmbH subsidiary notified Voxeljet AG that it had materially breached a 2003 Patent and Know-How Transfer Agreement and asserted its rights to set-off damages as a result of the breaches against the annual license fee due from the Company under the agreement. At this time, the Company cannot reasonably estimate a contingency, if any, related to this matter.

The Company is subject to various litigation, claims, and proceedings which have been or may be instituted or asserted from time to time in the ordinary course of business. Management does not believe that the outcome of any pending or threatened matters will have a material adverse effect, individually or in the aggregate, on the financial position, results of operations or cash flows of the Company.

Commitments

In the normal course of its operations, ExOne GmbH issues short-term financial guarantees and letters of credit to third parties in connection with certain commercial transactions requiring security through a credit facility with a German bank.

On February 24, 2020, ExOne GmbH entered into an amendment and replacement of its credit facility with a German bank. The credit facility amendments included the elimination of the overdraft credit and short-term loan features of the prior agreement and replaced them with an increased capacity amount of approximately $3,800 (€3,500) for the issuance of financial guarantees and letters of credit for commercial transactions requiring security. The cash collateral requirement for the issuance of financial guarantees and letters of credit for commercial transactions requiring security was eliminated for amounts up to approximately $1,100 (€1,000) as the amendment provided the German bank with a collateral interest in the accounts receivable of ExOne GmbH. Amounts in excess of approximately $1,100 (€1,000) continue to require cash collateral under the amended credit facility.

At March 31, 2020, total outstanding financial guarantees and letters of credit issued by ExOne GmbH under the amended credit facility were $863 (€785), with expiration dates ranging from October 2020 through February 2023. At December 31, 2019, total outstanding financial guarantees and letters of credit issued by ExOne GmbH under the former credit facility were $560 (€499).

 

14


Note 12. Related Party Revolving Credit Facility

On March 12, 2018, the Company and its ExOne Americas LLC and ExOne GmbH subsidiaries, as guarantors (collectively, the “Loan Parties”), entered into a Credit Agreement and related ancillary agreements with LBM Holdings, LLC (“LBM”), a company controlled by S. Kent Rockwell, who was the Executive Chairman of the Company (a related party) at such date and is currently Chairman of the Company, relating to a $15,000 revolving credit facility (the “Credit Agreement”) to provide additional funding to the Company for working capital and general corporate purposes. The Credit Agreement provided a credit facility for a term of three years (through March 12, 2021), bearing interest at a rate of one-month LIBOR plus an applicable margin of 500 basis points (6.8% at December 31, 2019 and 6.0% at March 31, 2020). The Credit Agreement required a commitment fee of 75 basis points, or 0.75%, on the unused portion of the facility, payable monthly in arrears. In addition, an up-front commitment fee of 125 basis points, or 1.25% ($188), was required at closing. Borrowings under the Credit Agreement were collateralized by the accounts receivable, inventories and machinery and equipment of the Loan Parties.

On February 18, 2020, the Loan Parties and LBM entered into a First Amendment to the Credit Agreement (the “Amendment”) which (i) reduced the available capacity under the revolving credit facility to $10,000, (ii) extended the term of the credit facility until March 31, 2024, (iii) increased the commitment fee to 100 basis points, or 1.00%, on the unused portion of the revolving credit facility, and (iv) provided a process for the replacement of the LIBOR index after 2021. In addition, the accounts receivable of ExOne GmbH no longer serve as collateral for borrowings under the amended revolving credit facility.

Borrowings under the credit facility are required to be made in minimum increments of $1,000. The Company may terminate or reduce the credit commitment at any time during the term of the amended Credit Agreement without penalty. The Company may also make prepayments against outstanding borrowings under the amended Credit Agreement at any time without penalty. At December 31, 2019 and March 31, 2020, the total estimated value of collateral was in significant excess of the maximum borrowing capacity under the credit facility.

The amended Credit Agreement contains several affirmative covenants including prompt payment of liabilities and taxes; maintenance of insurance, properties, and licenses; and compliance with laws. The amended Credit Agreement also contains several negative covenants including restricting the incurrence of certain additional debt; prohibiting future liens (other than permitted liens); prohibiting investment in third parties; limiting the ability to pay dividends; limiting mergers, acquisitions, and dispositions; and limiting the sale of certain property and equipment of the Loan Parties. The amended Credit Agreement does not contain any financial covenants. The amended Credit Agreement also contains events of default, including, but not limited to, cross-default to certain other debt, breaches of representations and warranties, change of control events and breaches of covenants.

The Company does not consider the Credit Agreement, as amended, indicative of a fair market value lending, as LBM was determined to be a related party based on common control by S. Kent Rockwell. S. Kent Rockwell is the indirect sole owner of LBM. Prior to execution, each of the Credit Agreement and the Amendment was reviewed and approved by the Audit Committee of the Board of Directors (the “Board”), in accordance with The ExOne Company Policy and Procedures with Respect to Related Person Transactions, and subsequently by a sub-committee of independent members of the Board. At the time of execution of the Credit Agreement, the available loan proceeds were deposited into an escrow account with an unrelated, third party financial institution acting as escrow agent pursuant to a separate Escrow Agreement by and among the parties. Loan proceeds held in escrow are available to the Company upon its submission to the escrow agent of a loan request. Such proceeds will not be available to LBM until payment in-full of the obligations under the amended Credit Agreement and termination of the amended Credit Agreement. Payments of principal and other obligations will be made to the escrow agent, while interest payments will be made directly to LBM. Provided there exists no potential default or event of default, the amended Credit Agreement and Escrow Agreement prohibit any acceleration of repayment of any amount outstanding under the amended Credit Agreement and prohibit termination of the amended Credit Agreement or withdrawal from escrow of any unused portion of the available loan proceeds.

There were no borrowings under the credit facility during the three months ended March 31, 2020 or 2019.

The Company incurred $265 in debt issuance costs associated with the inception of the credit facility (including the aforementioned up-front commitment fee paid at closing to LBM) and $41 in debt issuance costs associated with the Amendment.

During the three months ended March 31, 2020, the Company recorded interest expense relating to the credit facility of $45. Included in interest expense for the three months ended March 31, 2020 was $18 associated with amortization of debt issuance costs (resulting in $130 in remaining debt issuance costs at March 31, 2020, of which $33 was included in prepaid expenses and other current assets and $97 was included in other noncurrent assets in the accompanying consolidated balance sheet). Included in interest expense for the three months ended March 31, 2020 was $27 associated with the commitment fee on the unused portion of the revolving credit facility all of which was included in accounts payable in the accompanying consolidated balance sheet at March 31, 2020. In connection with the Company’s efforts to conserve cash as a result of the COVID-19 global pandemic, LBM agreed to defer cash payments of its commitment fee on the unused portion of the revolving credit facility to a future date (to be determined upon mutual agreement by the parties). There are no incremental interest or other fees to be incurred by the Company as a result of this deferral.

During the three months ended March 31, 2019, the Company recorded interest expense related to the credit facility of $50.

 

15


Note 13. Income Taxes

The provision (benefit) for income taxes for the three months ended March 31, 2020 and 2019 was $226 and ($800), respectively. The Company has completed a discrete period computation of its provision (benefit) for income taxes for each of the periods presented. The discrete period computation was required as a result of jurisdictions with losses before income taxes for which no tax benefit can be recognized and an inability to generate reliable estimates for results in certain jurisdictions as a result of inconsistencies in generating net operating profits (losses) in those jurisdictions.

The effective tax rate for the three months ended March 31, 2020 and 2019 was 6.6% (provision on a loss) and 15.1% (benefit on a loss), respectively. For the three months ended March 31, 2020, the effective tax rate differed from the United States federal statutory rate of 21.0% primarily due to net changes in valuation allowances for the period. For the three months ended March 31, 2019, the effective tax rate differed from the United States federal statutory rate of 21.0% primarily due to the reversal of previously recorded liabilities for uncertain tax positions (further described below) and net changes in valuation allowances for the period.

The Company has provided a valuation allowance for certain of its net deferred tax assets as a result of the Company not generating consistent net operating profits in certain jurisdictions in which it operates. As such, certain benefits from deferred taxes in the periods presented have been fully offset by changes in the valuation allowance for the related net deferred tax assets. The Company continues to assess its future taxable income by jurisdiction based on recent historical operating results, the expected timing of reversal of temporary differences, various tax planning strategies that the Company may be able to enact in future periods, the impact of potential operating changes on the business and forecast results from operations in future periods based on available information at the end of each reporting period. To the extent that the Company is able to reach the conclusion that net deferred tax assets are realizable based on any combination of the above factors in a single, or in multiple, taxing jurisdictions, a reversal of the related portion of the Company’s existing valuation allowances may occur.

A reconciliation of the beginning and ending amount of unrecognized tax benefits (including accrued interest and penalties) was as follows for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Balance at beginning of period

 

$

 

 

$

1,186

 

Additions based on tax positions related to the current year

 

 

 

 

 

 

Additions for tax positions of prior years

 

 

 

 

 

1

 

Reductions for tax positions of prior years

 

 

 

 

 

(1,075

)

Settlements

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

 

 

 

(10

)

Balance at end of period

 

$

 

 

$

102

 

 

The Company includes interest and penalties related to income taxes as a component of the provision (benefit) for income taxes in the accompanying condensed statement of consolidated operations and comprehensive loss. There were no such interest or penalties included in the provision (benefit) for income taxes for the three months ended March 31, 2020 or 2019.

At December 31, 2018, the Company’s ExOne GmbH (2010-2013) and ExOne Property GmbH (2013) subsidiaries were under examination by local taxing authorities in Germany. In January 2019, this examination was concluded by the local taxing authorities in Germany without significant adjustment to previously established tax positions. As a result, during the three months ended March 31, 2019, the Company recorded a reversal of certain of its previously recorded liabilities for uncertain tax positions of $1,075, of which $257 was offset against net operating loss carryforwards.

Note 14. Equity-Based Compensation

On January 24, 2013, the Board adopted the 2013 Equity Incentive Plan (the “Plan”). In connection with the adoption of the Plan, 500,000 shares of common stock were reserved for issuance pursuant to the Plan, with automatic increases in such reserve available each year annually on January 1 from 2014 through 2023 equal to the lesser of 3.0% of the total outstanding shares of common stock as of December 31 of the immediately preceding year or, a number of shares of common stock determined by the Board, provided that the maximum number of shares authorized under the Plan could not exceed 1,992,241 shares, subject to certain adjustments. The maximum number of shares authorized under the Plan was reached on January 1, 2017. At March 31, 2020, 602,283 shares remained available for future issuance under the Plan.

Stock options and restricted stock issued by the Company under the Plan are generally subject to service conditions resulting in annual vesting on the anniversary of the date of grant over a period typically ranging between one and three years. Certain stock options and restricted stock issued by the Company under the Plan vest immediately upon issuance. Stock options issued by the Company under the Plan have contractual lives which expire over a period typically ranging between five and ten years from the date of grant, subject to continued service to the Company by the participant.

16


On February 6, 2019, the Compensation Committee of the Board adopted the 2019 Annual Incentive Program (the “2019 Program”) as a subplan under the Plan. The 2019 Program provided an opportunity for performance-based compensation to senior executive officers of the Company, among others. The target annual incentive for each 2019 Program participant was expressed as a percentage of base salary and was conditioned on the achievement of certain financial goals (as approved by the Compensation Committee of the Board). The Compensation Committee of the Board retained negative discretion over amounts payable under the 2019 Program. During the three months ended March 31, 2019, the Company recorded $142 in equity-based compensation expense based on the estimated outcome of the defined financial goals for 2019 under the 2019 Program.

On February 5, 2020, the Compensation Committee of the Board adopted the 2020 Annual Incentive Program (the “2020 Program”) as a subplan under the Plan. The 2020 Program provided an opportunity for performance-based compensation to senior executive officers of the Company, among others. The target annual incentive for each 2020 Program participant was expressed as a percentage of base salary and was conditioned on the achievement of certain financial goals (as approved by the Compensation Committee of the Board). The Compensation Committee of the Board retained negative discretion over amounts payable under the 2020 Program. During the three months ended March 31, 2020, the Company recorded no equity-based compensation expense based on the estimated outcome of the defined financial goals for 2020 under the 2020 Program.

The following table summarizes the total equity-based compensation expense recognized by the Company for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Equity-based compensation expense recognized:

 

 

 

 

 

 

 

 

Stock options

 

$

145

 

 

$

166

 

Restricted stock

 

 

141

 

 

 

129

 

Other(a)

 

 

6

 

 

 

144

 

Total equity-based compensation expense before income taxes

 

 

292

 

 

 

439

 

Benefit for income taxes(b)

 

 

 

 

 

 

Total equity-based compensation expense net of income taxes

 

$

292

 

 

$

439

 

 

(a)

For 2020, Other represents expense associated with certain employee contractual amounts to be settled in equity. For 2019, Other represents expense associated with the 2019 Program and certain employee contractual amounts to be settled in equity.

(b)

The benefit for income taxes from equity-based compensation for each of the periods presented has been determined to be $0 based on valuation allowances against net deferred tax assets.

At March 31, 2020, total future compensation expense related to unvested awards yet to be recognized by the Company was $710 for stock options and $269 for restricted stock. Total future compensation expense related to unvested awards yet to be recognized by the Company is expected to be recognized over a weighted-average remaining vesting period of 1.3 years.

The fair value of stock options granted during the three months ended March 31, 2019, was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:

 

Weighted average fair value per stock option

 

$

3.48

 

Volatility

 

 

54.0

%

Average risk-free interest rate

 

 

2.5

%

Dividend yield

 

 

0.0

%

Expected term (years)

 

2.5

 

 

For certain stock option awards, volatility is estimated based on the historical volatility of the Company when the expected term of the award is less than the period for which the Company has been publicly traded. For certain stock option awards, volatility is estimated based on the historical volatilities of certain peer group companies when the expected term of the award exceeds the period for which the Company has been publicly traded. The average risk-free rate is based on a weighted average yield curve of risk-free interest rates consistent with the expected term of the awards. Expected dividend yield is based on historical dividend data as well as future expectations. Expected term is calculated using the simplified method as the Company does not have sufficient historical exercise experience upon which to base an estimate.

17


The activity for stock options was as follows for the periods indicated:

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

 

 

Number of

Options

 

 

Weighted Average

Exercise Price

 

 

Weighted Average

Grant Date Fair

Value

 

 

Number of

Options

 

 

Weighted Average

Exercise Price

 

 

Weighted Average

Grant Date Fair

Value

 

Outstanding at beginning of period

 

 

854,259

 

 

$

9.34

 

 

$

4.49

 

 

 

621,986

 

 

$

10.66

 

 

$

5.52

 

Stock options granted

 

 

 

 

$

 

 

$

 

 

 

3,300

 

 

$

9.89

 

 

$

3.48

 

Stock options exercised

 

 

 

 

$

 

 

$

 

 

 

(23,247

)

 

$

7.11

 

 

$

2.92

 

Stock options forfeited

 

 

(6,876

)

 

$

7.01

 

 

$

2.84

 

 

 

 

 

$

 

 

$

 

Stock options expired

 

 

(9,000

)

 

$

10.89

 

 

$

5.82

 

 

 

(7,500

)

 

$

17.25

 

 

$

10.55

 

Outstanding at end of period

 

 

838,383

 

 

$

9.35

 

 

$

4.49

 

 

 

594,539

 

 

$

10.71

 

 

$

5.55

 

Exercisable at end of period

 

 

499,139

 

 

$

10.74

 

 

$

5.52

 

 

 

400,566

 

 

$

11.84

 

 

$

6.40

 

Expected to vest at end of period

 

 

339,244

 

 

$

7.30

 

 

$

2.96

 

 

 

193,973

 

 

$

8.37

 

 

$

3.79

 

 

At March 31, 2020, intrinsic value associated with stock options exercisable was less than $1. At March 31, 2020, there was no intrinsic value associated with stock options expected to vest. The weighted average remaining contractual term of stock options exercisable and expected to vest at March 31, 2020, was 3.6 years and 4.5 years, respectively. During the three months ended March 31, 2019, stock options with an aggregate intrinsic value of $221 were exercised by employees resulting in proceeds to the Company from the exercise of stock options of $165. The Company received no income tax benefit related to these exercises. There were no stock option exercises during the three months ended March 31, 2020.

The activity for restricted stock was as follows for the periods indicated:

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

 

 

Shares of

Restricted

Stock

 

 

Weighted Average

Grant Date Fair

Value

 

 

Shares of

Restricted

Stock

 

 

Weighted Average

Grant Date Fair

Value

 

Outstanding at beginning of period

 

 

66,513

 

 

$

8.76

 

 

 

67,001

 

 

$

8.30

 

Restricted stock granted

 

 

37,500

 

 

$

7.12

 

 

 

30,000

 

 

$

9.89

 

Restricted stock vested

 

 

(35,500

)

 

$

9.63

 

 

 

(27,500

)

 

$

8.08

 

Restricted stock forfeited

 

 

 

 

$

 

 

 

 

 

$

 

Outstanding at end of period

 

 

68,513

 

 

$

7.41

 

 

 

69,501

 

 

$

9.07

 

Restricted stock expected to vest at end of period

 

 

68,513

 

 

$

7.41

 

 

 

69,501

 

 

$

9.07

 

 

Restricted stock that vested during the three months ended March 31, 2020 and 2019, had a fair value of $248 and $274, respectively.

During the three months ended March 31, 2019, the Company made cash payments for taxes of $68 relating to the net settlement of certain equity-based awards. There were no cash payments for taxes or net settlement of equity-based awards during the three months ended March 31, 2020.

 

Note 15. Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.

The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

 

Level 1

 

Observable inputs such as quoted prices in active markets for identical investments that the Company has the ability to access.

 

 

 

18


Level 2

 

Inputs include:

 

Quoted prices for similar assets or liabilities in active markets;

 

Quoted prices for identical or similar assets or liabilities in inactive markets;

 

Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and

 

Inputs that are derived principally from, or corroborated by, observable market data by correlation or other means.

 

 

 

Level 3

 

Inputs that are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.

 

The Company is required to disclose its estimate of the fair value of material financial instruments, including those recorded as assets or liabilities in its consolidated financial statements, in accordance with GAAP. At March 31, 2020 and December 31, 2019, the Company had no financial instruments (assets or liabilities) measured at fair value on a recurring basis.

The carrying values and fair values of other financial instruments (assets and liabilities) not required to be recorded at fair value were as follows as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

 

 

Carrying

Value

 

 

Fair

Value

 

 

Carrying

Value

 

 

Fair

Value

 

Cash and cash equivalents

 

$

16,813

 

 

$

16,813

 

 

$

5,265

 

 

$

5,265

 

Restricted cash

 

$

508

 

 

$

508

 

 

$

978

 

 

$

978

 

Debt issuance costs(a)

 

$

130

 

 

$

 

 

$

107

 

 

$

 

Current portion of long-term debt(b)

 

$

155

 

 

$

159

 

 

$

153

 

 

$

157

 

Long-term debt  ̶  net of current portion(b)

 

$

1,171

 

 

$

1,186

 

 

$

1,211

 

 

$

1,227

 

 

(a)

Represents debt issuance costs associated with the Company’s related party revolving credit facility (Note 12) of which $33 and $88 was included in prepaid expenses and other current assets and $97 and $19 was included in other noncurrent assets in the accompanying condensed consolidated balance sheet at March 31, 2020 and December 31, 2019, respectively.

(b)

Carrying values at March 31, 2020 and December 31, 2019 are net of unamortized debt issuance costs of $19 and $20, respectively.

 

The carrying amounts of cash and cash equivalents, restricted cash and current portion of long-term debt approximate fair value due to their short-term maturities. The fair value of long-term debt – net of current portion has been estimated by management based on the consideration of applicable interest rates (including certain instruments at variable or floating rates) and other available information (including quoted prices of similar instruments available to the Company). Cash and cash equivalents and restricted cash were classified as Level 1; Current portion of long-term debt and long-term debt – net of current portion were classified as Level 2.

Note 16. Concentration of Credit Risk

During the three months ended March 31, 2020 and 2019, the Company conducted a significant portion of its business with a limited number of customers, though not necessarily the same customers for each respective period. For the three months ended March 31, 2020 and 2019, the Company’s five most significant customers represented 33.1% and 30.9% of total revenue, respectively. At March 31, 2020 and December 31, 2019, accounts receivable from the Company’s five most significant customers were $1,775 and $3,230, respectively.

Note 17. Related Party Transactions

Purchases of products and/or services from related parties during the three months ended March 31, 2019 were $15.  Purchases of products and/or services by the Company during the three months ended March 31, 2019 included leased office space and website design services from related parties under common control by S. Kent Rockwell, (currently Chairman of the Board of the Company and previously the Executive Chairman and Chief Executive Officer of the Company). None of the transactions met a threshold requiring review and approval by the Audit Committee of the Board. There were no purchases of products and/or services from related parties during the three months ended March 31, 2020. There were no amounts due to related parties at either March 31, 2020 or December 31, 2019.  

Refer to Note 12 for further discussion relating to the Company’s revolving credit facility with a related party.

 

19


Note 18. Other (Income) Expense – Net

 

Other (income) expense – net consisted of the following for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Interest income

 

$

(12

)

 

$

(6

)

Foreign currency (gains) losses – net

 

 

(165

)

 

 

22

 

Other – net

 

 

(13

)

 

 

(4

)

 

 

$

(190

)

 

$

12

 

 

Note 19. Subsequent Events

Paycheck Protection Program

On April 18, 2020, the Company entered into an unsecured promissory note (the “Note”) in favor of The Huntington National Bank (the “Lender”) reflecting a loan in the principal amount of $2,194 (the “Loan”). The Loan was granted pursuant to the Paycheck Protection Program (the “PPP”) administered by the United States Small Business Administration (the “SBA”) as part of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”).

Pursuant to the terms of the Note, the Loan bears interest at a rate of 1.00% per annum and matures on April 18, 2022 (the “Maturity Date”). Principal and interest payments on the Loan are deferred until November 18, 2020, at which time equal installments of principal and interest will be due and payable monthly through the Maturity Date. The Note may be prepaid by the Company at any time prior to maturity without penalty. If the Company defaults on the Note, the Lender may, at its option, accelerate the maturity of the Company’s obligations under the Note.

Pursuant to the terms of the PPP, the Loan, or a portion thereof, may be forgiven if Loan proceeds are used for qualifying expenses as described in the CARES Act, such as payroll costs, costs used to continue group health care benefits, mortgage interest payments, rent and utilities. The Company intends to use all or a significant majority of the Loan proceeds for qualifying expenses. The terms of the Loan, including eligibility and forgiveness, may be subject to further requirements in regulations and guidance adopted by the SBA.

The Company has evaluated all of its activities and concluded that no other subsequent events have occurred that would require recognition in the condensed consolidated financial statements or disclosure in the notes to the condensed consolidated financial statements, except as described above.

20


Item 2.     Management’s Discussion and Analysis of Financial Condition and Results of Operations.

(dollars in thousands, except per-share amounts)

The following discussion and analysis should be read together with our unaudited condensed consolidated financial statements and related notes thereto set forth in this Quarterly Report on Form 10-Q as well as our Annual Report on Form 10-K for the year ended December 31, 2019.

This Quarterly Report on Form 10-Q may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to our future financial or business performance, strategies, or expectations. Forward-looking statements typically are identified by words or phrases such as “trend,” “potential,” “opportunity,” “pipeline,” “believe,” “comfortable,” “expect,” “anticipate,” “current,” “intention,” “estimate,” “position,” “assume,” “outlook,” “continue,” “remain,” “maintain,” “sustain,” “seek,” “achieve,” as well as similar expressions, or future or conditional verbs such as “will,” “would,” “should,” “could” and “may.”

We caution that forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made and we assume no duty, and do not undertake, to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and future results could differ materially from historical performance.

In addition to items described under “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019 and in Part II, Item 1A of this Quarterly Report on Form 10-Q, the following factors, among others, could cause results to differ materially from forward-looking statements or historical performance: the severity and duration of world health events, including the recent outbreak of the novel strain of coronavirus COVID-19 and the related economic repercussions and operational challenges; our ability to consistently generate operating profits; fluctuations in our revenues and operating results; our competitive environment and our competitive position; our ability to enhance our current three-dimensional (“3D”) printing machines and technology and develop and introduce new 3D printing machines; our ability to qualify more industrial materials in which we can print; demand for our products; the availability of skilled personnel; the impact of loss of key management; the impact of market conditions and other factors on the carrying value of long-lived assets; our ability to continue as a going concern; the impact of customer specific terms in machine sale agreements on the period in which we recognize revenue; risks related to global operations including effects of the COVID-19 global pandemic; foreign currency; the adequacy of sources of liquidity; the amount and sufficiency of funds for required capital expenditures, working capital, and debt service; dependency on certain critical suppliers; nature or impact of alliances and strategic investments; reliance on critical information technology systems; the effect of litigation, contingencies and warranty claims; liabilities under laws and regulations protecting the environment; the impact of governmental laws and regulations; operating hazards, war, terrorism and cancellation or unavailability of insurance coverage; the impact of disruption of our manufacturing facilities or ExOne Adoption Centers (“EACs”); the adequacy of our protection of our intellectual property; expectations regarding demand for our industrial products, operating revenues, operating and maintenance expenses, insurance expenses and deductibles, interest expenses, debt levels, and other matters with regard to outlook; and other factors beyond our control, including the impact of the COVID-19 global pandemic.

Overview

Our Business

We are a global provider of 3D printing machines and 3D printed and other products, materials and services to industrial customers. Our business primarily consists of manufacturing and selling 3D printing machines and printing products to specification for our customers using our installed base of 3D printing machines. Our machines serve direct (metal) and indirect (sand) applications.  Direct printing produces a component; indirect printing makes a tool to produce a component. We offer pre-production collaboration and print products for customers through our network of EACs. We also supply the associated materials, including consumables and replacement parts, and other services, including training and technical support, that are necessary for purchasers of our 3D printing machines to print products. We believe that our ability to print in a variety of industrial materials, as well as our industry-leading volumetric output (as measured by build box size and printing speed), uniquely position us to serve the needs of industrial customers.

Outlook

In March 2020, the World Health Organization declared the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide. The impact of the COVID-19 global pandemic and related economic, business and market disruptions are evolving rapidly, and their effects are uncertain. Other than a temporary closure of our North Huntingdon, Pennsylvania facility effective for the period from March 23 through March 30, 2020, our operations were not materially affected by the COVID-19 outbreak as of and for the three months ended March 31, 2020. Beginning in March 2020, restrictions imposed by various governmental authorities on international shipping and travel have caused a disruption to the timing of shipment of our 3D printing machines and our ability to complete installations of 3D printing machines. The duration and severity of the outbreak and its long-term impact on our business are uncertain at this time. We are unable to predict the impact that COVID-19 will have on our future financial position, results of operations and cash flows.

In response to adverse market conditions associated with the COVID-19 global pandemic, beginning in March 2020 and through April 2020, we initiated various cost savings actions including a mix of employee terminations, furloughs and pay rate reductions, as well as

21


reductions in consulting and other expenses, all in an effort to conserve cash and maintain adequate liquidity. We have targeted a net cost reduction for the remainder of 2020 of approximately $5,000 as a result of these actions. Given the high level of uncertainty associated with the timing and extent of the COVID-19 global pandemic, we expect to continue to assess whether additional cost actions are necessary to further adjust our operating model.

We are the global leader in industrial 3D printers utilizing binder jetting technology for non-polymer-based materials. Our continued focus is to achieve profitable growth via three strategic initiatives:

 

-

Expand Both Our Customer and Application Focus. We intend to leverage our substantial experience in binder jetting technology to focus on the highest value industries and applications. We have made a significant investment in our global commercial operations to drive our growth in this area.

 

-

Extend the Capabilities of Our Core Technology. We intend to expand our core binder jetting technology through our machine platforms while at the same time lowering the total cost of ownership of our systems for our customers. We are also focused on driving modularity among our various machine platforms for both direct (metal) and indirect (sand) applications.

 

-

Execute on Recurring Revenue Growth. We intend to execute on our plan to expand our offerings for 3D printed and other products, materials and services while better leveraging our growing global installed base of 3D printers.

Our results for the three months ended March 31, 2020, while favorable as compared to the three months ended March 31, 2019, continue to be impacted by a prolonged downturn in global manufacturing trends which has influenced the capital expenditure investments of our customers. Despite these headwinds, we ended the first quarter with a record backlog balance of approximately $33,800. We expect the combination of our backlog at March 31, 2020 and an acceleration in market adoption of our newly introduced printer platforms (our X1 25ProTM for metal applications and S-Max ProTM for sand applications, both introduced to market during the three months ended December 31, 2019) to provide the basis for our operating stability in 2020 despite continuing negative macroeconomic trends for global manufacturing, including the impact of the COVID-19 global pandemic.

Sale-Leaseback of European Headquarters and Operating Facility in Gersthofen, Germany

On December 10, 2019, ExOne Property GmbH and ExOne GmbH (our “German Subsidiaries”), entered into a purchase agreement (the “Purchase Agreement”) with Solidas Immobilien und Grundbesitz GmbH, a private, unaffiliated German real estate investor (the “Buyer”), for the sale of our European headquarters and operating facility in Gersthofen, Germany (the “Facility”) for a cash price of approximately $18,500 (€17,000), of which approximately $2,200 was received prior to December 31, 2019. Concurrently with the execution of the Purchase Agreement, ExOne GmbH and the Buyer entered into a rental contract (the “Lease”) for the leaseback of the Facility for an initial aggregate annual rent totaling approximately $1,700 (€1,500), plus applicable taxes, which is fixed during the initial three-year term and is subject to adjustment on an annual basis (in accordance with the consumer price index for Germany) during the two five-year option extension periods. The sale-leaseback transaction closed on February 18, 2020.

As a result of the completion of the sale-leaseback transaction further described above, we recorded or expect to record the following effects on our results of operations, financial condition and cash flows:

 

-

As indicated, we expect to incur annual rent expense (which commenced during the three months ending March 31, 2020) of approximately $1,700 (with an expected allocation of approximately $1,300, $200 and $200 to cost of sales, research and development and selling, general and administrative expenses, respectively, based on the relative utilization of the Facility). This is in place of annual depreciation associated with the Facility of approximately $600 (allocated approximately $400, $100 and $100 to cost of sales, research and development and selling, general and administrative expenses, respectively, based on the relative utilization of the Facility).

 

-

During the three months ended March 31, 2020, we recorded a gain from sale-leaseback of property and equipment of $1,462.

 

-

During the three months ended March 31, 2020, we recorded an operating right-of-use asset and corresponding operating lease liability of $4,605, which was representative of the present value of future minimum lease payments over the initial three-year term as there were no penalties or other factors associated with the lease that result in reasonable assurance of its extension at inception.

Backlog

At March 31, 2020, our backlog was approximately $33,800 of which approximately $29,800 is expected to be fulfilled during the next twelve months notwithstanding uncertainty related to the impact of the COVID-19 global pandemic (further discussed above) including, but not limited to, international shipping and travel restrictions brought about by the global pandemic which could have an adverse effect on the timing of delivery of products and/or services to customers. At December 31, 2019, our backlog was approximately $31,100.

Seasonality

Purchases of our 3D printing machines are often subject to the capital expenditure cycles of our customers. Generally, 3D printing machine sales are higher in our third and fourth quarters than in our first and second quarters; however, as acceptance of our 3D

22


printing machines as a credible alternative to traditional methods of production grows, we expect to limit the seasonality we experience.

We believe that the COVID-19 global pandemic may have an adverse effect on the future capital expenditure decisions of our customers outside of their normal spending cycles, which may impact the timing and extent of such decisions.

Results of Operations

Net Loss

Net loss for the three months ended March 31, 2020 was $3,648, or $0.22 per basic and diluted share, compared with a net loss of $4,496, or $0.28 per basic and diluted share, for the three months ended March 31, 2019. The decrease in our net loss was principally due to an increase in our revenues and gross profit driven by an increase in customer demand for our products, offset by an increase in our operating expenses based on investments made in our research and development activities (primarily headcount) and selling, general and administrative expenses (primarily headcount increases associated with our global marketing and sales infrastructure). During the three months ended March 31, 2020 we recognized a gain from sale-leaseback of property and equipment of $1,462 associated with the sale of our European headquarters and operating facility in Gersthofen, Germany. During the three months ended March 31, 2019, we recorded an income tax benefit of $818 associated with the reversal of previously recorded liabilities for uncertain tax positions following the completion of a tax examination of our German operations.

Revenue

The following table summarizes revenue by product group for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

3D printing machines

 

$

6,317

 

 

 

47.2

%

 

$

3,329

 

 

 

34.8

%

3D printed and other products, materials and services

 

 

7,066

 

 

 

52.8

%

 

 

6,250

 

 

 

65.2

%

 

 

$

13,383

 

 

 

100.0

%

 

$

9,579

 

 

 

100.0

%

Revenue for the three months ended March 31, 2020 was $13,383, compared with revenue of $9,579 for the three months ended March 31, 2019, an increase of $3,804, or 39.7%. The increase in revenue resulted from an increase in revenue attributable to both of our product groups.

The increase in revenues from 3D printing machines of $2,988, or 89.8%, resulted from higher volumes (14 units sold during the three months ended March 31, 2020 versus 8 units sold during the three months ended March 31, 2019) and a favorable mix of machines sold.

The increase in revenues from 3D printed and other products, materials and services of $816, or 13.1%, resulted from an increase of $593 in consumable materials and aftermarket revenues based on growth in our global installed base of 3D printing machines. We also experienced an increase in revenues of $417 associated with research and development arrangements primarily due to an automotive project which commenced during the three months ended December 31, 2019. Offsetting these increases were reductions in revenues of $144 from our global EACs (metal and sand) based on lower customer demand for printed products.

Cost of Sales and Gross Profit

Cost of sales for the three months ended March 31, 2020 was $9,754, compared with cost of sales of $6,937 for the three months ended March 31, 2019, an increase of $2,817, or 40.6%. Gross profit for the three months ended March 31, 2020 was $3,629, compared with gross profit of $2,642 for the three months ended March 31, 2019, an increase of $987. Gross profit percentage was 27.1% for the three months ended March 31, 2020, compared with 27.6% for the three months ended March 31, 2019.

The increase in gross profit was primarily due to our higher revenue volumes during the three months ended March 31, 2020, offset by lower realized pricing on sales between the periods which unfavorably impacted our gross profit as a percentage of sales. We experienced higher overhead costs during the three months ended March 31, 2020, based on an increased global headcount and facility rent expense (versus depreciation) following completion of the sale-leaseback of our European headquarters and operating facility in Gersthofen, Germany during the three months ended March 31, 2020, as well as comparably unfavorable product warranty experience of $157. Offsetting these unfavorable impacts was a reduction in net charges for slow-moving and obsolete inventories of $86 between the periods.

Research and Development

Research and development expenses for the three months ended March 31, 2020 were $2,476, compared with research and development expenses of $2,432 for the three months ended March 31, 2019, an increase of $44, or 1.8%. The increase in research

23


and development expenses was primarily due to an increase in employee-related costs (salaries and benefits) of $167 due to an increased headcount, offset by a decrease in consulting and professional fees of $82 associated with lower machine development costs.

Selling, General and Administrative

Selling, general and administrative expenses for the three months ended March 31, 2020 were $6,163, compared with selling, general and administrative expenses of $5,423 for the three months ended March 31, 2019, an increase of $740, or 13.6%. The increase in selling, general and administrative expenses was principally due to an increase in employee-related costs (salaries and benefits) of $655 due to investments made during 2019 and early 2020 in our global marketing and sales infrastructure and an increase of $144 in sales commissions based on higher revenues. In addition, during the three months ended March 31, 2020, we incurred a net provision for bad debts of $51 as compared to net recoveries for bad debts of $73 during the three months ended March 31, 2019. Offsetting these increases was a decrease in expense incurred under our annual incentive plans of $137 based on the expectation of under performance against targets established for 2020 in advance of the impact to market conditions of the COVID-19 global pandemic.

Interest Expense

Interest expense for the three months ended March 31, 2020 was $64, compared with interest expense of $71 for the three months ended March 31, 2019, a decrease of $7, or 9.9%. The decrease in interest expense was principally due to lower debt issuance cost amortization associated with our related party revolving credit facility following amendment and extension of the agreement in February 2020.

Other (Income) Expense – Net

Other (income) expense – net for the three months ended March 31, 2020 was ($190), compared with other (income) expense – net of $12 for the three months ended March 31, 2019. The change of $202 was principally due to favorable foreign exchange rate changes and the related impact on certain intercompany transactions between subsidiaries for which settlement has occurred or is planned.

Provision (Benefit) for Income Taxes

The provision (benefit) for income taxes for the three months ended March 31, 2020 and 2019 was $226 and ($800), respectively. We have completed a discrete period computation of our provision for income taxes for each of the periods presented. The discrete period computation was required as a result of jurisdictions with losses before income taxes for which no tax benefit can be recognized and an inability to generate reliable estimates for results in certain jurisdictions as a result of inconsistencies in generating net operating profits (losses) in those jurisdictions.  

The effective tax rate for the three months ended March 31, 2020 and 2019 was 6.6% (provision on a loss) and 15.1% (benefit on a loss), respectively. For the three months ended March 31, 2020, the effective tax rate differed from the United States federal statutory rate of 21.0% primarily due to net changes in valuation allowances for the period. For the three months ended March 31, 2019, the effective tax rate differed from the United States federal statutory rate of 21.0% primarily due to the reversal of previously recorded liabilities for uncertain tax positions (further described below) and net changes in valuation allowances for the period.

We have provided a valuation allowance for certain of our net deferred tax assets as a result of our inability to generate consistent net operating profits in certain jurisdictions in which we operate. As such, certain benefits from deferred taxes in the periods presented have been fully offset by changes in the valuation allowance for the related net deferred tax assets. We continue to assess our future taxable income by jurisdiction based on our recent historical operating results, the expected timing of reversal of temporary differences, various tax planning strategies that we may be able to enact in future periods, the impact of potential operating changes on our business and our forecast results from operations in future periods based on available information at the end of each reporting period. To the extent that we are able to reach the conclusion that net deferred tax assets are realizable based on any combination of the above factors in a single, or multiple, taxing jurisdictions, a reversal of the related portion of our existing valuation allowances may occur.

At December 31, 2018, our ExOne GmbH (2010-2013) and ExOne Property GmbH (2013) subsidiaries were under examination by local taxing authorities in Germany. In January 2019, this examination was concluded by the local taxing authorities in Germany without significant adjustment to previously established tax positions. As a result, during the three months ended March 31, 2019, we recorded a reversal of certain of our previously recorded liabilities for uncertain tax positions of $1,075, of which $257 was offset against net operating loss carryforwards.

Impairment

During the three months ended March 31, 2020, as a result of continued operating losses and cash flow deficiencies, we identified a triggering event requiring a test for the recoverability of long-lived assets held and used at the asset group level. Assessing the recoverability of long-lived assets held and used requires significant judgments and estimates by management.

For purposes of testing long-lived assets for recoverability, we operate as three separate asset groups: United States, Europe and Japan. In assessing the recoverability of long-lived assets held and used, we determined the carrying amount of long-lived assets held and used to be in excess of the estimated future undiscounted net cash flows of the related assets. We proceeded to determine the fair value of our long-lived assets held and used, principally through use of the market approach. Our use of the market approach included

24


consideration of market transactions for comparable assets. Management concluded that the fair value of long-lived assets held and used exceeded their carrying value, and as such, no impairment loss was recorded.   

A significant decrease in the market price of a long-lived asset, adverse change in the use or condition of a long-lived asset, adverse change in the business climate or legal or regulatory factors impacting a long-lived asset and continued operating losses and cash flow deficiencies associated with a long-lived asset, among other indicators, could cause a future assessment to be performed which may result in an impairment of long-lived assets held and used, which could result in a material adverse effect on our financial position and results of operations.

Impact of Inflation

Our results of operations and financial condition are presented based on historical cost. While it is difficult to accurately measure the impact of inflation due to the imprecise nature of the estimates required, we believe the effects of inflation, if any, on our results of operations and financial condition are not significant.

Liquidity and Capital Resources

Liquidity

We have incurred a net loss in each of our annual periods since our inception. We incurred a net loss of $3,648 for the three months ended March 31, 2020. At March 31, 2020, we had $16,813 in unrestricted cash and cash equivalents.

In addition to our unrestricted cash and cash equivalents, we also have access to additional capital through our $10,000 related party revolving credit facility (further discussed below). Also, on April 18, 2020, we received additional unrestricted cash proceeds of $2,194 in connection with a Paycheck Protection Program loan (further discussed below).

Since our inception we have received cumulative unrestricted net proceeds from the sale of our common stock (through our initial public offering and subsequent secondary offerings) of $168,361 to fund our operations. We maintain additional access to capital through our active shelf registration statement which allows for the sale of various equity or debt instruments up to an aggregate amount of $125,000. Future sales of securities through our active shelf registration are dependent on market conditions which may restrict the timing and extent of any future offering of securities by us.

We have previously exhibited our ability to modify our operating structure and support our liquidity position through various restructuring and other actions, including our 2018 global cost realignment program. As further discussed above, in response to adverse market conditions associated with the COVID-19 global pandemic, beginning in March 2020 and through April 2020, we commenced various cost savings actions including a mix of employee terminations, furloughs and pay rate reductions, as well as reductions in consulting and other expenses, all in an effort to conserve cash and maintain adequate liquidity.  

We believe that our existing capital resources will be sufficient to support our operating plan. If we anticipate that our actual results will differ from our operating plan, we believe we have sufficient capabilities to enact cost savings measures to preserve capital (in addition to those further described above). We may also seek to raise additional capital to support our growth through additional debt, equity or other alternatives (including asset sales) or a combination thereof.

Related Party Revolving Credit Facility

On March 12, 2018, we and our ExOne Americas LLC and ExOne GmbH subsidiaries, as guarantors (collectively, the “Loan Parties”), entered into a Credit Agreement and related ancillary agreements with LBM Holdings, LLC (“LBM”), a company controlled by S. Kent Rockwell, who was our Executive Chairman (a related party) at such date and is currently our Chairman, relating to a $15,000 revolving credit facility (the “Credit Agreement”) to provide additional funding to us for working capital and general corporate purposes. The Credit Agreement provided a credit facility for a term of three years (through March 12, 2021), bearing interest at a rate of one-month LIBOR plus an applicable margin of 500 basis points (6.8% at December 31, 2019 and 6.0% at March 31, 2020). The Credit Agreement required a commitment fee of 75 basis points, or 0.75%, on the unused portion of the facility, payable monthly in arrears. In addition, an up-front commitment fee of 125 basis points, or 1.25% ($188), was required at closing. Borrowings under the Credit Agreement were collateralized by the accounts receivable, inventories and machinery and equipment of the Loan Parties.

On February 18, 2020, the Loan Parties and LBM entered into a First Amendment to the Credit Agreement (the “Amendment”) which (i) reduced the available capacity under the revolving credit facility to $10,000, (ii) extended the term of the credit facility until March 31, 2024, (iii) increased the commitment fee to 100 basis points, or 1.00%, on the unused portion of the revolving credit facility, and (iv) provided a process for the replacement of the LIBOR index after 2021. In addition, the accounts receivable of ExOne GmbH no longer serve as collateral for borrowings under the amended revolving credit facility.

Borrowings under the credit facility are required to be made in minimum increments of $1,000. We may terminate or reduce the credit commitment at any time during the term of the amended Credit Agreement without penalty. We may also make prepayments against outstanding borrowings under the amended Credit Agreement at any time without penalty. At December 31, 2019 and March 31, 2020, the total estimated value of collateral was in significant excess of the maximum borrowing capacity under the credit facility.

25


The amended Credit Agreement contains several affirmative covenants including prompt payment of liabilities and taxes; maintenance of insurance, properties, and licenses; and compliance with laws. The amended Credit Agreement also contains several negative covenants including restricting the incurrence of certain additional debt; prohibiting future liens (other than permitted liens); prohibiting investment in third parties; limiting the ability to pay dividends; limiting mergers, acquisitions, and dispositions; and limiting the sale of certain property and equipment of the Loan Parties. The amended Credit Agreement does not contain any financial covenants. The amended Credit Agreement also contains events of default, including, but not limited to, cross-default to certain other debt, breaches of representations and warranties, change of control events and breaches of covenants.

We do not consider the Credit Agreement, as amended, indicative of a fair market value lending, as LBM was determined to be a related party based on common control by S. Kent Rockwell. S. Kent Rockwell is the indirect sole owner of LBM. Prior to execution, each of the Credit Agreement and the Amendment was reviewed and approved by the Audit Committee of the Board, in accordance with The ExOne Company Policy and Procedures with Respect to Related Person Transactions, and subsequently by a sub-committee of independent members of the Board. At the time of execution of the Credit Agreement, the available loan proceeds were deposited into an escrow account with an unrelated, third party financial institution acting as escrow agent pursuant to a separate Escrow Agreement by and among the parties. Loan proceeds held in escrow are available to us upon our submission to the escrow agent of a loan request. Such proceeds will not be available to LBM until payment in-full of the obligations under the amended Credit Agreement and termination of the amended Credit Agreement. Payments of principal and other obligations will be made to the escrow agent, while interest payments will be made directly to LBM. Provided there exists no potential default or event of default, the amended Credit Agreement and Escrow Agreement prohibit any acceleration of repayment of any amount outstanding under the amended Credit Agreement and prohibit termination of the amended Credit Agreement or withdrawal from escrow of any unused portion of the available loan proceeds.

There were no borrowings under the credit facility during the three months ended March 31, 2020 or 2019.

In connection with our efforts to conserve cash as a result of the COVID-19 global pandemic, LBM agreed to defer cash payments of its commitment fee on the unused portion of the revolving credit facility to a future date (to be determined upon mutual agreement by the parties). There are no incremental interest or other fees to be incurred by us as a result of this deferral.

Paycheck Protection Program

On April 18, 2020, we entered into an unsecured promissory note (the “Note”) in favor of The Huntington National Bank (the “Lender”) reflecting a loan in the principal amount of $2,194 (the “Loan”). The Loan is granted pursuant to the Paycheck Protection Program (the “PPP”) administered by the United States Small Business Administration (the “SBA”) as part of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”).

Pursuant to the terms of the Note, the Loan bears interest at a rate of 1.00% per annum and matures on April 18, 2022 (the “Maturity Date”). Principal and interest payments on the Loan are deferred until November 18, 2020, at which time equal installments of principal and interest will be due and payable monthly through the Maturity Date. The Note may be prepaid by us at any time prior to maturity without penalty. If we default on the Note, the Lender may, at its option, accelerate the maturity of our obligations under the Note.

Pursuant to the terms of the PPP, the Loan, or a portion thereof, may be forgiven if Loan proceeds are used for qualifying expenses as described in the CARES Act, such as payroll costs, costs used to continue group health care benefits, mortgage interest payments, rent and utilities. We intend to use all or a significant majority of the Loan proceeds for qualifying expenses. The terms of the Loan, including eligibility and forgiveness, may be subject to further requirements in regulations and guidance adopted by the SBA.

26


Cash Flows

The following table summarizes the significant components of cash flows for the periods indicated, and our cash, cash equivalents, and restricted cash balances as of the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Net cash used for operating activities

 

$

(4,739

)

 

$

(1,386

)

Net cash provided by (used for) investing activities

 

 

15,890

 

 

 

(347

)

Net cash (used for) provided by financing activities

 

 

(42

)

 

 

56

 

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

 

 

(31

)

 

 

(121

)

Net change in cash, cash equivalents, and restricted cash

 

$

11,078

 

 

$

(1,798

)

 

 

 

 

 

 

 

 

 

 

 

March 31,

2020

 

 

December 31,

2019

 

Cash and cash equivalents

 

$

16,813

 

 

$

5,265

 

Restricted cash

 

 

508

 

 

 

978

 

Cash, cash equivalents, and restricted cash

 

$

17,321

 

 

$

6,243

 

 

Operating Activities

Net cash used for operating activities for the three months ended March 31, 2020 was $4,739, compared with net cash used for operating activities of $1,386 for the three months ended March 31, 2019. The net increase in cash outflows of $3,353 was due to an increase in our net loss (net of noncash items) and a net increase in working capital attributable to a decrease in net cash inflows from customers (principally due to timing of cash collections on 3D printing machine sales) partially offset by a decrease in net cash outflows related to inventory production of our 3D printing machines and the timing of payments to our suppliers and vendors for our production and operating expenses.

We expect to maintain a balanced net working capital position for the remainder of 2020, with a targeted reduction in inventories consistent with our revised production plans expected to offset lower commercial activity (customer prepayments) stemming from the impact of the COVID-19 global pandemic.

Investing Activities

Net cash provided by investing activities for the three months ended March 31, 2020 was $15,890, compared with net cash used for investing activities of $347 for the three months ended March 31, 2019.

For the three months ended March 31, 2020, net cash provided by investing activities included $16,228 in proceeds from the sale of property and equipment, including the sale-leaseback of our European headquarters and operating facility in Gersthofen, Germany.

Activity for both periods included cash outflows for capital expenditures (consistent with our operating plans).

We expect our remaining 2020 capital expenditures to be limited to spending associated with sustaining our existing operations and strategic asset acquisition and deployment (additional estimated spending of approximately $1,000 to $2,000, which reflects a reduced spending target as part of our capital conservation plans in response to the COVID-19 global pandemic and its effect on our operations).

Financing Activities

Net cash used for financing activities for the three months ended March 31, 2020 was $42, compared with net cash provided by financing activities of $56 for the three months ended March 31, 2019.

Activity for both periods included principal payments on outstanding debt.

For the three months ended March 31, 2019, net cash provided by financing activities included $165 in cash inflows associated with proceeds from the exercise of stock options by employees. This amount was offset by $68 in cash outflows associated with taxes related to the net settlement of equity-based awards. There were no stock option exercises or taxes related to the net settlement of equity-based awards during the three months ended March 31, 2020.

Financial Condition

The following summarizes the material changes in our financial condition from December 31, 2019 to March 31, 2020:

Restricted cash decreased by $470 following an amendment to our credit facility agreement with a German bank completed in February 2020 which relieved us of a cash collateral requirement up to approximately $1,100 for financial guarantees and letters of credit issued by us for commercial transactions requiring security.

27


Accounts receivable decreased by $1,568 based on the timing of cash payments by customers (principally the timing of cash collections on 3D printing machine sales).

Inventories increased by $1,883 due to an increase in finished goods inventories (principally 3D printing machines prepared for sale in accordance with customer specifications pending delivery to or acceptance by customers) consistent with growth in our backlog. In addition, raw materials and components inventories increased in connection with our production plans.

Prepaid expenses and other current assets increased by $605, mostly due to increases in prepayments to suppliers for 3D printing machine components and subassemblies.

Property and equipment – net decreased by $18,175, mostly due to the impact of the sale-leaseback of our European headquarters and operating facility in Gersthofen, Germany (which resulted in a derecognition of $17,282 of related property and equipment) and depreciation expense of $923 incurred during the period.

Operating lease right-of-use assets increased by $4,357, principally as a result of the sale-leaseback transaction further discussed above.

Accounts payable decreased by $1,433 due to the timing of payments to our suppliers and vendors for our production and operating expenses.

Accrued expenses and other current liabilities decreased by $2,352, mostly due to the sale-leaseback transaction further discussed above based on the release of $2,243 of a deposit liability received from the buyer in December 2019.

Operating lease liabilities increased $4,357, principally as a result of the sale-leaseback transaction further discussed above.

Contract liabilities increased $1,744 based on the timing of cash payments by customers (principally the timing of cash collections on 3D printing machine sales consistent with growth in our backlog).   

Off Balance Sheet Arrangements

In the normal course of our operations, our ExOne GmbH subsidiary issues financial guarantees and letters of credit to third parties in connection with certain commercial transactions requiring security. At March 31, 2020, total outstanding financial guarantees and letters of credit issued by us were $863 (€785) with expiration dates ranging from October 2020 through February 2023. At December 31, 2019, total outstanding financial guarantees and letters of credit issued by us were $560 (€499). For further discussion related to financial guarantees and letters of credit issued by us, refer to Note 11 to the condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Recently Issued and Adopted Accounting Guidance

Refer to Note 1 to the condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Critical Accounting Policies and Estimates

Refer to Note 1 to the condensed consolidated financial statements in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2019.

 

28


Item 3.     Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and are not required to provide the information under this item.

Item 4.     Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our management, including our Chief Executive Officer and our Chief Financial Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, as a result of certain material weaknesses in our internal control over financial reporting (further described below), our disclosure controls and procedures were ineffective. 

In connection with the preparation of our condensed consolidated financial statements as of and for the three months ended March 31, 2020, we concluded that there are material weaknesses in the design and operating effectiveness of our internal control over financial reporting as defined in Securities and Exchange Commission Regulation S-X. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.

A description of the identified material weaknesses in internal control over financial reporting is as follows:

 

-

We did not maintain adequate control over user access rights for a significant information technology system.

 

-

We did not maintain adequate control over application changes for a significant information technology system.

 

-

We did not maintain adequate control over pricing and discounts associated with sales of certain of our products.

Notwithstanding the identified material weaknesses described above, management believes that the condensed consolidated financial statements and related notes thereto included in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented.

Changes in Internal Control over Financial Reporting

During the three months ended March 31, 2020, as a result of the identification of the material weaknesses further described above, management has commenced its remediation plans in an effort to ensure that our disclosure controls and procedures are effective. Our remediation plans include a comprehensive evaluation of the people, processes and systems responsible for each of the underlying control activities. We expect to complete this evaluation in 2020 and put measures in place in an effort to remediate the identified material weaknesses. However, we cannot be certain that the measures we may take will ensure that we establish and maintain adequate controls over our financial processes and reporting in the future or that material weaknesses identified will be remediated.

Other than the items further described above, there were no changes in our internal control over financial reporting during the three months ended March 31, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

29


PART II – OTHER INFORMATION

Item 1.     Legal Proceedings.

We are subject to various litigation, claims, and proceedings which have been or may be instituted or asserted from time to time in the ordinary course of business. Management does not believe that the outcome of any pending or threatened matters will have a material adverse effect, individually or in the aggregate, on our financial position, results of operations or cash flows.

Item 1A.     Risk Factors.

We face risks related to the COVID-19 global pandemic which could significantly disrupt our operations and impact our operating results and/or cash flows.

In addition to the commercial risks, the long-term effects of the COVID-19 global pandemic may also include risks associated with employee health and safety, resultant operating facility closures and supply chain disruption, each of which may have a material adverse effect, individually or in the aggregate, on our financial position, results of operations or cash flows.

There have been no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2019, except as described above.

Item 6.     Exhibits.

(a)(3) Exhibits

The Exhibits listed on the accompanying Index to Exhibits are filed as part of this Quarterly Report on Form 10-Q.

 

30


EXHIBIT INDEX

The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.

 

Exhibit

Number

 

Description

 

Method of Filing

 

 

 

 

 

  3.1

 

Amended and Restated Bylaws.

 

Incorporated by reference to Exhibit 3.1 of Form 8-K (#001-35806) filed on April 3, 2020.

 

 

 

 

 

  10.1

 

First Amendment to Credit Agreement dated February 18, 2020 among the Company, ExOne Americas LLC, ExOne GmbH and LBM Holdings LLC.

 

Incorporated by reference to Exhibit 10.13 of Form 10-K (#001-35806) filed on March 12, 2020.

 

 

 

 

 

  10.2

 

First Amendment to Employment Agreement dated April 3, 2020 between the Company and John F. Hartner.

 

Filed herewith.

 

 

 

 

 

  10.3

 

Separation and Release Agreement dated April 9, 2020 between the Company and Charlie Grace.

 

Filed herewith.

 

 

 

 

 

  10.4

 

Promissory Note (Paycheck Protection Program Loan) dated April 18, 2020 in favor of The Huntington National Bank.

 

Filed herewith.

 

 

 

 

 

  31.1

 

Rule 13(a)-14(a) Certification of Principal Executive Officer.

 

Filed herewith.

 

 

 

 

 

  31.2

 

Rule 13(a)-14(a) Certification of Principal Financial Officer.

 

Filed herewith.

 

 

 

 

 

  32

 

Section 1350 Certification of Principal Executive Officer and Principal Financial Officer.

 

Filed herewith.

 

 

 

 

 

101.INS

 

XBRL Instance Document.

 

Filed herewith.

 

 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema Document.

 

Filed herewith.

 

 

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document.

 

Filed herewith.

 

 

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document.

 

Filed herewith.

 

 

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document.

 

Filed herewith.

 

 

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document.

 

Filed herewith.

 

31


Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

The ExOne Company

 

 

By:

 

/s/ John F. Hartner

 

 

John F. Hartner

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

 

 

 

Date:

 

May 7, 2020

 

 

 

By:

 

/s/ Douglas D. Zemba

 

 

Douglas D. Zemba

 

 

Chief Financial Officer

 

 

(Principal Financial Officer and Principal Accounting Officer)

 

 

 

Date:

 

May 7, 2020

 

32

xone-ex102_14.htm

Exhibit 10.2

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT

 

This First Amendment is entered into this 3rd day of April, 2020 (the " Effective Date") and amends the Employment Agreement ("the Agreement") dated May 15, 2019 by and between John F. Hartner (hereinafter referred to as "Executive") and The ExOne Company ("ExOne"), a company duly organized under the laws of Delaware and having its principal office at 127 Industry Boulevard, North Huntingdon, PA,15642, U.S.A.

 

WHEREAS, Executive and ExOne entered into the Agreement; and

 

WHEREAS, Executive and ExOne wish to amend the Agreement with this First Amendment in light of the financial challenges caused by the COVID-19 pandemic; and

 

NOW, THEREFORE in consideration of the promises and mutual covenants contained herein and intending to be bound, the parties agree as follows:

 

The entire Agreement shall continue in effect in its present form with the sole exception that with respect to the language in Section 4.01 Base Salary, Executive and ExOne hereby agree to reduce the Executive’s base salary by 20%, to $300,000, for the second quarter of fiscal year 2020, effective April 6, 2020, and thereafter as mutually agreed by the parties.

 

There are no additional modifications to the remaining sections or provisions of the Agreement.  

 

This First Amendment is executed in writing pursuant to Section 10.02 of the Agreement and such amendment is effective upon the signatures of both parties below.

 

The Agreement, as amended by this First Amendment, constitutes the entire agreement between the parties with respect to the subject matter thereof and hereof, and supersedes all previous representations, agreements, understandings and negotiations with respect thereto.

 

This First Amendment may be executed in any number of counterparts, each of which when so executed and delivered shall be an original, but all of which shall constitute one and the same instrument.

 

IN WITNESS WHEREOF, the parties have duly executed this First Amendment to the Agreement.

 

 

THE EXONE COMPANY

 

By:

 

/s/ John F. Hartner

 

By:

 

/s/ Loretta L. Benec

 

 

John F. Hartner

 

 

 

Loretta L. Benec

 

 

 

 

 

 

General Counsel & Corporate Secretary

 

 

 

 

 

 

April 3, 2020

 

{CGAL3268.1}

xone-ex103_15.htm

Exhibit 10.3

CONFIDENTIAL SEPARATION AND RELEASE AGREEMENT

 

This Confidential Separation and Release Agreement (this “Agreement”) is by and between Charles Grace (“the Associate”) and The ExOne Company (“Company”).  In consideration of the promises and covenants contained in this Agreement, the sufficiency of which is acknowledged by both the Associate and the Company, and agreeing to be bound by the terms and conditions outlined herein, the parties agree to the following:  

 

1.Return of Company Property.  The Associate will return all Company property to a designated Company representative before any of the payments provided for in this Agreement are made to the Associate.  Company property includes uniforms, keys, credit cards, cell phones, computers and printers, automobiles, product information, customer lists, Company policies, Company procedures, Company financial information, Company confidential and proprietary information, trade secrets, and all other documents (whether paper or electronic) which were developed by, sent to or received by Associate in the course of Associate’s employment as well as all copies of such materials.

  

2.Continuing Obligations.  The Associate acknowledges that Associate previously, voluntarily entered into and executed The ExOne Company’s Employee/Independent Contractor Proprietary Information and Assignment of Inventions Agreement (“Confidentiality Agreement”) which remains in full force and effect.  The Associate acknowledges that certain of the obligations imposed on the Associate by the Confidentiality Agreement continue after the separation of the Associate’s employment with the Company.  The Associate agrees to continue to comply with and be bound by the Associate’s ongoing obligations under the Confidentiality Agreement in accordance with its terms. Notwithstanding any other provision of this Agreement or the provisions contained in the Confidentiality Agreement, Associate is advised that under the Defend Trade Secrets Act of 2016, Associate will not be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that: (a) is made: (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding.  If the Associate files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Associate may disclose the Company’s trade secrets to Associate’s attorney and use the trade secret information in the court proceeding if Associate:  (a) files any document containing the trade secret under seal; and (b) does not disclose the trade secret, except pursuant to court order.  

 

3.Confidentiality of Agreement.  Each Party will keep the terms of this Agreement confidential, except that the Associate may disclose its terms to Associate’s spouse, and, as necessary for purposes of legal or tax advice, to Associate’s attorney and tax advisor, who then will all be informed of and bound by this confidentiality provision, and the Company may make disclosures as required by law, including the securities laws.  This provision does not, in any way, restrict or impede the Associate from exercising protected rights to the extent that such rights cannot be waived by agreement or from complying with any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized government agency, provided that such compliance does not exceed that required by the law, regulation or order.  

 

 


 

4.Release. The Associate, for himself/herself and for the Associate’s heirs, executors, administrators, successors, and assigns, hereby releases and forever discharges the Company, including its predecessor and successor companies, its parent, subsidiaries, affiliates, and related companies, and all of their representatives, agents, owners, members, shareholders, directors, officers, and employees, (“the Releasees”), whether known or unknown, from the beginning of time to the date of the Associate’s execution of this Agreement, from all claims, demands, rights, liabilities, and causes of action at law or in equity of any kind or nature whatsoever, including claims or demands for attorneys fees, that the Associate has had, now has, or may have against the Releasees arising from or related to the Associate's employment with the Company and Associate’s separation from that employment, and any and all claims whether those claims, demands, rights, liabilities, and causes of action be now known or unknown, foreseen or unforeseen. The Associate fully understands that this Release specifically includes, but is not limited to, claims arising under any federal, state or local statute, regulation or ordinance, including, but not limited to the Age Discrimination in Employment Act of 1967 (ADEA), the Older Workers Benefit Protection Act (OWBPA), the Fair Labor Standards Act, the Equal Pay Act, the Occupational Safety and Health Act, the Americans with Disabilities Act of 1990, Title VII of the Civil Rights Act of 1964, the Worker Adjustment and Retraining Notification Act of 1988, the Employee Retirement Income Security Act (with respect to unvested benefits), the Civil Rights Act of 1991, Section 1981 of U.S.C. Title 42, the Sarbanes-Oxley Act of 2002, the Family and Medical Leave Act, the Uniform Services Employment and Reemployment Rights Act, the Genetic Information, Nondiscrimination Act of 2008, the Pennsylvania Human Relations Act, the Pennsylvania Equal Pay Law, and the Pennsylvania Whistleblower Law, the Massachusetts Fair Employment Practices Law, Gen. Laws ch. 151B; the Massachusetts Civil Rights Act, Gen. Laws ch. 12, § 11; the Massachusetts Equal Rights Act, Gen. Laws ch. 93; the Massachusetts Small Necessities Act, Gen. Laws ch. 149 § 52D; the Massachusetts Privacy Statute, Gen. Laws ch. 214, § 1B; the Massachusetts Equal Pay Act, Gen. Laws ch. 149 § 105A-C; the Massachusetts Parental Leave Act, Gen. Laws ch. 149, § 105D; the Massachusetts AIDS Testing Act, Gen. Laws ch. 111 § 70F; the Massachusetts Consumer Protection Act, Gen. Laws ch. 93A; the Massachusetts Equal Rights for the Elderly and Disabled Law, Gen. Laws ch. 93 § 103; the Massachusetts Anti-Sexual Harassment Statute, Gen. Laws ch. 214, § 1C; the Massachusetts Wage Act, Mass. Gen. Laws ch. 149, §§ 148 et seq.; the Massachusetts Wage and Hour Laws, Gen. Laws ch. 151 §§ 1A et seq.; the Massachusetts age discrimination law, Mass. Gen. Laws ch. 149, §§ 24A et seq., and for any known and unknown claims under any other federal, Massachusetts, or local statute, common law, acts, rules, ordinance, regulations, or other laws, all as amended, and all common law claims and common law theories, including, but not limited to breach of public policy, assault and battery, defamation, negligent supervision, and breach of contract (whether founded in tort or contract), tortious interference with contract or prospective business advantage, breach of the covenant of good faith and fair dealing, promissory estoppel, detrimental reliance, invasion of privacy, wrongful or retaliatory discharge, fraud, defamation, slander, libel, false imprisonment, negligent or intentional infliction of emotional distress, any and all claims for compensation of any type whatsoever, including but not limited to claims for salary, wages, bonuses, commissions, incentive compensation, vacation/paid time off and/or severance, and any and all claims for monetary or equitable relief, including but not limited to attorneys’ fees, back pay, front pay, reinstatement, experts’ fees, medical fees or expenses, costs and disbursements.

 

 


 

However, this Agreement shall not prohibit and the Associate does not waive, release or discharge, any right to file an administrative charge or complaint with the Equal Employment Opportunity Commission or other federal administrative agency, although the Associate waives any right to monetary relief related to such a charge or federal administrative complaint, and claims which cannot be waived by law, such as claims for unemployment benefit rights, workers’ compensation benefits, Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), or any rights to vested benefits, such as pension or retirement benefits.  

 

5.OWBPA Disclosure Notice.  Pursuant to the ADEA and OWBPA, the Company is providing the Associate with specific information because the Associate is 40 years of age or older, or included in a group with other associates who are 40 years of age or older, and being offered to execute a release of claims in connection with the Associate’s termination resulting from the Company’s continuing cost realignment.  The OWBPA Disclosure Notice is attached hereto as Exhibit A and made a part of this Agreement.  The OWBPA Disclosure Notice explains the decisional unit considered for employment termination; any eligibility factors for and time limits applicable to the offering of this Agreement; the job titles and ages of individuals who were selected for termination of employment; and the job titles and ages of individuals in the decisional unit not selected.  Please review Exhibit A before signing the Agreement.  

 

6.Specific Release of ADEA Claims.  In further consideration of the severance payments provided to the Associate in this Agreement, the Associate hereby irrevocably and unconditionally fully and forever waive, release and discharge the Releasees from any and all claims, whether known or unknown, from the beginning of time to the date of the Associate’s execution of this Agreement arising under the ADEA, as amended, and its implementing regulations. By signing this Agreement, the Associate hereby acknowledges and confirms that: (i) the Associate has read this Agreement in its entirety and understands all of its terms; (ii) the Associate has been advised of and has availed himself/herself of the Associate’s right to consult with an attorney prior to executing this Agreement; (iii) the Associate knowingly, freely and voluntarily assents to all of the terms and conditions set out in this Agreement including, without limitation, the waiver, release and covenants contained herein; (iv) the Associate is executing this Agreement, including the waiver and release, in exchange for good and valuable consideration in addition to anything of value to which the Associate is otherwise entitled; (v) the Associate was given at least forty-five (45) days to consider the terms of this Agreement and consult with an attorney of the Associate’s choice, although Associate may sign it sooner if desired; (vi) the Associate understands that the Associate has seven (7) days from the date that the Associate signs this Agreement to revoke the release in this paragraph by delivering notice of revocation to:  Mike Gaydos, Human Resources Director, at The ExOne Company, 127 Industry Blvd, North Huntingdon, PA 15642, by overnight delivery before the end of such seven-day period; and (vii) the Associate understands that the release contained in this paragraph does not apply to rights and claims that may arise after the date on which the Associate signs this Agreement.  This Agreement shall not become effective, until the eighth (8th) day after the Associate and the Company execute this Agreement, provided the Associate does not revoke the Associate’s acceptance within the revocation period outlined herein. Such date shall be the Effective Date of this Agreement. No payments due to the Associate hereunder shall be made or begin before the Effective Date.

 

 


 

7.Severance.  In consideration for the commitments and representations made by the Associate as set forth in Paragraphs 1 through 6 of this Agreement, and provided Associate does not revoke Associate’s acceptance of this Agreement, the Company will pay to the Associate the gross amount of $124,997.60, minus all relevant taxes and other withholdings (reflecting 6 months base pay as severance) (collectively “Severance Pay”), in a lump sum payment to be paid through the Company’s normal payroll processing, on the next regularly scheduled pay date following the Effective Date.  The Associate acknowledges that the Severance Pay under this paragraph is in addition to anything else due and owing to the Associate at the time of Associate’s termination from employment.  To the extent that there is any tax or other liability associated with the consideration described in this paragraph, such liability is Associate’s alone and Associate agrees to indemnify and hold harmless Releasees from any such liability and related penalties or costs.

 

The Company undertakes that it will not contest any application Associate makes for unemployment benefits.

 

Company provided medical, dental, and vision insurance coverage ends on April 30, 2020.  Medical, dental and vision insurance may be continued by requesting the coverage and paying the applicable monthly COBRA premium.  Enclosed is your COBRA Notice that explains your rights to benefit continuation, at your own cost under COBRA.  The COBRA Notice contains important information that is time sensitive, so please review and follow the instructions in the COBRA Notice.  If you timely elect to continue your coverage under COBRA by submitting the enclosed election form to the Company, the Company will pay your 6 months (May 2020 through October 2020) of COBRA continuation premium.  Any additional months of COBRA coverage are your full responsibility. COBRA continuation premiums must be timely received by the Company in accordance with the requirements in the COBRA Notice.  

 

All other Company insurance benefits, including Short Term Disability, Long Term Disability, Life, and Accidental Death and Dismemberment insurances will end on your date of termination listed in paragraph 1 above. Life Insurance is portable. It may be purchased directly from the insurance company if voluntary insurance had been elected during employment.

 

8.Representations by Associate.  The Associate makes the following representations:

 

 

a.

The Associate understands and agrees that the Company is making this severance payment to the Associate solely in consideration for the commitments the Associate has made as set forth in this Agreement;

 

b.

The Associate understands and agrees that if the Associate had not made these commitments the Associate would not be eligible under any Company policy to receive the Severance Pay outlined in the Agreement, and

 

c.

The Associate is receiving adequate consideration from the Company for the Associate’s commitments.

 

 


 

9.Non-admission. The Company does not admit that it or any of the Company's representatives, agents, or employees have acted toward the Associate in any unlawful or improper way, and the Company's willingness to enter into this Agreement may not be so construed.

 

10.Non-disparagement.  Neither party shall make any statements or take any actions that disparage, hold out to public embarrassment, or ridicule the other Party, its services, products, management, employees, image, tradecraft, practices, office environment, culture, or otherwise harm its reputation. This paragraph shall not prevent the Associate from making truthful statements in response to a subpoena or under oath in the course of an investigation conducted by the EEOC or another government administrative agency.

 

11.Controlling Law.  This Agreement, for all purposes, shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania without regard to conflicts-of-law principles. Any action or proceeding by either of the Parties to enforce this Agreement shall be brought only in any state or federal court located in the Commonwealth of Pennsylvania, county of Westmoreland.  The parties hereby irrevocably consent to the jurisdiction of the state and federal courts of the Commonwealth of Pennsylvania, County of Westmoreland, it being the intent of the parties that the internal laws and forums of the Commonwealth of Pennsylvania shall govern any and all disputes arising out of or relating to this Agreement.  

 

12.Entire Agreement.  This Agreement constitutes the entire agreement and understanding between the parties concerning the subject matter of this Agreement, supersedes all prior understandings, whether written or verbal, if any, between the parties and constitutes the sole obligations of the parties to one another, with the exception of the Confidentiality Agreement which remains in full force and effect and is attached hereto for the Associate’s reference and compliance with same.  This Agreement may not be modified, except by written consent of all Parties hereto. This Agreement shall be binding and inure to the benefit of the Parties and their successors and assigns.  A court’s ruling rendering any provision(s) of this Agreement as invalid or unenforceable shall not affect the validity of the remaining provisions of this Agreement.

 

 


 


 

ACKNOWLEDGMENT OF FULL UNDERSTANDING. THE ASSOCIATE ACKNOWLEDGES AND AGREES THAT THE ASSOCIATE HAS FULLY READ, UNDERSTANDS AND VOLUNTARILY ENTERS INTO THIS AGREEMENT. THE ASSOCIATE ACKNOWLEDGES AND AGREES THAT ASSOCIATE HAS HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF ASSOCIATE’S CHOICE BEFORE SIGNING THIS AGREEMENT. THE ASSOCIATE FURTHER ACKNOWLEDGES THAT ASSOCIATE’S SIGNATURE BELOW IS AN AGREEMENT TO RELEASE THE COMPANY FROM ANY AND ALL CLAIMS.

 

Executed at ________________________, this      9th   day of April                      , 2020 by the parties hereto, intending to be legally bound hereby.

 

 

/s/ Charles Grace

 

 

 

Charles Grace

 

The ExOne Company

 

 

 

 

 

 

By:

/s/ John Hartner

 

 

 

 

 

 

 

    John Hartner

 

 

 

Chief Executive Officer

 

 

 

 

xone-ex104_16.htm

Exhibit 10.4

 

PROMISSORY  NOTE

(Paycheck Protection Program Loan)

 

SBA Loan No. 51877270-00

Principal Amount $2,193,512.00

4/18/2020

 

FOR VALUE RECEIVED, the undersigned ("Borrower"), with an address of 127 Industry Blvd North Huntingdon, PA 15642, promises to pay to the order of The Huntington National Bank ("Lender", which term shall include any holder hereof) at such place as Lender may designate or, in the absence of such designation, at any of Lender's offices, the sum of $2,193,512.00 (the "Principal Sum") together with interest as hereinafter provided, and payable at the time(s) and in the manner(s) hereinafter provided.

 

INTEREST. Interest will accrue on the unpaid balance of the Principal Sum at the rate of 1.000% per annum and is computed on a simple interest 365/365 basis.

 

MANNER OF PAYMENT. The Principal Sum and accrued interest shall be repaid in eighteen installments of $122,828.79 beginning on 11/18/2020 and continuing on the same day of each month thereafter, with the final payment due on 4/18/2022 (the "Maturity Date"). Payments include principal and interest. On the Maturity Date, all unpaid principal and all accrued unpaid interest shall be due and payable.

 

The monthly payment amount specified above is based on the assumption that none of the Principal Sum is forgiven pursuant to Section 1106 of the Coronavirus Aid, Relief, and Economic Security Act (as amended, the "CARES Act"), its implementing regulations and Small Business Administration ("SBA") rules. If only part of the Principal Sum is forgiven in connection with the CARES Act, then after application of such forgiveness amount, the loan evidenced hereby shall be re-amortized and a new monthly payment amount shall be communicated to Borrower. In addition, the initial monthly payments made by Borrower shall be credited first to the interest that has accrued during the initial deferment period on any unforgiven portion of the Principal Sum until all accrued interest is paid.

 

This Note may be prepaid in full by Borrower at any time without penalty.

 

LATE CHARGE. If any payment is 11 days or more late, Borrower will be charged 5.00% of the regularly scheduled payment, to the extent permitted under applicable law and SBA rules.

 

DISHONORED ITEM FEE. Borrower will pay a fee to Lender of $15.00 if Borrower makes a payment on the loan and the check or preauthorized charge with which Borrower pays is later dishonored, to the extent permitted under applicable law and the SBA rules.

 

NO COLLATERAL. The loan evidenced hereby is unsecured and, notwithstanding anything to the contrary therein, is not secured by any existing collateral documents executed by Borrower or any other person in favor of Lender with respect to any other loans or obligations of Borrower.

 

DEFAULT. Upon the occurrence of any of the following events:

 

(1)Borrower fails to pay any installment when due hereunder or to perform any obligation of Borrower to Lender;

 

(2)Borrower fails to furnish true and complete financial statements from time to time on request of Lender;

 

Page 1 of 5


 

(3)the death of any individual Borrower;

 

(4)any representation, warranty, certification or other information given to Lender by Borrower proves to be false, untrue or misleading in any material respect; or

 

(5)the dissolution or termination of Borrower's existence as a going business, the insolvency of Borrower, the appointment of a receiver for any part of Borrower's property, any assignment for the benefit of creditors, or the commencement of any proceeding under any bankruptcy or insolvency laws by or against Borrower;

 

then Lender may, at its option, without further notice or demand, accelerate the maturity of the obligations evidenced hereby, which obligations shall become immediately due and payable. In the event Lender shall institute any action for the enforcement or collection of the obligations evidenced hereby, Borrower agree to pay all costs and expenses of such action, including reasonable attorneys' fees, to the extent permitted by law.

 

ACKNOWLEDGEMENT; WAIVER AND RELEASE; HOLD HARMLESS.

 

In connection with all aspects of the loan evidenced by this Note (the "PPP Loan"), Borrower acknowledges and agrees, on behalf of itself and, as applicable, its shareholders, partners, members, officers, managers, directors and affiliates (collectively, together with the Borrower, the "Borrower Parties"), that: (a)(i) this Note is an arm' s-length commercial transaction between Borrower, on the one hand, and Lender, on the other hand, (ii) each Borrower Party has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, (iii) each Borrower Party is capable of evaluating, and understands and accepts, the terms, risks and conditions of this Note, the PPP Loan and the Paycheck Protection Loan Borrower Application Form executed and delivered to Lender in connection with this Note (the "Application") and (iv) each Borrower Party has made its own independent determination regarding (A) Borrower's eligibility for the PPP Loan and the maximum permitted amount of the PPL Loan and (B) the ability of the Borrower Parties to make each of the representations, warranties and certifications made in the Application. Borrower hereby represents and warrants to Lender that all information set forth in the Application, all other information provided to Lender, and all representations, warranties and certifications of the Borrower Parties set forth in the Application are true and correct. Lender has no obligation to any Borrower Party with respect to this Note or the PPP Loan except those obligations expressly set forth in this Note. Borrower, on behalf of itself and the other Borrower Parties, hereby waives and releases, and agrees to hold the Lender harmless from, any claims that any Borrower Party may have against Lender with respect to or arising out of this Note, the PPP Loan, the Application and the transactions evidenced thereby, including any breach or alleged breach of agency or fiduciary duty.

 

ELIGIBILITY FOR LOAN FORGIVENESS. By execution of this Note, Borrower acknowledges the NOTICE REGARDING ABILITY TO APPLY FOR LOAN FORGIVENESS attached hereto and made a part hereof.

 

AUTHORIZATION.  Borrower represents and warrants to Lender that (A) Borrower is duly organized, validly existing, and in good standing under and by virtue of the laws of the state in which Borrower is organized; (B) Borrower is duly authorized to transact business in all other states in which Borrower is doing business, including registering as a foreign entity in any such states if necessary; (C) the execution, delivery, and performance of this Note on behalf of Borrower has been duly authorized and is not in conflict with Borrower's articles of incorporation, articles of organization, partnership agreement, joint venture agreement, bylaws or code of regulations, operating agreement, or other similar agreement; and (D) the person(s) executing this Note has been duly authorized to do so. At least thirty (30) days prior to the occurrence of any of the following events, Borrower shall deliver to Lender written notice of such impending event: (i) change in Borrower's principal place of business or chief executive office or residence (if Borrower is an individual) or (ii) change in Borrower's name, identity, or corporate structure.

 

Page 2 of 5


 

WAIVER OF PRESENTMENT. Borrower hereby waives presentment, notice of dishonor, protest, notice of protest, and diligence in bringing suit against any party hereto.

 

FEES AND EXPENSES. Borrower agrees to pay all costs, expenses (including reasonable attorneys' fees), and disbursements incurred by Lender (a) in all efforts made to enforce payment of the indebtedness represented by this Note, (b) in connection with entering into, modifying, amending, and enforcing this Note and all related agreements, documents and instruments, (c) in defending or prosecuting any actions or proceedings arising out of or relating to Lender's transactions with Borrower under this Note, or (d) in connection with any advice given to Lender with respect to its rights and obligations under this Note and all related agreements.

 

RIGHT OF SETOFF. To the extent permitted by applicable law, Lender reserves a right of setoff in all Borrower's accounts with Lender (whether checking, savings, or some other account). This includes all accounts Borrower holds jointly with someone else and all accounts Borrower may open in the future. However, this does not include any IRA or Keogh accounts, or any trust accounts, for which setoff would be prohibited by law. Borrower authorizes Lender, to the extent permitted by applicable law, to charge or setoff all sums owing on the indebtedness hereunder against any and all such accounts.

 

WAIVER/AMENDMENT. No waiver of any term or condition of this Note shall be effective unless in writing and signed by the party giving or granting the waiver. No amendment of any term or condition of this Note shall be effective unless in writing and signed by Borrower and Lender. No failure or delay on the part of Lender in exercising any right, power or privilege under this Note, related loan documents or law nor any course of dealing, shall operate as a waiver of such right, power or privilege or preclude any other or further exercise thereof or of any other right, power or privilege.

 

PREFERENCE. Borrower agrees that, to the extent that Borrower makes a payment or payments to Lender, which payment or payments or proceeds or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside and/or required to be repaid to Borrower, Borrower's estate, trustee, receiver or any other party under any bankruptcy law, state or federal law, common law or equitable cause, then to the extent of such payment or repayment, the obligations under this Note or the part thereof which has been paid, reduced or satisfied by such amount shall be reinstated and continued in full force and effect as of the date such initial payment, reduction or satisfaction occurred.

 

IMPORTANT INFORMATION ABOUT PROCEDURES REQUIRED BY THE USA PATRIOT ACT

 

To help the government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each entity or person who opens an account or establishes a relationship with Lender.

 

What this means: When an entity or person opens an account or establishes a relationship with Lender, Lender may ask for the name, address, date of birth, and other information that will allow Lender to identify the entity or person who opens an account or establishes a relationship with Lender. Lender may also ask to see identifying documents for the entity or person.

 

WAIVER OF RIGHT TO TRIAL BY JURY.  Borrower acknowledges that,  as  to any  and  all  disputes that may arise between Borrower and Lender, the commercial nature of the transaction out of which this  Note  arises  makes  any  such  dispute  unsuitable  for  trial  by  jury.   Accordingly,  Borrower hereby waives any right to trial by jury as to any and all disputes that may arise relating to this Note, or to any of the instruments or documents executed in connection therewith.

 

Page 3 of 5


 

SEVERABILITY; GOVERNING LAW. The captions used herein are for reference only and shall not be deemed a part of this Note. If any of the terms or provisions of this Note shall be deemed unenforceable, the enforceability of the remaining terms and provisions shall not be affected. This Note shall be governed by and construed in accordance with the law of the State of Ohio.

 

 

 

PRIOR TO SIGNING THIS NOTE, BORROWER HAS READ AND UNDERSTANDS All THE PROVISIONS OF THIS NOTE. BORROWER AGREES TO THE TERMS OF THE NOTE.

 

Borrower:

 

THE EXONE COMPANY

 

By:

 

/s/ Douglas D. Zemba

 

 

     Douglas D. Zemba

Chief Financial Officer & Treasurer

Print Name and Title

 

 

Page 4 of 5


 

NOTICE REGARDING ABILITY TO APPLY FOR LOAN FORGIVENESS

 

You are receiving a Paycheck Protection Program loan extended pursuant to Sections 1102 and 1106 of the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"), any implementing regulations and U.S. Small Business Administration (the "SBA") rules. Pursuant to Section 1106 of the CARES Act, some or all of the loan may be forgiven subject to satisfaction of certain conditions. You will be required to follow an application process to receive any loan forgiveness.

 

You will be eligible for forgiveness of the loan only in an amount equal to the sum of the following costs incurred and payments made during the 8-week period beginning on the date the loan is made (the "covered period"):

 

 

o

Payroll costs (as defined in Section 1102 of the CARES Act)

 

o

Interest on any mortgage obligation incurred prior to February 15, 2020 (does not include prepayment penalties or principal payments)

 

o

Rent under any leasing agreement entered into prior to February 15, 2020

 

o

Utilities for which service began prior to February 15, 2020 (electric, gas, water, transportation, telephone, internet service)

 

The SBA has stated that at least 75% of the requested forgiveness amount must have been used to fund payroll costs.

 

In addition, the amount of any loan forgiveness will be reduced based on reductions in wages or the number of full-time equivalent employees compared to certain prior periods. You have until June 30, 2020 to restore your full-time employment and salary levels for any changes made between February 15, 2020 and April 26, 2020.

 

When you apply for loan forgiveness, the following documentation of use of the loan funds for eligible expenses must be submitted:

 

 

o

Proof of payment (copies of cancelled checks or evidence of electronic payment, transcript of account, or other documents verifying payment)

 

o

Documentation verifying number of employees and pay rates for the applicable periods, including payroll reports, payroll tax filings reported to the Internal Revenue Service, and State income, payroll, and unemployment insurance filings

 

o

Any other documentation required by SBA rules

 

Please refer to the CARES Act and SBA rules for complete rules and requirements regarding forgiveness of the loan.

Page 5 of 5

xone-ex311_8.htm

 

Exhibit 31.1

CERTIFICATIONS

I, John F. Hartner, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of The ExOne Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 7, 2020

 

The ExOne Company

 

/s/ John F. Hartner

John F. Hartner

Chief Executive Officer

(Principal Executive Officer)

 

 

xone-ex312_7.htm

 

Exhibit 31.2

CERTIFICATIONS

I, Douglas D. Zemba, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of The ExOne Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 7, 2020

 

The ExOne Company

 

/s/ Douglas D. Zemba

Douglas D. Zemba

Chief Financial Officer

(Principal Financial Officer and Principal

Accounting Officer)

 

 

xone-ex32_6.htm

 

Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the filing of this Quarterly Report on Form 10-Q of The ExOne Company (the “Company”) for the quarterly period ended March 31, 2020, with the Securities and Exchange Commission on the date hereof (the “Report”), the Undersigned certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 7, 2020

 

/s/ John F. Hartner

John F. Hartner

Chief Executive Officer

(Principal Executive Officer)

 

/s/ Douglas D. Zemba

Douglas D. Zemba

Chief Financial Officer

(Principal Financial Officer and Principal

Accounting Officer)

 

v3.20.1
Related Party Transactions
3 Months Ended
Mar. 31, 2020
Related Party Transactions [Abstract]  
Related Party Transactions

Note 17. Related Party Transactions

Purchases of products and/or services from related parties during the three months ended March 31, 2019 were $15.  Purchases of products and/or services by the Company during the three months ended March 31, 2019 included leased office space and website design services from related parties under common control by S. Kent Rockwell, (currently Chairman of the Board of the Company and previously the Executive Chairman and Chief Executive Officer of the Company). None of the transactions met a threshold requiring review and approval by the Audit Committee of the Board. There were no purchases of products and/or services from related parties during the three months ended March 31, 2020. There were no amounts due to related parties at either March 31, 2020 or December 31, 2019.  

Refer to Note 12 for further discussion relating to the Company’s revolving credit facility with a related party.

v3.20.1
Accumulated Other Comprehensive Loss (Tables)
3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Summary of Changes in the Components of Accumulated Other Comprehensive Loss

The following table summarizes changes in the components of accumulated other comprehensive loss for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Foreign currency translation adjustments

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$

(11,483

)

 

$

(10,748

)

Other comprehensive loss

 

 

(838

)

 

 

(776

)

Balance at end of period

 

$

(12,321

)

 

$

(11,524

)

v3.20.1
Revenue - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Disaggregation Of Revenue [Line Items]      
Revenue, description of payment terms the Company’s terms of sale generally require payment within 30 to 60 days after delivery, although the Company also recognizes that longer payment periods are customary in certain countries where it transacts business.    
Revenue recognized related to contract liabilities $ 3,902    
Revenue, remaining performance obligation 33,800    
Allowance for doubtful accounts 548   $ 508
Provision (recoveries) for bad debts ̶ net $ 51 $ (73)  
Maximum [Member]      
Disaggregation Of Revenue [Line Items]      
Term till payment is required from date of shipment 60 days    
Minimum [Member]      
Disaggregation Of Revenue [Line Items]      
Term till payment is required from date of shipment 30 days    
v3.20.1
Accumulated Other Comprehensive Loss - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]    
Accumulated other comprehensive loss, tax $ 0 $ 0
Amounts reclassified to earnings from accumulated other comprehensive loss $ 0 $ 0
v3.20.1
Equity-Based Compensation - Summary of Equity-Based Compensation Expense (Parenthetical) (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]    
Benefit for income taxes from equity-based compensation [1] $ 0 $ 0
[1] The benefit for income taxes from equity-based compensation for each of the periods presented has been determined to be $0 based on valuation allowances against net deferred tax assets.
v3.20.1
Leases - Schedule of Net Investment in Sales-type Leases (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
Future minimum lease payments receivable $ 1,624  
Less: Allowance for doubtful accounts (415)  
Net future minimum lease payments receivable 1,209  
Less: Unearned interest income (208)  
Net investment in sales-type leases $ 1,001  
Future minimum lease payments receivable   $ 1,595
Less: Allowance for doubtful accounts   (424)
Net future minimum lease payments receivable   1,171
Less: Unearned interest income   (220)
Net investment in sales-type leases   $ 951
v3.20.1
Income Taxes - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Schedule Of Income Taxes [Line Items]    
Provision (benefit) for income taxes $ 226,000 $ (800,000)
Effective tax rate 6.60% 15.10%
United States statutory rate 21.00% 21.00%
Penalties and interest expense $ 0 $ 0
Subsidiaries [Member] | Local Taxing Authorities [Member] | Germany [Member]    
Schedule Of Income Taxes [Line Items]    
Reversal of previously recorded liabilities for uncertain tax positions   1,075,000
Uncertain tax positions expected amount to be offset against net operating loss carryforwards   $ 257,000
v3.20.1
Condensed Statement of Consolidated Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenue $ 13,383 $ 9,579
Cost of sales 9,754 6,937
Gross profit 3,629 2,642
Operating expenses    
Research and development 2,476 2,432
Selling, general and administrative 6,163 5,423
Gain from sale-leaseback of property and equipment (1,462)  
Total operating expenses 7,177 7,855
Loss from operations (3,548) (5,213)
Other (income) expense    
Interest expense 64 71
Other (income) expense ̶ net (190) 12
Total other (income) expense (126) 83
Loss before income taxes (3,422) (5,296)
Provision (benefit) for income taxes 226 (800)
Net loss $ (3,648) $ (4,496)
Net loss per common share:    
Basic $ (0.22) $ (0.28)
Diluted $ (0.22) $ (0.28)
Comprehensive loss:    
Net loss $ (3,648) $ (4,496)
Other comprehensive loss:    
Foreign currency translation adjustments (838) (776)
Comprehensive loss $ (4,486) $ (5,272)
v3.20.1
Property and Equipment - Summary of Property and Equipment (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Property Plant And Equipment [Line Items]      
Total gross property and equipment before accumulated depreciation $ 38,624   $ 59,272
Less: Accumulated depreciation (18,306)   (21,478)
Property and equipment, excluding construction-in-progress 20,318   37,794
Construction-in-progress 402   1,101
Property and equipment ̶ net 20,720 $ 38,895 38,895
Land [Member]      
Property Plant And Equipment [Line Items]      
Total gross property and equipment before accumulated depreciation 3,378   6,980
Building and Related Improvements [Member]      
Property Plant And Equipment [Line Items]      
Total gross property and equipment before accumulated depreciation $ 9,989   25,675
Building and Related Improvements [Member] | Minimum [Member]      
Property Plant And Equipment [Line Items]      
Property and equipment, Economic Life 5 years    
Building and Related Improvements [Member] | Maximum [Member]      
Property Plant And Equipment [Line Items]      
Property and equipment, Economic Life 40 years    
Machinery and Equipment [Member]      
Property Plant And Equipment [Line Items]      
Total gross property and equipment before accumulated depreciation $ 19,208   19,531
Machinery and Equipment [Member] | Minimum [Member]      
Property Plant And Equipment [Line Items]      
Property and equipment, Economic Life 3 years    
Machinery and Equipment [Member] | Maximum [Member]      
Property Plant And Equipment [Line Items]      
Property and equipment, Economic Life 20 years    
Other [Member]      
Property Plant And Equipment [Line Items]      
Total gross property and equipment before accumulated depreciation $ 6,049   $ 7,086
Other [Member] | Minimum [Member]      
Property Plant And Equipment [Line Items]      
Property and equipment, Economic Life 3 years    
Other [Member] | Maximum [Member]      
Property Plant And Equipment [Line Items]      
Property and equipment, Economic Life 20 years    
v3.20.1
Condensed Statement of Changes in Consolidated Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Beginning Balance at Dec. 31, 2018 $ 62,775 $ 162 $ 175,214 $ (101,853) $ (10,748)
Beginning Balance, Shares at Dec. 31, 2018   16,234,000      
Net loss (4,496)     (4,496)  
Other comprehensive income (loss) (776)       (776)
Equity-based compensation 439   439    
Exercise of employee stock options $ 165 $ 1 164    
Exercise of employee stock options, shares 23,247 23,000      
Taxes related to the net share settlement of equity-based awards $ (68)   (68)    
Common stock issued from equity incentive plan, shares   28,000      
Ending Balance at Mar. 31, 2019 58,039 $ 163 175,749 (106,349) (11,524)
Ending Balance, Shares at Mar. 31, 2019   16,285,000      
Beginning Balance at Dec. 31, 2019 $ 48,582 $ 163 176,850 (116,948) (11,483)
Beginning Balance, Shares at Dec. 31, 2019 16,346,960 16,347,000      
Net loss $ (3,648)     (3,648)  
Other comprehensive income (loss) (838)       (838)
Equity-based compensation $ 292 $ 1 291    
Exercise of employee stock options, shares 0        
Common stock issued from equity incentive plan, shares   39,000      
Ending Balance at Mar. 31, 2020 $ 44,388 $ 164 $ 177,141 $ (120,596) $ (12,321)
Ending Balance, Shares at Mar. 31, 2020 16,386,487 16,386,000      
v3.20.1
Leases - Additional Information (Detail)
€ in Thousands
1 Months Ended 3 Months Ended
Dec. 10, 2019
USD ($)
RenewalOption
Dec. 10, 2019
EUR (€)
RenewalOption
Dec. 30, 2019
USD ($)
Dec. 30, 2019
EUR (€)
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Dec. 10, 2019
EUR (€)
Leases [Line Items]                
Lease expiration year         2026      
Short term lease cost         $ 31,000 $ 65,000    
Lease cost         504,000 113,000    
Operating lease right-of-use asset         4,789,000   $ 432,000  
Operating lease liability         $ 4,789,000      
Minimum [Member]                
Leases [Line Items]                
Operating lease arrangement terms         1 year      
Maximum [Member]                
Leases [Line Items]                
Operating lease arrangement terms         5 years      
Germany [Member] | Purchase Agreement [Member] | Sale-Leaseback of Gersthofen, Germany Facility [Member]                
Leases [Line Items]                
Purchase price from sale leaseback $ 18,500,000             € 17,000
Proceeds from sale leaseback     $ 2,200,000 € 2,000        
Sale leaseback annual rent $ 1,700,000 € 1,500            
Sale leaseback transaction, lease terms         Concurrent with the execution of the Purchase Agreement, ExOne GmbH and the Buyer entered into a rental contract (the “Lease”) for the leaseback of the Facility for an initial aggregate annual rent totaling approximately $1,700 (€1,500), plus applicable taxes, which is fixed during the initial three-year term and is subject to adjustment on an annual basis (in accordance with the consumer price index for Germany) during the two five-year option extension periods.      
Sale leaseback, term of contract 3 years 3 years            
Number of renewal option for sale leaseback | RenewalOption 2 2            
Sale lease back renewal term 5 years 5 years            
Sale-leaseback transaction closed date February 18, 2020 February 18, 2020            
Operating lease right-of-use asset $ 4,605              
Operating lease liability $ 4,605              
Related Parties Under Common Control [Member]                
Leases [Line Items]                
Short term lease cost           $ 12,000    
v3.20.1
Fair Value Measurements - Carrying Values and Fair Values of Other Financial Instruments (Detail) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Carrying Value [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents $ 16,813 $ 5,265
Restricted cash 508 978
Debt issuance costs 130 107
Current portion of long-term debt 155 153
Long-term debt ̶ net of current portion 1,171 1,211
Fair Value [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents 16,813 5,265
Restricted cash 508 978
Current portion of long-term debt 159 157
Long-term debt ̶ net of current portion $ 1,186 $ 1,227
v3.20.1
Equity-Based Compensation - Assumptions for Fair Value of Stock Options Granted Estimated on the Date of Grant Using the Black-Scholes Option (Detail) - Stock Options [Member]
3 Months Ended
Mar. 31, 2019
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted average fair value per stock option $ 3.48
Volatility 54.00%
Average risk-free interest rate 2.50%
Dividend yield 0.00%
Expected term (years) 2 years 6 months
v3.20.1
Other (Income) Expense - Net - Schedule of Other (Income) Expense - Net (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Other Income And Expenses [Abstract]    
Interest income $ (12) $ (6)
Foreign currency (gains) losses – net (165) 22
Other – net (13) (4)
Other expense (income) - net $ (190) $ 12
v3.20.1
Income Taxes
3 Months Ended
Mar. 31, 2020
Income Tax Disclosure [Abstract]  
Income Taxes

 

Note 13. Income Taxes

The provision (benefit) for income taxes for the three months ended March 31, 2020 and 2019 was $226 and ($800), respectively. The Company has completed a discrete period computation of its provision (benefit) for income taxes for each of the periods presented. The discrete period computation was required as a result of jurisdictions with losses before income taxes for which no tax benefit can be recognized and an inability to generate reliable estimates for results in certain jurisdictions as a result of inconsistencies in generating net operating profits (losses) in those jurisdictions.

The effective tax rate for the three months ended March 31, 2020 and 2019 was 6.6% (provision on a loss) and 15.1% (benefit on a loss), respectively. For the three months ended March 31, 2020, the effective tax rate differed from the United States federal statutory rate of 21.0% primarily due to net changes in valuation allowances for the period. For the three months ended March 31, 2019, the effective tax rate differed from the United States federal statutory rate of 21.0% primarily due to the reversal of previously recorded liabilities for uncertain tax positions (further described below) and net changes in valuation allowances for the period.

The Company has provided a valuation allowance for certain of its net deferred tax assets as a result of the Company not generating consistent net operating profits in certain jurisdictions in which it operates. As such, certain benefits from deferred taxes in the periods presented have been fully offset by changes in the valuation allowance for the related net deferred tax assets. The Company continues to assess its future taxable income by jurisdiction based on recent historical operating results, the expected timing of reversal of temporary differences, various tax planning strategies that the Company may be able to enact in future periods, the impact of potential operating changes on the business and forecast results from operations in future periods based on available information at the end of each reporting period. To the extent that the Company is able to reach the conclusion that net deferred tax assets are realizable based on any combination of the above factors in a single, or in multiple, taxing jurisdictions, a reversal of the related portion of the Company’s existing valuation allowances may occur.

A reconciliation of the beginning and ending amount of unrecognized tax benefits (including accrued interest and penalties) was as follows for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Balance at beginning of period

 

$

 

 

$

1,186

 

Additions based on tax positions related to the current year

 

 

 

 

 

 

Additions for tax positions of prior years

 

 

 

 

 

1

 

Reductions for tax positions of prior years

 

 

 

 

 

(1,075

)

Settlements

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

 

 

 

(10

)

Balance at end of period

 

$

 

 

$

102

 

 

The Company includes interest and penalties related to income taxes as a component of the provision (benefit) for income taxes in the accompanying condensed statement of consolidated operations and comprehensive loss. There were no such interest or penalties included in the provision (benefit) for income taxes for the three months ended March 31, 2020 or 2019.

At December 31, 2018, the Company’s ExOne GmbH (2010-2013) and ExOne Property GmbH (2013) subsidiaries were under examination by local taxing authorities in Germany. In January 2019, this examination was concluded by the local taxing authorities in Germany without significant adjustment to previously established tax positions. As a result, during the three months ended March 31, 2019, the Company recorded a reversal of certain of its previously recorded liabilities for uncertain tax positions of $1,075, of which $257 was offset against net operating loss carryforwards.

v3.20.1
Revenue
3 Months Ended
Mar. 31, 2020
Revenue From Contract With Customer [Abstract]  
Revenue

Note 5. Revenue

The Company derives revenue from the sale of 3D printing machines and 3D printed and other products, materials and services. Revenue is recognized when the Company satisfies its performance obligation(s) under a contract (either implicit or explicit) by transferring the promised product or service to a customer either when (or as) the customer obtains control of the product or service. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. A contract’s transaction price is allocated to each distinct performance obligation.

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales, value add, and other taxes collected from customers and remitted to governmental authorities are accounted for on a net (excluded from revenue) basis. Shipping and handling costs are included in cost of sales.

Certain of the Company’s contracts with customers provide for multiple performance obligations. Sales of 3D printing machines may also include optional equipment, materials, replacement components and services (installation, training and other services, including maintenance services and/or an extended warranty). Certain other contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation using the Company’s best estimate of stand-alone selling price for each distinct product or service in the contract, which is generally based on an observable price.

The Company’s revenue from products is transferred to customers at a point in time. The Company’s contracts for 3D printing machines generally include substantive customer acceptance provisions. Revenue under these contracts is recognized when customer acceptance provisions have been satisfied. For all other product sales, the Company recognizes revenue at the point in time in which the customer obtains control of the product, which is generally when product title passes to the customer upon delivery. In limited cases, title does not transfer and revenue is not recognized until the customer has received the products at its physical location.

The Company’s revenue from service arrangements includes deferred maintenance contracts and extended warranties that can be purchased at the customer’s option. The Company generally provides a standard one-year warranty on the Company’s 3D printing machines, which is considered an assurance type warranty, and not considered a separate performance obligation (Note 9). Revenue associated with deferred maintenance contracts is generally recognized at a point in time when the related services are performed where sufficient historical evidence indicates that the costs of performing the related services under the contract are not incurred on a straight-line basis, with such revenue recognized in proportion to the costs expected to be incurred. Revenue associated with extended warranties is generally recognized over time on a straight-line basis over the related contract period.

The Company’s revenue from service arrangements includes contracts with the Federal government under fixed-fee, cost reimbursable and time and materials arrangements (certain of which may have periods of performance greater than one year). Revenue under these contracts is generally recognized over time using an input measure based upon labor hours incurred and provisional rates provided under the contracts. As such, the nature of these contracts may give rise to variable consideration, primarily based upon completion of the Company’s annual Incurred Cost Submission filing as required by the Federal government. Historically, amounts associated with variable consideration have not been significant.

The Company’s revenue from service arrangements includes certain research and development services. Revenue under research and development service contracts is generally recognized over time using an output measure, specifically units or parts delivered, based upon certain customer acceptance and delivery requirements. Revenue recognized over time using an output measure is not significant.

The following table summarizes the Company’s revenue by product group for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

2019

 

3D printing machines

 

$

6,317

 

 

$

3,329

 

3D printed and other products, materials and services

 

 

7,066

 

 

 

6,250

 

 

 

$

13,383

 

 

$

9,579

 

 

Revenue from 3D printing machines includes leasing revenue whereby the Company is the lessor of 3D printing machines to its customers. Leasing revenue is accounted for under ASU 2016-02 (Note 10).

The timing of revenue recognition, billings and cash collections results in billed receivables, unbilled receivables (contract assets) and deferred revenue and customer prepayments (contract liabilities) in the accompanying condensed consolidated balance sheet. The Company considers a number of factors in its evaluation of the creditworthiness of its customers, including past due amounts, past payment history, and current economic conditions. For 3D printing machines, the Company’s terms of sale vary by transaction. To reduce credit risk in connection with 3D printing machine sales, the Company may, depending upon the circumstances, require customers to furnish letters of credit or bank guarantees or to provide advanced payment (either partial or in full). For 3D printed and other products and materials, the Company’s terms of sale generally require payment within 30 to 60 days after delivery, although the Company also recognizes that longer payment periods are customary in certain countries where it transacts business. Service arrangements are generally billed in accordance with specific contract terms and are typically billed in advance or in proportion to performance of the related services.

For the three months ended March 31, 2020, the Company recognized revenue of $3,902 related to contract liabilities at January 1, 2020. There were no other significant changes in contract liabilities during the three months ended March 31, 2020. Contract assets are not significant.

As of March 31, 2020, the Company has approximately $33,800 of remaining performance obligations (including contract liabilities), which is also referred to as backlog, of which approximately $29,800 is expected to be fulfilled during the next twelve months notwithstanding uncertainty related to the impact of the COVID-19 global pandemic (Note 1) including, but not limited to, international shipping and travel restrictions brought about by the global pandemic which could have an adverse effect on the timing of delivery of products and/or services to customers.

The Company has elected to apply the practical expedient associated with incremental costs of obtaining a contract, and as such, sales commission expense is generally expensed when incurred because the amortization period would be one year or less. These costs are recorded within selling, general and administrative expenses.

Accounts receivable and net investment in sales-type leases (Note 10) are reported at their net realizable value. The Company carries its investment in sales-type leases based on discounting the minimum lease payments by the interest rate implicit in the lease and less an allowance for doubtful accounts. The Company’s estimate of the allowance for doubtful accounts related to accounts receivable and net investment in sales-type leases is based on the Company’s evaluation of customer accounts with past-due outstanding balances or specific accounts for which it has information that the customer may be unable to meet its financial obligations. Based upon review of these accounts, and management’s analysis and judgment, the Company records a specific allowance for that customer’s accounts receivable or net investment in sales-type lease balance to reduce the outstanding balance to the amount expected to be collected. The allowance is re-evaluated and adjusted periodically as additional information is received that impacts the allowance amount reserved. At March 31, 2020 and December 31, 2019, the allowance for doubtful accounts was $548 and $508, respectively. During the three months ended March 31, 2020 and 2019, the Company recorded a net provision (recoveries) for bad debts of $51 and ($73), respectively.

v3.20.1
Product Warranty Reserves
3 Months Ended
Mar. 31, 2020
Product Warranties Disclosures [Abstract]  
Product Warranty Reserves

Note 9. Product Warranty Reserves

Substantially all of the Company’s 3D printing machines are covered by a standard one-year warranty. Generally, at the time of sale, a liability is recorded (with an offset to cost of sales) based upon the expected cost of replacement parts and labor to be incurred over the life of the standard warranty. Expected cost is estimated using historical experience for similar products. The Company periodically assesses the adequacy of the product warranty reserves based on changes in these factors and records any necessary adjustments if actual experience indicates that adjustments are necessary. Future claims experience could be materially different from prior results because of the introduction of new, more complex products, a change in the Company’s warranty policy in response to industry trends, competition or other external forces, or manufacturing changes that could impact product quality. In the event that the Company determines that its current or future product repair and replacement costs exceed estimates, an adjustment to these reserves would be charged to cost of sales in the period such a determination is made.

The following table summarizes changes in product warranty reserves, which amounts were reflected in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Balance at beginning of period

 

$

866

 

 

$

1,670

 

     Provisions for new issuances

 

 

276

 

 

 

146

 

     Payments

 

 

(344

)

 

 

(391

)

     Reserve adjustments

 

 

20

 

 

 

(159

)

     Foreign currency translation adjustments

 

 

(8

)

 

 

(15

)

Balance at end of period

 

$

810

 

 

$

1,251

 

 

v3.20.1
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Equity-Based Compensation Expense

The following table summarizes the total equity-based compensation expense recognized by the Company for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Equity-based compensation expense recognized:

 

 

 

 

 

 

 

 

Stock options

 

$

145

 

 

$

166

 

Restricted stock

 

 

141

 

 

 

129

 

Other(a)

 

 

6

 

 

 

144

 

Total equity-based compensation expense before income taxes

 

 

292

 

 

 

439

 

Benefit for income taxes(b)

 

 

 

 

 

 

Total equity-based compensation expense net of income taxes

 

$

292

 

 

$

439

 

 

(a)

For 2020, Other represents expense associated with certain employee contractual amounts to be settled in equity. For 2019, Other represents expense associated with the 2019 Program and certain employee contractual amounts to be settled in equity.

(b)

The benefit for income taxes from equity-based compensation for each of the periods presented has been determined to be $0 based on valuation allowances against net deferred tax assets.

Assumptions for Fair Value of Stock Options Granted Estimated on the Date of Grant Using the Black-Scholes Option

The fair value of stock options granted during the three months ended March 31, 2019, was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:

 

Weighted average fair value per stock option

 

$

3.48

 

Volatility

 

 

54.0

%

Average risk-free interest rate

 

 

2.5

%

Dividend yield

 

 

0.0

%

Expected term (years)

 

2.5

 

Summary of Activity for Stock Options The activity for stock options was as follows for the periods indicated:

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

 

 

Number of

Options

 

 

Weighted Average

Exercise Price

 

 

Weighted Average

Grant Date Fair

Value

 

 

Number of

Options

 

 

Weighted Average

Exercise Price

 

 

Weighted Average

Grant Date Fair

Value

 

Outstanding at beginning of period

 

 

854,259

 

 

$

9.34

 

 

$

4.49

 

 

 

621,986

 

 

$

10.66

 

 

$

5.52

 

Stock options granted

 

 

 

 

$

 

 

$

 

 

 

3,300

 

 

$

9.89

 

 

$

3.48

 

Stock options exercised

 

 

 

 

$

 

 

$

 

 

 

(23,247

)

 

$

7.11

 

 

$

2.92

 

Stock options forfeited

 

 

(6,876

)

 

$

7.01

 

 

$

2.84

 

 

 

 

 

$

 

 

$

 

Stock options expired

 

 

(9,000

)

 

$

10.89

 

 

$

5.82

 

 

 

(7,500

)

 

$

17.25

 

 

$

10.55

 

Outstanding at end of period

 

 

838,383

 

 

$

9.35

 

 

$

4.49

 

 

 

594,539

 

 

$

10.71

 

 

$

5.55

 

Exercisable at end of period

 

 

499,139

 

 

$

10.74

 

 

$

5.52

 

 

 

400,566

 

 

$

11.84

 

 

$

6.40

 

Expected to vest at end of period

 

 

339,244

 

 

$

7.30

 

 

$

2.96

 

 

 

193,973

 

 

$

8.37

 

 

$

3.79

 

Summary of Activity for Restricted Stock Awards The activity for restricted stock was as follows for the periods indicated:

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

 

 

Shares of

Restricted

Stock

 

 

Weighted Average

Grant Date Fair

Value

 

 

Shares of

Restricted

Stock

 

 

Weighted Average

Grant Date Fair

Value

 

Outstanding at beginning of period

 

 

66,513

 

 

$

8.76

 

 

 

67,001

 

 

$

8.30

 

Restricted stock granted

 

 

37,500

 

 

$

7.12

 

 

 

30,000

 

 

$

9.89

 

Restricted stock vested

 

 

(35,500

)

 

$

9.63

 

 

 

(27,500

)

 

$

8.08

 

Restricted stock forfeited

 

 

 

 

$

 

 

 

 

 

$

 

Outstanding at end of period

 

 

68,513

 

 

$

7.41

 

 

 

69,501

 

 

$

9.07

 

Restricted stock expected to vest at end of period

 

 

68,513

 

 

$

7.41

 

 

 

69,501

 

 

$

9.07

 

v3.20.1
Property and Equipment (Tables)
3 Months Ended
Mar. 31, 2020
Long Lived Assets [Abstract]  
Summary of Property and Equipment

Property and equipment consisted of the following as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

Economic Life

 

 

2020

 

 

2019

 

 

(in years)

Land

 

$

3,378

 

 

$

6,980

 

 

N/A

Buildings and related improvements

 

 

9,989

 

 

 

25,675

 

 

5 - 40

Machinery and equipment

 

 

19,208

 

 

 

19,531

 

 

3 - 20

Other

 

 

6,049

 

 

 

7,086

 

 

3 - 20

 

 

 

38,624

 

 

 

59,272

 

 

 

Less: Accumulated depreciation

 

 

(18,306

)

 

 

(21,478

)

 

 

 

 

 

20,318

 

 

 

37,794

 

 

 

Construction-in-progress

 

 

402

 

 

 

1,101

 

 

 

Property and equipment  ̶  net

 

$

20,720

 

 

$

38,895

 

 

 

v3.20.1
Condensed Consolidated Balance Sheet - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 16,813 $ 5,265
Restricted cash 508 978
Accounts receivable ̶ net 4,954 6,522
Current portion of net investment in sales-type leases 289 213
Inventories ̶ net 21,653 19,770
Prepaid expenses and other current assets 2,787 2,182
Total current assets 47,004 34,930
Property and equipment ̶ net 20,720 38,895
Operating lease right-of-use assets 4,789 432
Net investment in sales-type leases ̶ net of current portion 712 738
Other noncurrent assets 244 371
Total assets 73,469 75,366
Current liabilities:    
Current portion of long-term debt 155 153
Accounts payable 4,385 5,818
Accrued expenses and other current liabilities 4,590 6,942
Current portion of operating lease liabilities 1,684 158
Current portion of contract liabilities 13,646 11,846
Total current liabilities 24,460 24,917
Long-term debt ̶ net of current portion 1,171 1,211
Operating lease liabilities ̶ net of current portion 3,105 274
Contract liabilities ̶ net of current portion 230 286
Other noncurrent liabilities 115 96
Total liabilities 29,081 26,784
Contingencies and commitments
Stockholders' equity    
Common stock, $0.01 par value, 200,000,000 shares authorized, 16,386,487 (2020) and 16,346,960 (2019) shares issued and outstanding 164 163
Additional paid-in capital 177,141 176,850
Accumulated deficit (120,596) (116,948)
Accumulated other comprehensive loss (12,321) (11,483)
Total stockholders' equity 44,388 48,582
Total liabilities and stockholders' equity $ 73,469 $ 75,366
v3.20.1
Inventories - Summary of Changes in Allowance for Slow-moving and Obsolete Inventories (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Inventory Disclosure [Abstract]    
Balance at beginning of period $ 3,443 $ 4,143
Provision for slow-moving and obsolete inventories ̶ net 22 107
Reductions for physical disposal (sale or scrap) of previously reserved amounts (36)  
Foreign currency translation adjustments (59) (73)
Balance at end of period $ 3,370 $ 4,177
v3.20.1
Basis of Presentation
3 Months Ended
Mar. 31, 2020
Accounting Policies [Abstract]  
Basis of Presentation

Note 1. Basis of Presentation

Organization

The ExOne Company (“ExOne”) is a corporation organized under the laws of the state of Delaware. ExOne was formed on January 1, 2013, when The Ex One Company, LLC, a Delaware limited liability company, merged with and into a Delaware corporation, which survived and changed its name to The ExOne Company (the “Reorganization”). As a result of the Reorganization, The Ex One Company, LLC became ExOne, the common and preferred interest holders of The Ex One Company, LLC became holders of common stock and preferred stock, respectively, of ExOne, and the subsidiaries of The Ex One Company, LLC became the subsidiaries of ExOne. The condensed consolidated financial statements include the accounts of ExOne, its wholly-owned subsidiaries, ExOne Americas LLC (United States); ExOne GmbH (Germany); ExOne Property GmbH (Germany); and ExOne KK (Japan). Collectively, the consolidated group is referred to as the “Company”.

The Company filed a registration statement on Form S-3 (No. 333-223690) with the Securities and Exchange Commission on March 15, 2018. The purpose of the Form S-3 was to register various equity and debt securities. Subsidiaries of the Company are co-registrants with the Company (“Subsidiary Guarantors”), and the registration statement registered guarantees of debt securities by one or more of the Subsidiary Guarantors. The Subsidiary Guarantors are 100% owned by the Company and any guarantees by the Subsidiary Guarantors will be full and unconditional. There have been no transactions undertaken subject to the Form S-3 since its initial filing.

Basis of Presentation

The condensed consolidated financial statements of the Company are unaudited. The condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, considered necessary by management to fairly state the results of operations, financial position and cash flows of the Company. All material intercompany transactions and balances have been eliminated in consolidation. The results reported in these condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the entire year. The December 31, 2019 condensed consolidated balance sheet data was derived from the audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). This Quarterly Report on Form 10-Q should be read in connection with the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, which includes all disclosures required by GAAP.

The preparation of these condensed consolidated financial statements requires the Company to make certain judgments, estimates and assumptions regarding uncertainties that affect the reported amounts of assets, liabilities, revenue and expenses and related disclosure of contingent assets and liabilities. Areas that require significant judgments, estimates and assumptions include accounting for accounts receivable (including the allowance for doubtful accounts); inventories (including the allowance for slow-moving and obsolete inventories); product warranty reserves; contingencies; income taxes (including the valuation allowance on certain deferred tax assets and liabilities for uncertain tax positions); equity-based compensation (including the valuation of certain equity-based compensation awards issued by the Company); and testing for impairment of long-lived assets (including the identification of asset groups by management, estimates of future cash flows of identified asset groups and fair value estimates used in connection with assessing the valuation of identified asset groups). The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

Certain amounts relating to operating lease right-of-use assets ($432), current portion of operating lease liabilities ($158) and operating lease liabilities – net of current portion ($274) in the accompanying condensed consolidated balance sheet at December 31, 2019, have been reclassified from other noncurrent assets, accrued expenses and other current liabilities and other noncurrent liabilities, respectively, to conform to current period presentation.

Certain amounts relating to foreign exchange (gains) losses on intercompany transactions – net, for 2019 ($11) in the accompanying condensed statement of consolidated cash flows have been reclassified from effect of exchange rate changes on cash, cash equivalents, and restricted cash, to conform to current period presentation.

COVID-19

In March 2020, the World Health Organization declared the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide. The impact of the COVID-19 global pandemic and related economic, business and market disruptions are evolving rapidly, and their effects are uncertain. Other than a temporary closure of the Company’s North Huntingdon, Pennsylvania facility effective for the period from March 23 through March 30, 2020, the Company’s operations were not materially affected by the COVID-19 outbreak as of and for the three months ended March 31, 2020. Beginning in March 2020, restrictions imposed by various governmental authorities on international shipping and travel have caused a disruption to the timing of shipment of the Company’s 3D printing machines and the Company’s ability to complete installations of 3D printing machines. The duration and severity of the outbreak and its long-term impact on the Company’s business are uncertain at this time. The Company is unable to predict the impact that COVID-19 will have on its future financial position, results of operations and cash flows.

Recently Accounting Pronouncements

The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (the “FASB”). Recently issued ASUs not listed below either were assessed and determined to be not applicable or are currently expected to have no impact on the consolidated financial statements of the Company.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses.” This ASU added a new impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses. The CECL model applies to most debt instruments, trade receivables, lease receivables, financial guarantee contracts, and other loan commitments. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. As a smaller reporting company pursuant to Rule 12b-2 of the Securities Exchange Act of 1934, as amended, these changes become effective for the Company on January 1, 2023. Management is currently evaluating the potential impact of these changes on the consolidated financial statements of the Company.

v3.20.1
Product Warranty Reserves - Summary of Changes in Product Warranty Reserves (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Guarantees [Abstract]    
Balance at beginning of period $ 866 $ 1,670
Provisions for new issuances 276 146
Payments (344) (391)
Reserve adjustments 20 (159)
Foreign currency translation adjustments (8) (15)
Balance at end of period $ 810 $ 1,251
v3.20.1
Subsequent Events - Additional Information (Detail) - Subsequent Event [Member] - Paycheck Protection Program Loan [Member]
$ in Thousands
Apr. 18, 2020
USD ($)
Subsequent Event [Line Items]  
Loan principal amount $ 2,194
Loan bears interest rate 1.00%
Maturity date Apr. 18, 2022
Lender  
Subsequent Event [Line Items]  
Loan principal amount $ 2,194
v3.20.1
Fair Value Measurements - Carrying Values and Fair Values of Other Financial Instruments (Parenthetical) (Detail) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Unamortized debt issuance costs $ 19 $ 20
Revolving Credit Facility [Member] | Prepaid Expenses and Other Current Assets [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Debt issuance costs 33 88
Revolving Credit Facility [Member] | Other Noncurrent Assets [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Debt issuance costs $ 97 $ 19
v3.20.1
Equity-Based Compensation - Summary of Activity for Stock Options (Detail) - $ / shares
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]    
Stock options outstanding, Beginning balance 854,259 621,986
Stock options granted 0 3,300
Stock options exercised 0 (23,247)
Stock options forfeited (6,876) 0
Stock options expired (9,000) (7,500)
Stock options outstanding, Ending balance 838,383 594,539
Exercisable at end of period 499,139 400,566
Expected to vest at end of period 339,244 193,973
Weighted average exercise price, Beginning balance $ 9.34 $ 10.66
Weighted average exercise price, Stock options granted 0 9.89
Weighted average exercise price, Stock options exercised 0 7.11
Weighted average exercise price, Stock options forfeited 7.01 0
Weighted average exercise price, Stock options expired 10.89 17.25
Weighted average exercise price, Ending balance 9.35 10.71
Weighted average exercise price, Exercisable 10.74 11.84
Weighted average exercise price, Expected to vest, net of forfeitures 7.30 8.37
Weighted average grant date fair value, Beginning balance 4.49 5.52
Weighted average grant date fair value, Stock options granted 0 3.48
Weighted average grant date fair value, Stock options exercised 0 2.92
Weighted average grant date fair value, Stock options forfeited 2.84 0
Weighted average grant date fair value, Stock options expired 5.82 10.55
Weighted average grant date fair value, Ending balance 4.49 5.55
Weighted average grant date fair value, Exercisable 5.52 6.40
Weighted average grant date fair value, Expected to vest, net of forfeitures $ 2.96 $ 3.79
v3.20.1
Loss Per Share
3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Loss Per Share

Note 4. Loss Per Share

The Company presents basic and diluted loss per common share amounts. Basic loss per common share is calculated by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the applicable period. Diluted loss per common share is calculated by dividing net loss available to common stockholders by the weighted average number of common shares and common equivalent shares outstanding during the applicable period.

As the Company incurred a net loss during each of the three months ended March 31, 2020 and 2019, basic average common shares outstanding and diluted average common shares outstanding were the same because the effect of potential shares of common stock, including stock options (838,383 – 2020 and 594,539 – 2019) and unvested restricted stock issued (66,513 – 2020 and 69,501 – 2019), was anti-dilutive.

The information used to compute basic and diluted net loss per common share was as follows for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Net loss

 

$

(3,648

)

 

$

(4,496

)

Weighted average shares outstanding (basic and diluted)

 

 

16,369,390

 

 

 

16,253,104

 

Net loss per common share:

 

 

 

 

 

 

 

 

Basic

 

$

(0.22

)

 

$

(0.28

)

Diluted

 

$

(0.22

)

 

$

(0.28

)

v3.20.1
Property and Equipment
3 Months Ended
Mar. 31, 2020
Long Lived Assets [Abstract]  
Property and Equipment

Note 8. Property and Equipment

Property and equipment consisted of the following as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

Economic Life

 

 

2020

 

 

2019

 

 

(in years)

Land

 

$

3,378

 

 

$

6,980

 

 

N/A

Buildings and related improvements

 

 

9,989

 

 

 

25,675

 

 

5 - 40

Machinery and equipment

 

 

19,208

 

 

 

19,531

 

 

3 - 20

Other

 

 

6,049

 

 

 

7,086

 

 

3 - 20

 

 

 

38,624

 

 

 

59,272

 

 

 

Less: Accumulated depreciation

 

 

(18,306

)

 

 

(21,478

)

 

 

 

 

 

20,318

 

 

 

37,794

 

 

 

Construction-in-progress

 

 

402

 

 

 

1,101

 

 

 

Property and equipment  ̶  net

 

$

20,720

 

 

$

38,895

 

 

 

 

For the three months ended March 31, 2020 and 2019, depreciation expense was $923 and $1,165, respectively.

On February 18, 2020, the Company completed a sale-leaseback transaction associated with its European headquarters and operating facility in Gersthofen, Germany (Note 10). As a result of the completion of this transaction, the Company derecognized $17,282 in net property and equipment during the three months ended March 31, 2020. Sale of the facility resulted in a gain of $1,462 during the three months ended March 31, 2020.

During the three months ended March 31, 2020, as a result of continued operating losses and cash flow deficiencies, the Company identified a triggering event requiring a test for the recoverability of long-lived assets held and used at the asset group level. Assessing the recoverability of long-lived assets held and used requires significant judgments and estimates by management.

For purposes of testing long-lived assets for recoverability, the Company operates as three separate asset groups: United States, Europe and Japan. In assessing the recoverability of long-lived assets held and used, the Company determined the carrying amount of long-lived assets held and used to be in excess of the estimated future undiscounted net cash flows of the related assets. The Company proceeded to determine the fair value of its long-lived assets held and used, principally through use of the market approach. The Company’s use of the market approach included consideration of market transactions for comparable assets. Management concluded that the fair value of long-lived assets held and used exceeded their carrying value, and as such, no impairment loss was recorded.   

A significant decrease in the market price of a long-lived asset, adverse change in the use or condition of a long-lived asset, adverse change in the business climate or legal or regulatory factors impacting a long-lived asset and continued operating losses and cash flow deficiencies associated with a long-lived asset, among other indicators, could cause a future assessment to be performed which may result in an impairment of long-lived assets held and used, which could result in a material adverse effect on the financial position and results of operations of the Company.

v3.20.1
Related Party Revolving Credit Facility
3 Months Ended
Mar. 31, 2020
Related Party Transactions [Abstract]  
Related Party Revolving Credit Facility

 

Note 12. Related Party Revolving Credit Facility

On March 12, 2018, the Company and its ExOne Americas LLC and ExOne GmbH subsidiaries, as guarantors (collectively, the “Loan Parties”), entered into a Credit Agreement and related ancillary agreements with LBM Holdings, LLC (“LBM”), a company controlled by S. Kent Rockwell, who was the Executive Chairman of the Company (a related party) at such date and is currently Chairman of the Company, relating to a $15,000 revolving credit facility (the “Credit Agreement”) to provide additional funding to the Company for working capital and general corporate purposes. The Credit Agreement provided a credit facility for a term of three years (through March 12, 2021), bearing interest at a rate of one-month LIBOR plus an applicable margin of 500 basis points (6.8% at December 31, 2019 and 6.0% at March 31, 2020). The Credit Agreement required a commitment fee of 75 basis points, or 0.75%, on the unused portion of the facility, payable monthly in arrears. In addition, an up-front commitment fee of 125 basis points, or 1.25% ($188), was required at closing. Borrowings under the Credit Agreement were collateralized by the accounts receivable, inventories and machinery and equipment of the Loan Parties.

On February 18, 2020, the Loan Parties and LBM entered into a First Amendment to the Credit Agreement (the “Amendment”) which (i) reduced the available capacity under the revolving credit facility to $10,000, (ii) extended the term of the credit facility until March 31, 2024, (iii) increased the commitment fee to 100 basis points, or 1.00%, on the unused portion of the revolving credit facility, and (iv) provided a process for the replacement of the LIBOR index after 2021. In addition, the accounts receivable of ExOne GmbH no longer serve as collateral for borrowings under the amended revolving credit facility.

Borrowings under the credit facility are required to be made in minimum increments of $1,000. The Company may terminate or reduce the credit commitment at any time during the term of the amended Credit Agreement without penalty. The Company may also make prepayments against outstanding borrowings under the amended Credit Agreement at any time without penalty. At December 31, 2019 and March 31, 2020, the total estimated value of collateral was in significant excess of the maximum borrowing capacity under the credit facility.

The amended Credit Agreement contains several affirmative covenants including prompt payment of liabilities and taxes; maintenance of insurance, properties, and licenses; and compliance with laws. The amended Credit Agreement also contains several negative covenants including restricting the incurrence of certain additional debt; prohibiting future liens (other than permitted liens); prohibiting investment in third parties; limiting the ability to pay dividends; limiting mergers, acquisitions, and dispositions; and limiting the sale of certain property and equipment of the Loan Parties. The amended Credit Agreement does not contain any financial covenants. The amended Credit Agreement also contains events of default, including, but not limited to, cross-default to certain other debt, breaches of representations and warranties, change of control events and breaches of covenants.

The Company does not consider the Credit Agreement, as amended, indicative of a fair market value lending, as LBM was determined to be a related party based on common control by S. Kent Rockwell. S. Kent Rockwell is the indirect sole owner of LBM. Prior to execution, each of the Credit Agreement and the Amendment was reviewed and approved by the Audit Committee of the Board of Directors (the “Board”), in accordance with The ExOne Company Policy and Procedures with Respect to Related Person Transactions, and subsequently by a sub-committee of independent members of the Board. At the time of execution of the Credit Agreement, the available loan proceeds were deposited into an escrow account with an unrelated, third party financial institution acting as escrow agent pursuant to a separate Escrow Agreement by and among the parties. Loan proceeds held in escrow are available to the Company upon its submission to the escrow agent of a loan request. Such proceeds will not be available to LBM until payment in-full of the obligations under the amended Credit Agreement and termination of the amended Credit Agreement. Payments of principal and other obligations will be made to the escrow agent, while interest payments will be made directly to LBM. Provided there exists no potential default or event of default, the amended Credit Agreement and Escrow Agreement prohibit any acceleration of repayment of any amount outstanding under the amended Credit Agreement and prohibit termination of the amended Credit Agreement or withdrawal from escrow of any unused portion of the available loan proceeds.

There were no borrowings under the credit facility during the three months ended March 31, 2020 or 2019.

The Company incurred $265 in debt issuance costs associated with the inception of the credit facility (including the aforementioned up-front commitment fee paid at closing to LBM) and $41 in debt issuance costs associated with the Amendment.

During the three months ended March 31, 2020, the Company recorded interest expense relating to the credit facility of $45. Included in interest expense for the three months ended March 31, 2020 was $18 associated with amortization of debt issuance costs (resulting in $130 in remaining debt issuance costs at March 31, 2020, of which $33 was included in prepaid expenses and other current assets and $97 was included in other noncurrent assets in the accompanying consolidated balance sheet). Included in interest expense for the three months ended March 31, 2020 was $27 associated with the commitment fee on the unused portion of the revolving credit facility all of which was included in accounts payable in the accompanying consolidated balance sheet at March 31, 2020. In connection with the Company’s efforts to conserve cash as a result of the COVID-19 global pandemic, LBM agreed to defer cash payments of its commitment fee on the unused portion of the revolving credit facility to a future date (to be determined upon mutual agreement by the parties). There are no incremental interest or other fees to be incurred by the Company as a result of this deferral.

During the three months ended March 31, 2019, the Company recorded interest expense related to the credit facility of $50.

v3.20.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Carrying Values and Fair Values of Other Financial Instruments

The carrying values and fair values of other financial instruments (assets and liabilities) not required to be recorded at fair value were as follows as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

 

 

Carrying

Value

 

 

Fair

Value

 

 

Carrying

Value

 

 

Fair

Value

 

Cash and cash equivalents

 

$

16,813

 

 

$

16,813

 

 

$

5,265

 

 

$

5,265

 

Restricted cash

 

$

508

 

 

$

508

 

 

$

978

 

 

$

978

 

Debt issuance costs(a)

 

$

130

 

 

$

 

 

$

107

 

 

$

 

Current portion of long-term debt(b)

 

$

155

 

 

$

159

 

 

$

153

 

 

$

157

 

Long-term debt  ̶  net of current portion(b)

 

$

1,171

 

 

$

1,186

 

 

$

1,211

 

 

$

1,227

 

(a)

Represents debt issuance costs associated with the Company’s related party revolving credit facility (Note 12) of which $33 and $88 was included in prepaid expenses and other current assets and $97 and $19 was included in other noncurrent assets in the accompanying condensed consolidated balance sheet at March 31, 2020 and December 31, 2019, respectively.

(b)

Carrying values at March 31, 2020 and December 31, 2019 are net of unamortized debt issuance costs of $19 and $20, respectively.

v3.20.1
Product Warranty Reserves (Tables)
3 Months Ended
Mar. 31, 2020
Product Warranties Disclosures [Abstract]  
Summary of Changes in Product Warranty Reserves

The following table summarizes changes in product warranty reserves, which amounts were reflected in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Balance at beginning of period

 

$

866

 

 

$

1,670

 

     Provisions for new issuances

 

 

276

 

 

 

146

 

     Payments

 

 

(344

)

 

 

(391

)

     Reserve adjustments

 

 

20

 

 

 

(159

)

     Foreign currency translation adjustments

 

 

(8

)

 

 

(15

)

Balance at end of period

 

$

810

 

 

$

1,251

 

v3.20.1
Concentration of Credit Risk
3 Months Ended
Mar. 31, 2020
Risks And Uncertainties [Abstract]  
Concentration of Credit Risk

Note 16. Concentration of Credit Risk

During the three months ended March 31, 2020 and 2019, the Company conducted a significant portion of its business with a limited number of customers, though not necessarily the same customers for each respective period. For the three months ended March 31, 2020 and 2019, the Company’s five most significant customers represented 33.1% and 30.9% of total revenue, respectively. At March 31, 2020 and December 31, 2019, accounts receivable from the Company’s five most significant customers were $1,775 and $3,230, respectively.

v3.20.1
Basis of Presentation (Policies)
3 Months Ended
Mar. 31, 2020
Accounting Policies [Abstract]  
Organization

Organization

The ExOne Company (“ExOne”) is a corporation organized under the laws of the state of Delaware. ExOne was formed on January 1, 2013, when The Ex One Company, LLC, a Delaware limited liability company, merged with and into a Delaware corporation, which survived and changed its name to The ExOne Company (the “Reorganization”). As a result of the Reorganization, The Ex One Company, LLC became ExOne, the common and preferred interest holders of The Ex One Company, LLC became holders of common stock and preferred stock, respectively, of ExOne, and the subsidiaries of The Ex One Company, LLC became the subsidiaries of ExOne. The condensed consolidated financial statements include the accounts of ExOne, its wholly-owned subsidiaries, ExOne Americas LLC (United States); ExOne GmbH (Germany); ExOne Property GmbH (Germany); and ExOne KK (Japan). Collectively, the consolidated group is referred to as the “Company”.

The Company filed a registration statement on Form S-3 (No. 333-223690) with the Securities and Exchange Commission on March 15, 2018. The purpose of the Form S-3 was to register various equity and debt securities. Subsidiaries of the Company are co-registrants with the Company (“Subsidiary Guarantors”), and the registration statement registered guarantees of debt securities by one or more of the Subsidiary Guarantors. The Subsidiary Guarantors are 100% owned by the Company and any guarantees by the Subsidiary Guarantors will be full and unconditional. There have been no transactions undertaken subject to the Form S-3 since its initial filing.

Basis of Presentation

The condensed consolidated financial statements of the Company are unaudited. The condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, considered necessary by management to fairly state the results of operations, financial position and cash flows of the Company. All material intercompany transactions and balances have been eliminated in consolidation. The results reported in these condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the entire year. The December 31, 2019 condensed consolidated balance sheet data was derived from the audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). This Quarterly Report on Form 10-Q should be read in connection with the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, which includes all disclosures required by GAAP.

The preparation of these condensed consolidated financial statements requires the Company to make certain judgments, estimates and assumptions regarding uncertainties that affect the reported amounts of assets, liabilities, revenue and expenses and related disclosure of contingent assets and liabilities. Areas that require significant judgments, estimates and assumptions include accounting for accounts receivable (including the allowance for doubtful accounts); inventories (including the allowance for slow-moving and obsolete inventories); product warranty reserves; contingencies; income taxes (including the valuation allowance on certain deferred tax assets and liabilities for uncertain tax positions); equity-based compensation (including the valuation of certain equity-based compensation awards issued by the Company); and testing for impairment of long-lived assets (including the identification of asset groups by management, estimates of future cash flows of identified asset groups and fair value estimates used in connection with assessing the valuation of identified asset groups). The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

Certain amounts relating to operating lease right-of-use assets ($432), current portion of operating lease liabilities ($158) and operating lease liabilities – net of current portion ($274) in the accompanying condensed consolidated balance sheet at December 31, 2019, have been reclassified from other noncurrent assets, accrued expenses and other current liabilities and other noncurrent liabilities, respectively, to conform to current period presentation.

Certain amounts relating to foreign exchange (gains) losses on intercompany transactions – net, for 2019 ($11) in the accompanying condensed statement of consolidated cash flows have been reclassified from effect of exchange rate changes on cash, cash equivalents, and restricted cash, to conform to current period presentation.

COVID-19

COVID-19

In March 2020, the World Health Organization declared the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide. The impact of the COVID-19 global pandemic and related economic, business and market disruptions are evolving rapidly, and their effects are uncertain. Other than a temporary closure of the Company’s North Huntingdon, Pennsylvania facility effective for the period from March 23 through March 30, 2020, the Company’s operations were not materially affected by the COVID-19 outbreak as of and for the three months ended March 31, 2020. Beginning in March 2020, restrictions imposed by various governmental authorities on international shipping and travel have caused a disruption to the timing of shipment of the Company’s 3D printing machines and the Company’s ability to complete installations of 3D printing machines. The duration and severity of the outbreak and its long-term impact on the Company’s business are uncertain at this time. The Company is unable to predict the impact that COVID-19 will have on its future financial position, results of operations and cash flows.

Recently Accounting Pronouncements

Recently Accounting Pronouncements

The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (the “FASB”). Recently issued ASUs not listed below either were assessed and determined to be not applicable or are currently expected to have no impact on the consolidated financial statements of the Company.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses.” This ASU added a new impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses. The CECL model applies to most debt instruments, trade receivables, lease receivables, financial guarantee contracts, and other loan commitments. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. As a smaller reporting company pursuant to Rule 12b-2 of the Securities Exchange Act of 1934, as amended, these changes become effective for the Company on January 1, 2023. Management is currently evaluating the potential impact of these changes on the consolidated financial statements of the Company.

Loss Per Share

The Company presents basic and diluted loss per common share amounts. Basic loss per common share is calculated by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the applicable period. Diluted loss per common share is calculated by dividing net loss available to common stockholders by the weighted average number of common shares and common equivalent shares outstanding during the applicable period.

Revenue

The Company derives revenue from the sale of 3D printing machines and 3D printed and other products, materials and services. Revenue is recognized when the Company satisfies its performance obligation(s) under a contract (either implicit or explicit) by transferring the promised product or service to a customer either when (or as) the customer obtains control of the product or service. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. A contract’s transaction price is allocated to each distinct performance obligation.

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales, value add, and other taxes collected from customers and remitted to governmental authorities are accounted for on a net (excluded from revenue) basis. Shipping and handling costs are included in cost of sales.

Certain of the Company’s contracts with customers provide for multiple performance obligations. Sales of 3D printing machines may also include optional equipment, materials, replacement components and services (installation, training and other services, including maintenance services and/or an extended warranty). Certain other contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation using the Company’s best estimate of stand-alone selling price for each distinct product or service in the contract, which is generally based on an observable price.

v3.20.1
Revenue - Additional Information (Detail 1)
$ in Thousands
Mar. 31, 2020
USD ($)
Disaggregation Of Revenue [Line Items]  
Revenue, remaining performance obligation $ 33,800
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-04-01  
Disaggregation Of Revenue [Line Items]  
Revenue, remaining performance obligation $ 29,800
Revenue, remaining performance obligation, Expected timing of satisfaction, period 12 months
v3.20.1
Loss Per Share - Additional Information (Detail) - shares
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Stock Option [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Potential shares of anti-dilutive common stock 838,383 594,539
Restricted Stock [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Potential shares of anti-dilutive common stock 66,513 69,501
v3.20.1
Leases - Schedule of Operating and Sales-type Lease Arrangements (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Leases [Abstract]    
Operating lease revenue $ 208 $ 320
Sales-type lease interest income [1] $ 18 $ 28
[1] Interest income relating to sales-type leases is recorded as a component of revenue in the accompanying condensed statement of consolidated operations and comprehensive loss for each of the periods presented.
v3.20.1
Related Party Revolving Credit Facility - Additional Information (Detail) - USD ($)
3 Months Ended
Feb. 18, 2020
Mar. 12, 2018
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Related Party Transaction [Line Items]          
Amortization of debt issuance costs     $ 19,000 $ 23,000  
Revolving Credit Facility [Member] | Prepaid Expenses and Other Current Assets [Member]          
Related Party Transaction [Line Items]          
Debt issuance costs, net     33,000   $ 88,000
Revolving Credit Facility [Member] | Other Noncurrent Assets [Member]          
Related Party Transaction [Line Items]          
Debt issuance costs, net     $ 97,000   $ 19,000
Revolving Credit Facility [Member] | LBM Holdings, LLC [Member]          
Related Party Transaction [Line Items]          
Line of credit facility, maximum borrowing capacity   $ 15,000,000      
Credit facility, expiration period   3 years      
Credit facility, expiration date   Mar. 12, 2021      
Credit facility, description of variable rate basis     one-month LIBOR    
Credit facility, interest rate     6.00%   6.80%
Credit facility, commitment fee on unused portion, percentage   0.75%      
Credit facility, commitment fee on unused portion, payable term     The Credit Agreement required a commitment fee of 75 basis points, or 0.75%, on the unused portion of the facility, payable monthly in arrears    
Credit facility, up-front commitment fee percentage   1.25%      
Credit facility, up-front commitment fee amount   $ 188,000      
Credit facility, minimum increments   $ 1,000,000      
Credit facility, borrowings     $ 0 0  
Debt issuance costs, gross     265,000    
Interest expense relating to the Credit Agreement     45,000 $ 50,000  
Amortization of debt issuance costs     18,000    
Debt issuance costs, net     130,000    
Interest expense related to commitment fee     27,000    
Accounts payable     27,000    
Incremental interest or other fees on deferral of cash payments     0    
Revolving Credit Facility [Member] | LBM Holdings, LLC [Member] | Prepaid Expenses and Other Current Assets [Member]          
Related Party Transaction [Line Items]          
Debt issuance costs, net     33,000    
Revolving Credit Facility [Member] | LBM Holdings, LLC [Member] | Other Noncurrent Assets [Member]          
Related Party Transaction [Line Items]          
Debt issuance costs, net     97,000    
Revolving Credit Facility [Member] | LBM Holdings, LLC [Member] | One-Month LIBOR [Member]          
Related Party Transaction [Line Items]          
Credit facility, basis spread on variable rate   5.00%      
Amended Revolving Credit Facility [Member] | LBM Holdings, LLC [Member]          
Related Party Transaction [Line Items]          
Line of credit facility, maximum borrowing capacity $ 10,000,000        
Credit facility, expiration date Mar. 31, 2024        
Credit facility, commitment fee on unused portion, percentage 1.00%        
Debt issuance costs, gross     $ 41,000    
v3.20.1
Equity-Based Compensation - Summary of Equity-Based Compensation Expense (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Equity-based compensation expense recognized:    
Total equity-based compensation expense before income taxes $ 292 $ 439
Benefit for income taxes [1] 0 0
Total equity-based compensation expense net of income taxes 292 439
Stock Options [Member]    
Equity-based compensation expense recognized:    
Total equity-based compensation expense before income taxes 145 166
Restricted Stock [Member]    
Equity-based compensation expense recognized:    
Total equity-based compensation expense before income taxes 141 129
Other [Member]    
Equity-based compensation expense recognized:    
Total equity-based compensation expense before income taxes [2] $ 6 $ 144
[1] The benefit for income taxes from equity-based compensation for each of the periods presented has been determined to be $0 based on valuation allowances against net deferred tax assets.
[2] For 2020, Other represents expense associated with certain employee contractual amounts to be settled in equity. For 2019, Other represents expense associated with the 2019 Program and certain employee contractual amounts to be settled in equity.
v3.20.1
Related Party Transactions - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Related Party Transaction [Line Items]      
Purchases from related parties $ 0    
Amounts due to related party $ 0   $ 0
Chairman of the Board of Directors [Member]      
Related Party Transaction [Line Items]      
Purchases from related parties   $ 15,000  
v3.20.1
Fair Value Measurements - Additional Information (Detail) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Fair Value Disclosures [Abstract]    
Financial instruments (assets or liabilities) measured at fair value $ 0 $ 0
v3.20.1
Accumulated Other Comprehensive Loss
3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Accumulated Other Comprehensive Loss

Note 3. Accumulated Other Comprehensive Loss

The following table summarizes changes in the components of accumulated other comprehensive loss for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Foreign currency translation adjustments

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$

(11,483

)

 

$

(10,748

)

Other comprehensive loss

 

 

(838

)

 

 

(776

)

Balance at end of period

 

$

(12,321

)

 

$

(11,524

)

 

Foreign currency translation adjustments consist of the effect of translation of functional currency financial statements (denominated in the euro and Japanese yen) to the reporting currency of the Company (United States dollar) and certain long-term intercompany transactions between subsidiaries for which settlement is not planned or anticipated in the foreseeable future.

There were no tax impacts related to income tax rate changes and no amounts were reclassified to earnings for either of the periods presented.

v3.20.1
Leases - Schedule of Future Minimum Lease Payments of Operating Leases Arrangements (Detail)
$ in Thousands
Mar. 31, 2020
USD ($)
Leases [Abstract]  
2020 $ 1,419
2021 1,861
2022 1,827
2023 23
2024 11
Thereafter 2
Total minimum lease payments 5,143
Less: Present value discount (354)
Total operating lease liabilities $ 4,789
v3.20.1
Inventories - Schedule of Inventories (Detail) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Inventory Disclosure [Abstract]    
Raw materials and components $ 9,374 $ 8,841
Work in process 5,284 4,922
Finished goods 6,995 6,007
Inventories $ 21,653 $ 19,770
v3.20.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2020
May 07, 2020
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2020  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q1  
Trading Symbol XONE  
Entity Registrant Name ExOne Co  
Entity Central Index Key 0001561627  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Common Stock, Shares Outstanding   16,455,000
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Title of 12(b) Security Common stock  
Security Exchange Name NASDAQ  
Entity File Number 001-35806  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 46-1684608  
Entity Address, Address Line One 127 Industry Boulevard  
Entity Address, City or Town North Huntingdon  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 15642  
City Area Code 724  
Local Phone Number 863-9663  
v3.20.1
Property and Equipment - Additional Information (Details)
3 Months Ended 12 Months Ended
Mar. 31, 2020
USD ($)
Asset_Group
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Long Lived Assets [Abstract]      
Depreciation $ 923,000 $ 1,165,000  
Derecognized net property and equipment 17,282,000    
Gain on sale of facility $ 1,462,000    
Number of operating asset groups | Asset_Group 3    
Long-lived assets held for use impairment loss $ 0   $ 0
v3.20.1
Condensed Statement of Consolidated Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating activities    
Net loss $ (3,648,000) $ (4,496,000)
Adjustments to reconcile net loss to net cash used for operations:    
Depreciation 923,000 1,165,000
Equity-based compensation 292,000 439,000
Amortization of debt issuance costs 19,000 23,000
Provision (recoveries) for bad debts ̶ net 51,000 (73,000)
Provision for slow-moving, obsolete and lower of cost or net realizable value inventories ̶ net 22,000 107,000
Foreign exchange (gains) losses on intercompany transactions ̶ net (165,000) (11,000)
Gain from sale-leaseback of property and equipment (1,462,000)  
Gain from disposal of property and equipment ̶ net (2,000)  
Deferred income taxes 195,000  
Changes in assets and liabilities, excluding effects of foreign currency translation adjustments:    
Decrease in accounts receivable 1,487,000 2,877,000
(Increase) decrease in net investment in sales-type leases (50,000) 87,000
Increase in inventories (2,146,000) (1,576,000)
Increase in prepaid expenses and other assets (672,000) (509,000)
Decrease in accounts payable (1,408,000) (793,000)
Decrease in accrued expenses and other liabilities (24,000) (1,748,000)
Increase in contract liabilities 1,849,000 3,122,000
Net cash used for operating activities (4,739,000) (1,386,000)
Investing activities    
Capital expenditures (338,000) (347,000)
Proceeds from sale of property and equipment 16,228,000  
Net cash provided by (used for) investing activities 15,890,000 (347,000)
Financing activities    
Payments on long-term debt (39,000) (36,000)
Proceeds from exercise of employee stock options   165,000
Taxes related to the net share settlement of equity-based awards 0 (68,000)
Other (3,000) (5,000)
Net cash (used for) provided by financing activities (42,000) 56,000
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (31,000) (121,000)
Net change in cash, cash equivalents, and restricted cash 11,078,000 (1,798,000)
Cash, cash equivalents, and restricted cash at beginning of period 6,243,000 9,140,000
Cash, cash equivalents, and restricted cash at end of period 17,321,000 7,342,000
Supplemental disclosure of noncash investing and financing activities    
Transfer of internally developed 3D printing machines from inventories to property and equipment for internal use or leasing activities 852,000 819,000
Transfer of internally developed 3D printing machines from property and equipment to inventories for sale 823,000  
Property and equipment included in accounts payable 56,000 23,000
Property and equipment included in accrued expenses and other current liabilities   $ 7,000
Debt issuance costs included in accounts payable $ 41,000  
v3.20.1
Income Taxes (Tables)
3 Months Ended
Mar. 31, 2020
Income Tax Disclosure [Abstract]  
Reconciliation of Unrecognized Tax Benefits (Including Accrued Interest and Penalties)

A reconciliation of the beginning and ending amount of unrecognized tax benefits (including accrued interest and penalties) was as follows for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Balance at beginning of period

 

$

 

 

$

1,186

 

Additions based on tax positions related to the current year

 

 

 

 

 

 

Additions for tax positions of prior years

 

 

 

 

 

1

 

Reductions for tax positions of prior years

 

 

 

 

 

(1,075

)

Settlements

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

 

 

 

(10

)

Balance at end of period

 

$

 

 

$

102

 

v3.20.1
Inventories (Tables)
3 Months Ended
Mar. 31, 2020
Inventory Disclosure [Abstract]  
Schedule of Inventories

Inventories consisted of the following as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Raw materials and components

 

$

9,374

 

 

$

8,841

 

Work in process

 

 

5,284

 

 

 

4,922

 

Finished goods

 

 

6,995

 

 

 

6,007

 

 

 

$

21,653

 

 

$

19,770

 

Summary of Changes in Allowance for Slow-moving and Obsolete Inventories The following table summarizes changes in the allowance for slow-moving and obsolete inventories for the periods indicated:

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Balance at beginning of period

 

$

3,443

 

 

$

4,143

 

Provision for slow-moving and obsolete inventories  ̶  net

 

 

22

 

 

 

107

 

Reductions for physical disposal (sale or scrap) of previously reserved

   amounts

 

 

(36

)

 

 

 

Foreign currency translation adjustments

 

 

(59

)

 

 

(73

)

Balance at end of period

 

$

3,370

 

 

$

4,177

 

v3.20.1
Basis of Presentation - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]      
Entity Incorporation, State or Country Code DE    
Date of incorporation Jan. 01, 2013    
Operating lease liabilities – net of current portion $ 3,105   $ 274
Operating lease right-of-use assets 4,789   432
Current portion of operating lease liabilities 1,684   $ 158
Foreign exchange (gains) losses on intercompany transactions ̶ net $ (165) $ (11)  
Subsidiary Guarantors [Member]      
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]      
Percentage of ownership in subsidiary guarantors 100.00%    
v3.20.1
Cash, Cash Equivalents, and Restricted Cash
3 Months Ended
Mar. 31, 2020
Cash And Cash Equivalents [Abstract]  
Cash, Cash Equivalents, and Restricted Cash

Note 6. Cash, Cash Equivalents, and Restricted Cash

The following provides a reconciliation of cash, cash equivalents, and restricted cash as reported in the accompanying condensed consolidated balance sheet to the same such amounts shown in the accompanying condensed statement of consolidated cash flows as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Cash and cash equivalents

 

$

16,813

 

 

$

5,265

 

Restricted cash

 

 

508

 

 

 

978

 

Cash, cash equivalents, and restricted cash

 

$

17,321

 

 

$

6,243

 

 

Restricted cash at both March 31, 2020 and December 31, 2019 included $508 associated with cash collateral required by a United States bank to offset certain short-term, unsecured lending commitments associated with the Company’s corporate credit card program. 

Restricted cash at December 31, 2019 included $470 associated with cash collateral required by a German bank for short-term financial guarantees issued by ExOne GmbH in connection with certain commercial transactions requiring security. Refer to Note 11 for further discussion related to an amendment to this cash collateral requirement effective in February 2020.

Each of the balances described above are considered legally restricted by the Company.

v3.20.1
Leases
3 Months Ended
Mar. 31, 2020
Leases [Abstract]  
Leases

Note 10. Leases

Lessee

The Company leases facilities, machinery and other equipment and vehicles under operating lease arrangements (with initial terms greater than twelve months), expiring in various years through 2026. In addition, the Company leases certain equipment and vehicles under finance lease arrangements, which are not significant.

For all operating lease arrangements (with the exception of short-term lease arrangements), the Company presents at the commencement date: a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. 

The Company has elected, as a practical expedient, not to separate non-lease components from lease components, and instead account for each separate component as a single lease component for all lease arrangements, as lessee. In addition, the Company has elected, as a practical expedient, not to apply lease recognition requirements to short-term lease arrangements, generally those with a lease term of less than twelve months, for all classes of underlying assets. In determination of the lease term, the Company considers the likelihood of lease renewal options and lease termination provisions. As a result, lease payments under these short-term lease arrangements are recognized in the accompanying condensed statement of consolidated operations and comprehensive loss on a straight-line basis over the lease term.  

The Company uses its incremental borrowing rate in determining the present value of lease payments, as the implicit rate of the lease arrangements is generally not readily determinable.

Through July 2019, certain of the Company’s operating lease arrangements were with related parties under common control (Note 17). Lease cost under operating lease agreements with related parties, included within short-term lease cost below, was $12 for the three months ended March 31, 2019.

Future minimum lease payments of operating lease arrangements (with initial terms greater than twelve months) at March 31, 2020, were as follows:

 

2020

 

$

1,419

 

2021

 

 

1,861

 

2022

 

 

1,827

 

2023

 

 

23

 

2024

 

 

11

 

Thereafter

 

 

2

 

Total minimum lease payments

 

 

5,143

 

Less: Present value discount

 

 

(354

)

Total operating lease liabilities

 

$

4,789

 

 

For the three months ended March 31, 2020 and 2019, lease cost under operating lease arrangements was $504 and $113, including $31 and $65 relating to short-term lease arrangements, respectively.

Supplemental information related to operating lease arrangements was as follows as of and for the three months ended March 31, 2020:

 

Operating lease right-of-use assets

 

$

4,789

 

Current portion of operating lease liabilities

 

$

1,684

 

Operating lease liabilities  ̶  net of current portion

 

$

3,105

 

Right-of-use assets obtained in exchange for new operating lease liabilities

 

$

4,785

 

Cash paid for amounts included in the measurement of operating lease liabilities

 

$

473

 

Weighted average remaining lease term (in years)

 

 

2.8

 

Weighted average discount rate

 

 

5.1

%

On December 10, 2019, ExOne Property GmbH and ExOne GmbH, the German subsidiaries of the Company (the “German Subsidiaries”), entered into a purchase agreement (the “Purchase Agreement”) with Solidas Immobilien und Grundbesitz GmbH, a private, unaffiliated German real estate investor (the “Buyer”), for the sale of the Company’s European headquarters and operating facility in Gersthofen, Germany (the “Facility”) for a purchase price of approximately $18,500 (€17,000), of which approximately $2,200 (€2,000) was received prior to December 31, 2019. Concurrent with the execution of the Purchase Agreement, ExOne GmbH and the Buyer entered into a rental contract (the “Lease”) for the leaseback of the Facility for an initial aggregate annual rent totaling approximately $1,700 (€1,500), plus applicable taxes, which is fixed during the initial three-year term and is subject to adjustment on an annual basis (in accordance with the consumer price index for Germany) during the two five-year option extension periods. The sale-leaseback transaction closed on February 18, 2020. In connection with the completion of the sale-leaseback transaction, the Company recorded an operating lease right-of-use asset and corresponding operating lease liability of $4,605, which was representative of the present value of future minimum lease payments over the initial three-year term, as there were no penalties or other factors associated with the lease that result in reasonable assurance of its extension at inception.

Lessor

The Company leases machinery and equipment to customers (principally 3D printing machines and related equipment) under lease arrangements classified as either operating leases or sales-type leases. The Company’s operating lease arrangements have initial terms generally ranging from one to five years, certain of which may contain extension or termination clauses, or both. Such operating lease arrangements also generally include a purchase option to acquire the related machinery and equipment at the end of the lease term for either a fixed amount as determined at inception, or a subsequently negotiated fair market value. At March 31, 2020, the Company estimated that the total fair market value significantly exceeded the related net book value of the machinery and equipment held under the Company’s operating lease arrangements. The Company’s sales-type lease arrangements generally include transfer of ownership at the end of the lease term, and as such, the Company’s net investment in sale-type lease arrangements presented in the Company’s accompanying condensed consolidated balance sheet generally does not include an amount of unguaranteed residual value.

For certain of its arrangements, the Company separates and allocates (Note 5) certain non-lease components (principally maintenance services) from lease components. Sales, value add, and other taxes collected from customers and remitted to governmental authorities are accounted for on a net (excluded from lease income) basis. In determination of the lease term, the Company considers the likelihood of lease renewal options and lease termination provisions. Additionally, certain of the Company’s lease arrangements do not qualify as sale-type leases, as collectability is not reasonably assured.

The Company recognized the following components under operating and sales-type lease arrangements in the accompanying condensed statement of consolidated operations and comprehensive loss for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

 

 

Operating

 

 

Sales-type

 

 

Operating

 

 

Sales-type

 

Revenue

 

$

208

 

 

$

 

 

$

320

 

 

$

 

Interest income(a)

 

$

 

 

$

18

 

 

$

 

 

$

28

 

 

(a)

Interest income relating to sales-type leases is recorded as a component of revenue in the accompanying condensed statement of consolidated operations and comprehensive loss for each of the periods presented.

The Company’s net investment in sales-type leases consisted of the following as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Future minimum lease payments receivable

 

$

1,624

 

 

$

1,595

 

Less: Allowance for doubtful accounts

 

 

(415

)

 

 

(424

)

Net future minimum lease payments receivable

 

 

1,209

 

 

 

1,171

 

Less: Unearned interest income

 

 

(208

)

 

 

(220

)

   Net investment in sales-type leases

 

$

1,001

 

 

$

951

 

 

Future minimum lease payments of non-cancellable operating and sales-type lease arrangements at March 31, 2020 were as follows:

 

 

 

Operating

 

 

Sales-type

 

2020

 

$

432

 

 

$

411

 

2021

 

 

48

 

 

 

427

 

2022

 

 

 

 

 

378

 

2023

 

 

 

 

 

408

 

2024

 

 

 

 

 

 

Thereafter

 

 

 

 

 

 

Total minimum lease payments

 

$

480

 

 

$

1,624

 

Less: Allowance for doubtful accounts

 

 

 

 

 

 

(415

)

Less: Present value discount

 

 

 

 

 

 

(208

)

Future minimum lease payments receivable

 

 

 

 

 

$

1,001

 

 

v3.20.1
Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Loss Per Common Share

The information used to compute basic and diluted net loss per common share was as follows for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Net loss

 

$

(3,648

)

 

$

(4,496

)

Weighted average shares outstanding (basic and diluted)

 

 

16,369,390

 

 

 

16,253,104

 

Net loss per common share:

 

 

 

 

 

 

 

 

Basic

 

$

(0.22

)

 

$

(0.28

)

Diluted

 

$

(0.22

)

 

$

(0.28

)

v3.20.1
Equity-Based Compensation
3 Months Ended
Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Equity-Based Compensation

Note 14. Equity-Based Compensation

On January 24, 2013, the Board adopted the 2013 Equity Incentive Plan (the “Plan”). In connection with the adoption of the Plan, 500,000 shares of common stock were reserved for issuance pursuant to the Plan, with automatic increases in such reserve available each year annually on January 1 from 2014 through 2023 equal to the lesser of 3.0% of the total outstanding shares of common stock as of December 31 of the immediately preceding year or, a number of shares of common stock determined by the Board, provided that the maximum number of shares authorized under the Plan could not exceed 1,992,241 shares, subject to certain adjustments. The maximum number of shares authorized under the Plan was reached on January 1, 2017. At March 31, 2020, 602,283 shares remained available for future issuance under the Plan.

Stock options and restricted stock issued by the Company under the Plan are generally subject to service conditions resulting in annual vesting on the anniversary of the date of grant over a period typically ranging between one and three years. Certain stock options and restricted stock issued by the Company under the Plan vest immediately upon issuance. Stock options issued by the Company under the Plan have contractual lives which expire over a period typically ranging between five and ten years from the date of grant, subject to continued service to the Company by the participant.

On February 6, 2019, the Compensation Committee of the Board adopted the 2019 Annual Incentive Program (the “2019 Program”) as a subplan under the Plan. The 2019 Program provided an opportunity for performance-based compensation to senior executive officers of the Company, among others. The target annual incentive for each 2019 Program participant was expressed as a percentage of base salary and was conditioned on the achievement of certain financial goals (as approved by the Compensation Committee of the Board). The Compensation Committee of the Board retained negative discretion over amounts payable under the 2019 Program. During the three months ended March 31, 2019, the Company recorded $142 in equity-based compensation expense based on the estimated outcome of the defined financial goals for 2019 under the 2019 Program.

On February 5, 2020, the Compensation Committee of the Board adopted the 2020 Annual Incentive Program (the “2020 Program”) as a subplan under the Plan. The 2020 Program provided an opportunity for performance-based compensation to senior executive officers of the Company, among others. The target annual incentive for each 2020 Program participant was expressed as a percentage of base salary and was conditioned on the achievement of certain financial goals (as approved by the Compensation Committee of the Board). The Compensation Committee of the Board retained negative discretion over amounts payable under the 2020 Program. During the three months ended March 31, 2020, the Company recorded no equity-based compensation expense based on the estimated outcome of the defined financial goals for 2020 under the 2020 Program.

The following table summarizes the total equity-based compensation expense recognized by the Company for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Equity-based compensation expense recognized:

 

 

 

 

 

 

 

 

Stock options

 

$

145

 

 

$

166

 

Restricted stock

 

 

141

 

 

 

129

 

Other(a)

 

 

6

 

 

 

144

 

Total equity-based compensation expense before income taxes

 

 

292

 

 

 

439

 

Benefit for income taxes(b)

 

 

 

 

 

 

Total equity-based compensation expense net of income taxes

 

$

292

 

 

$

439

 

 

(a)

For 2020, Other represents expense associated with certain employee contractual amounts to be settled in equity. For 2019, Other represents expense associated with the 2019 Program and certain employee contractual amounts to be settled in equity.

(b)

The benefit for income taxes from equity-based compensation for each of the periods presented has been determined to be $0 based on valuation allowances against net deferred tax assets.

At March 31, 2020, total future compensation expense related to unvested awards yet to be recognized by the Company was $710 for stock options and $269 for restricted stock. Total future compensation expense related to unvested awards yet to be recognized by the Company is expected to be recognized over a weighted-average remaining vesting period of 1.3 years.

The fair value of stock options granted during the three months ended March 31, 2019, was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:

 

Weighted average fair value per stock option

 

$

3.48

 

Volatility

 

 

54.0

%

Average risk-free interest rate

 

 

2.5

%

Dividend yield

 

 

0.0

%

Expected term (years)

 

2.5

 

 

For certain stock option awards, volatility is estimated based on the historical volatility of the Company when the expected term of the award is less than the period for which the Company has been publicly traded. For certain stock option awards, volatility is estimated based on the historical volatilities of certain peer group companies when the expected term of the award exceeds the period for which the Company has been publicly traded. The average risk-free rate is based on a weighted average yield curve of risk-free interest rates consistent with the expected term of the awards. Expected dividend yield is based on historical dividend data as well as future expectations. Expected term is calculated using the simplified method as the Company does not have sufficient historical exercise experience upon which to base an estimate.

The activity for stock options was as follows for the periods indicated:

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

 

 

Number of

Options

 

 

Weighted Average

Exercise Price

 

 

Weighted Average

Grant Date Fair

Value

 

 

Number of

Options

 

 

Weighted Average

Exercise Price

 

 

Weighted Average

Grant Date Fair

Value

 

Outstanding at beginning of period

 

 

854,259

 

 

$

9.34

 

 

$

4.49

 

 

 

621,986

 

 

$

10.66

 

 

$

5.52

 

Stock options granted

 

 

 

 

$

 

 

$

 

 

 

3,300

 

 

$

9.89

 

 

$

3.48

 

Stock options exercised

 

 

 

 

$

 

 

$

 

 

 

(23,247

)

 

$

7.11

 

 

$

2.92

 

Stock options forfeited

 

 

(6,876

)

 

$

7.01

 

 

$

2.84

 

 

 

 

 

$

 

 

$

 

Stock options expired

 

 

(9,000

)

 

$

10.89

 

 

$

5.82

 

 

 

(7,500

)

 

$

17.25

 

 

$

10.55

 

Outstanding at end of period

 

 

838,383

 

 

$

9.35

 

 

$

4.49

 

 

 

594,539

 

 

$

10.71

 

 

$

5.55

 

Exercisable at end of period

 

 

499,139

 

 

$

10.74

 

 

$

5.52

 

 

 

400,566

 

 

$

11.84

 

 

$

6.40

 

Expected to vest at end of period

 

 

339,244

 

 

$

7.30

 

 

$

2.96

 

 

 

193,973

 

 

$

8.37

 

 

$

3.79

 

 

At March 31, 2020, intrinsic value associated with stock options exercisable was less than $1. At March 31, 2020, there was no intrinsic value associated with stock options expected to vest. The weighted average remaining contractual term of stock options exercisable and expected to vest at March 31, 2020, was 3.6 years and 4.5 years, respectively. During the three months ended March 31, 2019, stock options with an aggregate intrinsic value of $221 were exercised by employees resulting in proceeds to the Company from the exercise of stock options of $165. The Company received no income tax benefit related to these exercises. There were no stock option exercises during the three months ended March 31, 2020.

The activity for restricted stock was as follows for the periods indicated:

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

 

 

Shares of

Restricted

Stock

 

 

Weighted Average

Grant Date Fair

Value

 

 

Shares of

Restricted

Stock

 

 

Weighted Average

Grant Date Fair

Value

 

Outstanding at beginning of period

 

 

66,513

 

 

$

8.76

 

 

 

67,001

 

 

$

8.30

 

Restricted stock granted

 

 

37,500

 

 

$

7.12

 

 

 

30,000

 

 

$

9.89

 

Restricted stock vested

 

 

(35,500

)

 

$

9.63

 

 

 

(27,500

)

 

$

8.08

 

Restricted stock forfeited

 

 

 

 

$

 

 

 

 

 

$

 

Outstanding at end of period

 

 

68,513

 

 

$

7.41

 

 

 

69,501

 

 

$

9.07

 

Restricted stock expected to vest at end of period

 

 

68,513

 

 

$

7.41

 

 

 

69,501

 

 

$

9.07

 

 

Restricted stock that vested during the three months ended March 31, 2020 and 2019, had a fair value of $248 and $274, respectively.

During the three months ended March 31, 2019, the Company made cash payments for taxes of $68 relating to the net settlement of certain equity-based awards. There were no cash payments for taxes or net settlement of equity-based awards during the three months ended March 31, 2020.

v3.20.1
Other (Income) Expense – Net
3 Months Ended
Mar. 31, 2020
Other Income And Expenses [Abstract]  
Other (Income) Expense – Net

 

Note 18. Other (Income) Expense – Net

 

Other (income) expense – net consisted of the following for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Interest income

 

$

(12

)

 

$

(6

)

Foreign currency (gains) losses – net

 

 

(165

)

 

 

22

 

Other – net

 

 

(13

)

 

 

(4

)

 

 

$

(190

)

 

$

12

 

 

v3.20.1
Leases - Schedule of Future Minimum Lease Payment Receivable of Non-Cancellable Operating and Sales-type Lease (Details)
$ in Thousands
Mar. 31, 2020
USD ($)
Operating lease arrangements  
2020 $ 432
2021 48
Total minimum lease payments 480
Sales-type lease arrangements  
2020 411
2021 427
2022 378
2023 408
Total minimum lease payments 1,624
Less: Allowance for doubtful accounts (415)
Less: Present value discount (208)
Future minimum lease payments receivable $ 1,001
v3.20.1
Income Taxes - Reconciliation of Unrecognized Tax Benefits (Including Accrued Interest and Penalties) (Detail)
$ in Thousands
3 Months Ended
Mar. 31, 2019
USD ($)
Income Tax Disclosure [Abstract]  
Balance at beginning of period $ 1,186
Additions for tax positions of prior years 1
Reductions for tax positions of prior years (1,075)
Foreign currency translation adjustments (10)
Balance at end of period $ 102
v3.20.1
Revenue - Summary of Revenue by Product Group (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenue from External Customer [Line Items]    
Revenue $ 13,383 $ 9,579
3D Printing Machines [Member]    
Revenue from External Customer [Line Items]    
Revenue 6,317 3,329
3D Printed and Other Products, Materials and Services [Member]    
Revenue from External Customer [Line Items]    
Revenue $ 7,066 $ 6,250
v3.20.1
Accumulated Other Comprehensive Loss - Summary of Changes in the Components of Accumulated Other Comprehensive Loss (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]    
Balance at beginning of period $ (11,483) $ (10,748)
Other comprehensive loss (838) (776)
Balance at end of period $ (12,321) $ (11,524)
v3.20.1
Cash, Cash Equivalents, and Restricted Cash - Additional Information (Detail) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Cash Cash Equivalents And Restricted Cash [Line Items]    
Restricted cash associated with cash collateral $ 508 $ 978
United States Bank [Member]    
Cash Cash Equivalents And Restricted Cash [Line Items]    
Restricted cash associated with cash collateral $ 508 508
German Bank [Member]    
Cash Cash Equivalents And Restricted Cash [Line Items]    
Restricted cash associated with cash collateral   $ 470
v3.20.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 15. Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.

The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

 

Level 1

 

Observable inputs such as quoted prices in active markets for identical investments that the Company has the ability to access.

 

 

 

Level 2

 

Inputs include:

 

Quoted prices for similar assets or liabilities in active markets;

 

Quoted prices for identical or similar assets or liabilities in inactive markets;

 

Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and

 

Inputs that are derived principally from, or corroborated by, observable market data by correlation or other means.

 

 

 

Level 3

 

Inputs that are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.

 

The Company is required to disclose its estimate of the fair value of material financial instruments, including those recorded as assets or liabilities in its consolidated financial statements, in accordance with GAAP. At March 31, 2020 and December 31, 2019, the Company had no financial instruments (assets or liabilities) measured at fair value on a recurring basis.

The carrying values and fair values of other financial instruments (assets and liabilities) not required to be recorded at fair value were as follows as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

 

 

Carrying

Value

 

 

Fair

Value

 

 

Carrying

Value

 

 

Fair

Value

 

Cash and cash equivalents

 

$

16,813

 

 

$

16,813

 

 

$

5,265

 

 

$

5,265

 

Restricted cash

 

$

508

 

 

$

508

 

 

$

978

 

 

$

978

 

Debt issuance costs(a)

 

$

130

 

 

$

 

 

$

107

 

 

$

 

Current portion of long-term debt(b)

 

$

155

 

 

$

159

 

 

$

153

 

 

$

157

 

Long-term debt  ̶  net of current portion(b)

 

$

1,171

 

 

$

1,186

 

 

$

1,211

 

 

$

1,227

 

 

(a)

Represents debt issuance costs associated with the Company’s related party revolving credit facility (Note 12) of which $33 and $88 was included in prepaid expenses and other current assets and $97 and $19 was included in other noncurrent assets in the accompanying condensed consolidated balance sheet at March 31, 2020 and December 31, 2019, respectively.

(b)

Carrying values at March 31, 2020 and December 31, 2019 are net of unamortized debt issuance costs of $19 and $20, respectively.

 

The carrying amounts of cash and cash equivalents, restricted cash and current portion of long-term debt approximate fair value due to their short-term maturities. The fair value of long-term debt – net of current portion has been estimated by management based on the consideration of applicable interest rates (including certain instruments at variable or floating rates) and other available information (including quoted prices of similar instruments available to the Company). Cash and cash equivalents and restricted cash were classified as Level 1; Current portion of long-term debt and long-term debt – net of current portion were classified as Level 2.

v3.20.1
Subsequent Events
3 Months Ended
Mar. 31, 2020
Subsequent Events [Abstract]  
Subsequent Events

Note 19. Subsequent Events

Paycheck Protection Program

On April 18, 2020, the Company entered into an unsecured promissory note (the “Note”) in favor of The Huntington National Bank (the “Lender”) reflecting a loan in the principal amount of $2,194 (the “Loan”). The Loan was granted pursuant to the Paycheck Protection Program (the “PPP”) administered by the United States Small Business Administration (the “SBA”) as part of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”).

Pursuant to the terms of the Note, the Loan bears interest at a rate of 1.00% per annum and matures on April 18, 2022 (the “Maturity Date”). Principal and interest payments on the Loan are deferred until November 18, 2020, at which time equal installments of principal and interest will be due and payable monthly through the Maturity Date. The Note may be prepaid by the Company at any time prior to maturity without penalty. If the Company defaults on the Note, the Lender may, at its option, accelerate the maturity of the Company’s obligations under the Note.

Pursuant to the terms of the PPP, the Loan, or a portion thereof, may be forgiven if Loan proceeds are used for qualifying expenses as described in the CARES Act, such as payroll costs, costs used to continue group health care benefits, mortgage interest payments, rent and utilities. The Company intends to use all or a significant majority of the Loan proceeds for qualifying expenses. The terms of the Loan, including eligibility and forgiveness, may be subject to further requirements in regulations and guidance adopted by the SBA.

The Company has evaluated all of its activities and concluded that no other subsequent events have occurred that would require recognition in the condensed consolidated financial statements or disclosure in the notes to the condensed consolidated financial statements, except as described above.

v3.20.1
Revenue (Tables)
3 Months Ended
Mar. 31, 2020
Revenue From Contract With Customer [Abstract]  
Summary of Revenue by Product Group

The following table summarizes the Company’s revenue by product group for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

2019

 

3D printing machines

 

$

6,317

 

 

$

3,329

 

3D printed and other products, materials and services

 

 

7,066

 

 

 

6,250

 

 

 

$

13,383

 

 

$

9,579

 

v3.20.1
Contingencies and Commitments - Additional Information (Detail) - Amended GmbH Credit Agreement [Member] - Financial Guarantees and Letters of Credit [Member]
€ in Thousands, $ in Thousands
3 Months Ended
Feb. 24, 2020
USD ($)
Feb. 24, 2020
EUR (€)
Mar. 31, 2020
USD ($)
Mar. 31, 2020
EUR (€)
Dec. 31, 2019
USD ($)
Dec. 31, 2019
EUR (€)
Line Of Credit Facility [Line Items]            
Line of credit facility, increased capacity amount $ 3,800 € 3,500        
German Bank [Member]            
Line Of Credit Facility [Line Items]            
Credit facility, outstanding amount     $ 863 € 785 $ 560 € 499
Debt expiration dates range start     Oct. 31, 2020      
Debt expiration dates range end     Feb. 28, 2023      
Minimum [Member] | German Bank [Member]            
Line Of Credit Facility [Line Items]            
Issuance of financial guarantees and letters of credit 1,100 1,000        
Maximum [Member] | Cash Collateral [Member] | German Bank [Member]            
Line Of Credit Facility [Line Items]            
Issuance of financial guarantees and letters of credit $ 1,100 € 1,000        
v3.20.1
Equity-Based Compensation - Additional Information (Detail) - USD ($)
3 Months Ended
Jan. 24, 2013
Mar. 31, 2020
Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Equity-based compensation expense   $ 292,000 $ 439,000
Weighted-average remaining vesting period   1 year 3 months 18 days  
Proceeds from exercise of employee stock options     $ 165,000
Incentive stock options exercised   0 23,247
Cash payment for taxes relating to net settlement of equity based awrds   $ 0 $ 68,000
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Equity-based compensation expense   145,000 166,000
Total future compensation expense   710,000  
Intrinsic value, stock options expected to vest   $ 0  
Weighted average remaining contractual term of stock options exercisable   3 years 7 months 6 days  
Weighted average remaining contractual term of stock options expected to vest   4 years 6 months  
Intrinsic value of stock options exercised     221,000
Proceeds from exercise of employee stock options     165,000
Income tax benefit     0
Incentive stock options exercised   0  
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Equity-based compensation expense   $ 141,000 129,000
Total future compensation expense   269,000  
Fair value of restricted shares vested   $ 248,000 $ 274,000
Maximum [Member] | Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period   3 years  
Stock options contractual expiration period   10 years  
Intrinsic value, stock options exercisable   $ 1,000  
Maximum [Member] | Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period   3 years  
Minimum [Member] | Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period   1 year  
Stock options contractual expiration period   5 years  
Minimum [Member] | Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period   1 year  
Common Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Incentive stock options exercised     23,000
2013 Equity Incentive Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock reserved for issuance 500,000    
Remaining shares available for future issuance   602,283  
2013 Equity Incentive Plan [Member] | Common Stock [Member] | Maximum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of outstanding shares of common stock 3.00%    
Number of Shares authorized 1,992,241    
2019 Annual Incentive Program [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Equity-based compensation expense     $ 142,000
2020 Annual Incentive Program [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Equity-based compensation expense   $ 0  
v3.20.1
Cash, Cash Equivalents, and Restricted Cash - Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash (Detail) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Cash And Cash Equivalents [Abstract]    
Cash and cash equivalents $ 16,813 $ 5,265
Restricted cash 508 978
Cash, cash equivalents, and restricted cash $ 17,321 $ 6,243
v3.20.1
Loss Per Share - Computation of Basic and Diluted Loss Per Common Share (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Earnings Per Share [Abstract]    
Net loss $ (3,648) $ (4,496)
Weighted average shares outstanding (basic and diluted) 16,369,390 16,253,104
Net loss per common share:    
Basic $ (0.22) $ (0.28)
Diluted $ (0.22) $ (0.28)
v3.20.1
Liquidity - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 25 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Apr. 18, 2020
Dec. 31, 2019
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Net loss $ (3,648) $ (4,496)      
Cash and cash equivalents 16,813   $ 16,813   $ 5,265
Sale of equity or debt instruments $ 125,000        
Initial And Secondary Public Offerings [Member]          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Cumulative unrestricted net proceeds from common stock     $ 168,361    
Subsequent Event [Member] | Revolving Credit Facility [Member]          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Related party revolving credit facility       $ 10,000  
Subsequent Event [Member] | Paycheck Protection Program Loan [Member]          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Unrestricted cash proceeds in connection with loan       $ 2,194  
v3.20.1
Concentration of Credit Risk - Additional Information (Detail) - Five Most Significant Customers [Member] - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Revenue, Major Customer [Line Items]      
Accounts receivable from significant customers $ 1,775   $ 3,230
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]      
Revenue, Major Customer [Line Items]      
Revenue concentration, by most significant customers 33.10% 30.90%  
v3.20.1
Equity-Based Compensation - Summary of Activity for Restricted Stock Awards (Detail) - Restricted Stock [Member] - $ / shares
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Restricted Shares, outstanding, Beginning Balance 66,513 67,001
Number of Restricted Shares, granted 37,500 30,000
Number of Restricted Shares, vested (35,500) (27,500)
Number of Restricted Shares, forfeited 0 0
Number of Restricted Shares, outstanding, Ending Balance 68,513 69,501
Number of Restricted Shares, expected to vest 68,513 69,501
Weighted Average Grant Date Fair Value, Beginning Balance $ 8.76 $ 8.30
Weighted Average Grant Date Fair Value, granted 7.12 9.89
Weighted Average Grant Date Fair Value, vested 9.63 8.08
Weighted Average Grant Date Fair Value, forfeited 0 0
Weighted Average Grant Date Fair Value, Ending Balance 7.41 9.07
Weighted Average Grant Date Fair Value, expected to vest $ 7.41 $ 9.07
v3.20.1
Inventories - Additional Information (Detail) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Inventory Disclosure [Abstract]        
Allowance for slow-moving and obsolete inventories $ 3,370 $ 3,443 $ 4,177 $ 4,143
v3.20.1
Product Warranty Reserves - Additional Information (Detail)
3 Months Ended
Mar. 31, 2020
Product Warranties Disclosures [Abstract]  
Standard product warranty period Substantially all of the Company’s 3D printing machines are covered by a standard one-year warranty. Generally, at the time of sale, a liability is recorded (with an offset to cost of sales) based upon the expected cost of replacement parts and labor to be incurred over the life of the standard warranty.
v3.20.1
Condensed Consolidated Balance Sheet (Parenthetical) - $ / shares
Mar. 31, 2020
Dec. 31, 2019
Statement Of Financial Position [Abstract]    
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 16,386,487 16,346,960
Common stock, shares outstanding 16,386,487 16,346,960
v3.20.1
Liquidity
3 Months Ended
Mar. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Liquidity

Note 2. Liquidity

The Company has incurred a net loss in each of its annual periods since its inception. As shown in the accompanying condensed statement of consolidated operations and comprehensive loss, the Company incurred a net loss of $3,648 for the three months ended March 31, 2020. At March 31, 2020, the Company had $16,813 in unrestricted cash and cash equivalents.

In addition to its unrestricted cash and cash equivalents, the Company also has access to additional capital through its $10,000 related party revolving credit facility (Note 12). Also, on April 18, 2020, the Company received additional unrestricted cash proceeds of $2,194 in connection with a Paycheck Protection Program loan (Note 19).

Since its inception, the Company has received cumulative unrestricted net proceeds from the sale of its common stock (through its initial public offering and subsequent secondary offerings) of $168,361 to fund its operations. The Company maintains additional access to capital through its active shelf registration statement (Note 1) which allows for the sale of various equity or debt instruments up to an aggregate amount of $125,000. Future sales of securities through the Company’s active shelf registration are dependent on market conditions which may restrict the timing and extent of any future offering of securities by the Company.

The Company has previously exhibited its ability to modify its operating structure and support its liquidity position through various restructuring and other actions, including its 2018 global cost realignment program. In response to adverse market conditions associated with the COVID-19 global pandemic, beginning in March 2020 and through April 2020, the Company initiated various cost savings actions including a mix of employee terminations, furloughs and pay rate reductions, as well as reductions in consulting and other expenses, all in an effort to conserve cash and maintain adequate liquidity.  

Management believes that the Company’s existing capital resources will be sufficient to support the Company’s operating plan. If management anticipates that the Company’s actual results will differ from its operating plan, management believes it has sufficient capabilities to enact cost savings measures to preserve capital (in addition to those further described above). The Company may also seek to raise additional capital to support its growth through additional debt, equity or other alternatives (including asset sales) or a combination thereof.

v3.20.1
Leases - Schedule of Supplemental Information Related to Operating Lease Arrangements (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
Operating lease right-of-use assets $ 4,789 $ 432
Current portion of operating lease liabilities 1,684 158
Operating lease liabilities – net of current portion 3,105 $ 274
Right-of-use assets obtained in exchange for new operating lease liabilities 4,785  
Cash paid for amounts included in the measurement of operating lease liabilities $ 473  
Weighted average remaining lease term (in years) 2 years 9 months 18 days  
Weighted average discount rate 5.10%  
v3.20.1
Other (Income) Expense – Net (Tables)
3 Months Ended
Mar. 31, 2020
Other Income And Expenses [Abstract]  
Schedule of Other (Income) Expense – Net

Other (income) expense – net consisted of the following for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Interest income

 

$

(12

)

 

$

(6

)

Foreign currency (gains) losses – net

 

 

(165

)

 

 

22

 

Other – net

 

 

(13

)

 

 

(4

)

 

 

$

(190

)

 

$

12

 

v3.20.1
Leases (Tables)
3 Months Ended
Mar. 31, 2020
Leases [Abstract]  
Schedule of Future Minimum Lease Payments of Operating Leases Arrangements

Future minimum lease payments of operating lease arrangements (with initial terms greater than twelve months) at March 31, 2020, were as follows:

 

2020

 

$

1,419

 

2021

 

 

1,861

 

2022

 

 

1,827

 

2023

 

 

23

 

2024

 

 

11

 

Thereafter

 

 

2

 

Total minimum lease payments

 

 

5,143

 

Less: Present value discount

 

 

(354

)

Total operating lease liabilities

 

$

4,789

 

Schedule of Supplemental Information Related to Operating Lease Arrangements

Supplemental information related to operating lease arrangements was as follows as of and for the three months ended March 31, 2020:

 

Operating lease right-of-use assets

 

$

4,789

 

Current portion of operating lease liabilities

 

$

1,684

 

Operating lease liabilities  ̶  net of current portion

 

$

3,105

 

Right-of-use assets obtained in exchange for new operating lease liabilities

 

$

4,785

 

Cash paid for amounts included in the measurement of operating lease liabilities

 

$

473

 

Weighted average remaining lease term (in years)

 

 

2.8

 

Weighted average discount rate

 

 

5.1

%

Schedule of Operating and Sales-type Lease Arrangements

The Company recognized the following components under operating and sales-type lease arrangements in the accompanying condensed statement of consolidated operations and comprehensive loss for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

 

 

Operating

 

 

Sales-type

 

 

Operating

 

 

Sales-type

 

Revenue

 

$

208

 

 

$

 

 

$

320

 

 

$

 

Interest income(a)

 

$

 

 

$

18

 

 

$

 

 

$

28

 

 

(a)

Interest income relating to sales-type leases is recorded as a component of revenue in the accompanying condensed statement of consolidated operations and comprehensive loss for each of the periods presented.

Schedule of Net Investment in Sales-type Leases

The Company’s net investment in sales-type leases consisted of the following as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Future minimum lease payments receivable

 

$

1,624

 

 

$

1,595

 

Less: Allowance for doubtful accounts

 

 

(415

)

 

 

(424

)

Net future minimum lease payments receivable

 

 

1,209

 

 

 

1,171

 

Less: Unearned interest income

 

 

(208

)

 

 

(220

)

   Net investment in sales-type leases

 

$

1,001

 

 

$

951

 

Schedule of Future Minimum Lease Payment Receivable of Non-Cancellable Operating and Sales-type Lease

 

Future minimum lease payments of non-cancellable operating and sales-type lease arrangements at March 31, 2020 were as follows:

 

 

 

Operating

 

 

Sales-type

 

2020

 

$

432

 

 

$

411

 

2021

 

 

48

 

 

 

427

 

2022

 

 

 

 

 

378

 

2023

 

 

 

 

 

408

 

2024

 

 

 

 

 

 

Thereafter

 

 

 

 

 

 

Total minimum lease payments

 

$

480

 

 

$

1,624

 

Less: Allowance for doubtful accounts

 

 

 

 

 

 

(415

)

Less: Present value discount

 

 

 

 

 

 

(208

)

Future minimum lease payments receivable

 

 

 

 

 

$

1,001

 

v3.20.1
Cash, Cash Equivalents, and Restricted Cash (Tables)
3 Months Ended
Mar. 31, 2020
Cash And Cash Equivalents [Abstract]  
Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash The following provides a reconciliation of cash, cash equivalents, and restricted cash as reported in the accompanying condensed consolidated balance sheet to the same such amounts shown in the accompanying condensed statement of consolidated cash flows as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Cash and cash equivalents

 

$

16,813

 

 

$

5,265

 

Restricted cash

 

 

508

 

 

 

978

 

Cash, cash equivalents, and restricted cash

 

$

17,321

 

 

$

6,243

 

v3.20.1
Inventories
3 Months Ended
Mar. 31, 2020
Inventory Disclosure [Abstract]  
Inventories

Note 7. Inventories

Inventories consisted of the following as of the dates indicated:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Raw materials and components

 

$

9,374

 

 

$

8,841

 

Work in process

 

 

5,284

 

 

 

4,922

 

Finished goods

 

 

6,995

 

 

 

6,007

 

 

 

$

21,653

 

 

$

19,770

 

 

Raw materials and components consist of consumable materials and component parts and subassemblies associated with 3D printing machine manufacturing and support activities. Work in process consists of 3D printing machines and other products in varying stages of completion. Finished goods consist of 3D printing machines and other products prepared for sale in accordance with customer specifications.

At March 31, 2020 and December 31, 2019, the allowance for slow-moving and obsolete inventories was $3,370 and $3,443, respectively, and has been reflected as a reduction to inventories (principally raw materials and components). The following table summarizes changes in the allowance for slow-moving and obsolete inventories for the periods indicated:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Balance at beginning of period

 

$

3,443

 

 

$

4,143

 

Provision for slow-moving and obsolete inventories  ̶  net

 

 

22

 

 

 

107

 

Reductions for physical disposal (sale or scrap) of previously reserved

   amounts

 

 

(36

)

 

 

 

Foreign currency translation adjustments

 

 

(59

)

 

 

(73

)

Balance at end of period

 

$

3,370

 

 

$

4,177

 

 

v3.20.1
Contingencies and Commitments
3 Months Ended
Mar. 31, 2020
Commitments And Contingencies Disclosure [Abstract]  
Contingencies and Commitments

Note 11. Contingencies and Commitments

Contingencies

On March 1, 2018, the Company’s ExOne GmbH subsidiary notified Voxeljet AG that it had materially breached a 2003 Patent and Know-How Transfer Agreement and asserted its rights to set-off damages as a result of the breaches against the annual license fee due from the Company under the agreement. At this time, the Company cannot reasonably estimate a contingency, if any, related to this matter.

The Company is subject to various litigation, claims, and proceedings which have been or may be instituted or asserted from time to time in the ordinary course of business. Management does not believe that the outcome of any pending or threatened matters will have a material adverse effect, individually or in the aggregate, on the financial position, results of operations or cash flows of the Company.

Commitments

In the normal course of its operations, ExOne GmbH issues short-term financial guarantees and letters of credit to third parties in connection with certain commercial transactions requiring security through a credit facility with a German bank.

On February 24, 2020, ExOne GmbH entered into an amendment and replacement of its credit facility with a German bank. The credit facility amendments included the elimination of the overdraft credit and short-term loan features of the prior agreement and replaced them with an increased capacity amount of approximately $3,800 (€3,500) for the issuance of financial guarantees and letters of credit for commercial transactions requiring security. The cash collateral requirement for the issuance of financial guarantees and letters of credit for commercial transactions requiring security was eliminated for amounts up to approximately $1,100 (€1,000) as the amendment provided the German bank with a collateral interest in the accounts receivable of ExOne GmbH. Amounts in excess of approximately $1,100 (€1,000) continue to require cash collateral under the amended credit facility.

At March 31, 2020, total outstanding financial guarantees and letters of credit issued by ExOne GmbH under the amended credit facility were $863 (€785), with expiration dates ranging from October 2020 through February 2023. At December 31, 2019, total outstanding financial guarantees and letters of credit issued by ExOne GmbH under the former credit facility were $560 (€499).